Growthink logo white

Pharmaceutical Business Plan Template

Written by Dave Lavinsky

pharmaceutical business plan

Pharmaceutical Business Plan

Over the past 20+ years, we have helped over 500 entrepreneurs and business owners create business plans to start and grow their pharmaceutical companies.

If you’re unfamiliar with creating a pharmaceutical business plan, you may think creating one will be a time-consuming and frustrating process. For most entrepreneurs it is, but for you, it won’t be since we’re here to help. We have the experience, resources, and knowledge to help you create a great business plan.

In this article, you will learn some background information on why business planning is important. Then, you will learn how to write a pharmaceutical business plan step-by-step so you can create your plan today.

Download our Ultimate Business Plan Template here >

What is a Pharmaceutical Business Plan?

A business plan provides a snapshot of your pharmaceutical business as it stands today, and lays out your growth plan for the next five years. It explains your business goals and your strategies for reaching them. It also includes market research to support your plans.

Why You Need a Business Plan for a Pharmaceutical Company

If you’re looking to start a pharmaceutical business or grow your existing company, you need a business plan. A business plan will help you raise funding, if needed, and plan out the growth of your pharmaceutical company to improve your chances of success. Your business plan is a living document that should be updated annually as your company grows and changes.

Sources of Funding for Pharmaceutical Businesses

With regards to funding, the main sources of funding for a pharmaceutical business are personal savings, credit cards, bank loans, and angel investors. When it comes to bank loans, banks will want to review your business plan and gain confidence that you will be able to repay your loan and interest. To acquire this confidence, the loan officer will not only want to ensure that your financials are reasonable, but they will also want to see a professional plan. Such a plan will give them the confidence that you can successfully and professionally operate a business. Personal savings and bank loans are the most common funding paths for pharmaceutical businesses.

Finish Your Business Plan Today!

How to write a business plan for a pharmaceutical company.

If you want to start a pharmaceutical company or expand your current one, you need a business plan. The guide below details the necessary information for how to write each essential component of your pharmaceutical business plan.

Executive Summary

Your executive summary provides an introduction to your business plan, but it is normally the last section you write because it provides a summary of each key section of your plan.

The goal of your executive summary is to quickly engage the reader. Explain to them the kind of pharmaceutical business you are running and the status. For example, are you a startup, do you have a company that you would like to grow, or are you operating pharmaceutical companies in multiple markets?

Next, provide an overview of each of the subsequent sections of your plan.

  • Give a brief overview of the pharmaceutical industry.
  • Discuss the type of pharmaceutical business you are operating.
  • Detail your direct competitors. Give an overview of your target customers.
  • Provide a snapshot of your marketing strategy. Identify the key members of your team.
  • Offer an overview of your financial plan.

Company Overview

In your company overview, you will detail the type of pharmaceutical company you are operating.

For example, you might specialize in one of the following types of pharmaceutical businesses:

  • Generic Pharmaceutical Manufacturing : this type of pharmaceutical business develops prescription or over-the-counter drugs products that do not have patent protection.
  • Vitamin & Supplement Manufacturing: this type of pharmaceutical company primarily develops products that contain ingredients intended to supplement the diet.
  • Brand Name Pharmaceutical Manufacturing: this type of pharmaceutical business engages in significant research and development of patent-protected prescription and over-the-counter medications.

In addition to explaining the type of pharmaceutical business you will operate, the company overview needs to provide background on the business.

Include answers to questions such as:

  • When and why did you start the business?
  • What milestones have you achieved to date? Milestones could include the number of patents awarded, the extent of your product portfolio, reaching X number of distributors under contract, etc.
  • Your legal business Are you incorporated as an S-Corp? An LLC? A sole proprietorship? Explain your legal structure here.

Industry Analysis

In your industry or market analysis, you need to provide an overview of the pharmaceutical industry.

While this may seem unnecessary, it serves multiple purposes.

First, researching the pharmaceutical industry educates you. It helps you understand the market in which you are operating.

Secondly, market research can improve your marketing strategy, particularly if your analysis identifies market trends.

The third reason is to prove to readers that you are an expert in your industry. By conducting the research and presenting it in your plan, you achieve just that.

The following questions should be answered in the industry analysis section:

  • How big is the pharmaceutical industry (in dollars)?
  • Is the market declining or increasing?
  • Who are the key competitors in the market?
  • Who are the key suppliers in the market?
  • What trends are affecting the industry?
  • What is the industry’s growth forecast over the next 5 – 10 years?
  • What is the relevant market size? That is, how big is the potential target market for your pharmaceutical company? You can extrapolate such a figure by assessing the size of the market in the entire country and then applying that figure to your local population.

Customer Analysis

The customer analysis section of your business plan must detail the customers you serve and/or expect to serve.

The following are examples of customer segments: healthcare providers, chain pharmacies, independent retailers, and consumers.

As you can imagine, the customer segment(s) you choose will have a great impact on the type of pharmaceutical business you operate. Clearly, individuals would respond to different marketing promotions than hospitals, for example.

Try to break out your target customers in terms of their demographic and psychographic profiles. With regards to demographics, including a discussion of the ages, genders, locations, and income levels of the potential customers you seek to serve.

Psychographic profiles explain the wants and needs of your target customers. The more you can recognize and define these needs, the better you will do in attracting and retaining your customers.

Finish Your Pharmaceutical Business Plan in 1 Day!

Don’t you wish there was a faster, easier way to finish your business plan?

With Growthink’s Ultimate Business Plan Template you can finish your plan in just 8 hours or less!

Competitive Analysis

Your competitive analysis should identify the indirect and direct competitors your business faces and then focus on the latter.

Direct competitors are other pharmaceutical businesses.

Indirect competitors are other options that customers have to purchase from that aren’t directly competing with your product or service. This includes imported alternatives, herbal remedies, or customers’ nutritional self-care. You need to mention such competition as well.

For each such competitor, provide an overview of their business and document their strengths and weaknesses. Unless you once worked at your competitors’ businesses, it will be impossible to know everything about them. But you should be able to find out key things about them such as

  • What types of products do they manufacture?
  • What are their research and development capabilities?
  • What is their pricing (premium, low, etc.)?
  • What are they good at?
  • What are their weaknesses?

With regards to the last two questions, think about your answers from the customers’ perspective. And don’t be afraid to ask your competitors’ customers what they like most and least about them.

The final part of your competitive analysis section is to document your areas of competitive advantage. For example:

  • Will you provide product development?
  • Will you offer products or services that your competition doesn’t?
  • Will you provide better customer service?
  • Will you offer better pricing?

Think about ways you will outperform your competition and document them in this section of your plan.  

Marketing Plan

Traditionally, a marketing plan includes the four P’s: Product, Price, Place, and Promotion. For a pharmaceutical company, your marketing strategy should include the following:

Product : In the product section, you should reiterate the type of pharmaceutical business that you documented in your company overview. Then, detail the specific products or services you will be offering. For example, will you manufacture patent-protected prescription medications, or a range of vitamins?

Price : Document the prices you will offer and how they compare to your competitors. Essentially in the product and price sub-sections of your plan, you are presenting the products and/or services you offer and their prices.

Place : Place refers to the site of your pharmaceutical business. Document where your company is situated and mention how the site will impact your success. For example, is your pharmaceutical company located in an industrial district, near a major medical and/or scientific hub, or near input markets? Discuss how your site might be the ideal location for your customers.

Promotions : The final part of your pharmaceutical marketing plan is where you will document how you will drive potential customers to your location(s). The following are some promotional methods you might consider:

  • Advertise in local papers, radio stations and/or magazines
  • Advertise in trade publications
  • Reach out to websites
  • Distribute flyers
  • Engage in email marketing
  • Advertise on social media platforms
  • Improve the SEO (search engine optimization) on your website for targeted keywords

Operations Plan

While the earlier sections of your business plan explained your goals, your operations plan describes how you will meet them. Your operations plan should have two distinct sections as follows.

Everyday short-term processes include all of the tasks involved in running your pharmaceutical company, including meeting with potential customers, creating and distributing product information, developing and manufacturing products, etc.

Long-term goals are the milestones you hope to achieve. These could include the dates when you expect to produce your Xth product, or when you hope to reach $X in revenue. It could also be when you expect to expand your pharmaceutical business to a new city.  

Management Team

To demonstrate your pharmaceutical company’s potential to succeed, a strong management team is essential. Highlight your key players’ backgrounds, emphasizing those skills and experiences that prove their ability to grow a company.

Ideally, you and/or your team members have direct experience in managing pharmaceutical businesses. If so, highlight this experience and expertise. But also highlight any experience that you think will help your business succeed.

If your team is lacking, consider assembling an advisory board. An advisory board would include 2 to 8 individuals who would act as mentors to your business. They would help answer questions and provide strategic guidance. If needed, look for advisory board members with experience in managing a pharmaceutical business or successfully running a R&D company.  

Financial Plan

Your financial plan should include your 5-year financial statement broken out both monthly or quarterly for the first year and then annually. Your financial statements include your income statement, balance sheet, and cash flow statements.

Income Statement

An income statement is more commonly called a Profit and Loss statement or P&L. It shows your revenue and then subtracts your costs to show whether you turned a profit or not.

In developing your income statement, you need to devise assumptions including your sales projections. For example, will you manufacture a line of general sales products, or will you specialize in manufacturing controlled drugs? And will sales grow by 2% or 10% per year? As you can imagine, your choice of assumptions will greatly impact the financial forecasts for your business. As much as possible, conduct research to try to root your assumptions in reality.

Balance Sheets

Balance sheets show your assets and liabilities. While balance sheets can include much information, try to simplify them to the key items you need to know about. For instance, if you spend $50,000 on building out your pharmaceutical company, this will not give you immediate profits. Rather it is an asset that will hopefully help you generate profits for years to come. Likewise, if a lender writes you a check for $50,000, you don’t need to pay it back immediately. Rather, that is a liability you will pay back over time.

Cash Flow Statement

Your cash flow statement will help determine how much money you need to start or grow your business, and ensure you never run out of money. What most entrepreneurs and business owners don’t realize is that you can turn a profit but run out of money and go bankrupt.

When creating your Income Statement and Balance Sheets be sure to include several of the key costs needed in starting or growing a pharmaceutical company:

  • Cost of equipment and supplies
  • Payroll or salaries paid to staff
  • Business insurance
  • Other start-up expenses (if you’re a new business) like legal expenses, permits, computer software, and equipment

Attach your full financial projections in the appendix of your plan along with any supporting documents that make your plan more compelling. For example, you might include your facility blueprint or a list of products you manufacture.  

Writing a business plan for your pharmaceutical business is a worthwhile endeavor. If you follow the template above, by the time you are done, you will truly be an expert. You will understand the pharmaceutical company industry, your competition, and your customers. You will develop a marketing strategy and will understand what it takes to launch and grow a successful pharmaceutical company.  

Pharmaceutical Business Plan Template FAQs

What is the easiest way to complete my pharmaceutical business plan.

Growthink's Ultimate Business Plan Template allows you to quickly and easily write your pharmaceutical business plan.

How Do You Start a Pharmaceutical Business?

Starting a pharmaceutical business is easy with these 14 steps:

  • Choose the Name for Your Pharmaceutical Business
  • Create Your Pharmaceutical Business Plan
  • Choose the Legal Structure for Your Pharmaceutical Business
  • Secure Startup Funding for Your Pharmaceutical Business (If Needed)
  • Secure a Location for Your Business
  • Register Your Pharmaceutical Business with the IRS
  • Open a Business Bank Account
  • Get a Business Credit Card
  • Get the Required Business Licenses and Permits
  • Get Business Insurance for Your Pharmaceutical Business
  • Buy or Lease the Right Pharmaceutical Business Equipment
  • Develop Your Pharmaceutical Business Marketing Materials
  • Purchase and Setup the Software Needed to Run Your Pharmaceutical Business
  • Open for Business

Don’t you wish there was a faster, easier way to finish your Pharmaceutical business plan?

OR, Let Us Develop Your Plan For You

Since 1999, Growthink has developed business plans for thousands of companies who have gone on to achieve tremendous success.   Click here to see how Growthink’s business plan writers can create your business plan for you.

Other Helpful Business Plan Articles & Templates

Business Plan Template For Small Businesses & Entrepreneurs

  • Sample Business Plans
  • Medical & Health Care

Pharmacy Business Plan

Executive summary image

Many pharmacists dream of opening their pharmacies. But more often than not, the collection of funds and resources becomes an overwhelming and off-putting process.

But it doesn’t need to be. A pharmacy business plan can help you at every step of setting up your pharmacy business.

If you are planning to start a new pharmacy business, the first thing you will need is a business plan. Use our sample Pharmacy Business Plan created using Upmetrics business plan software to start writing your business plan in no time.

Before you start writing a business plan, spend as much time as you can reading through some samples of medical and health-related business plans .

Industry Overview

The pharmaceutical industry stood at a market value of 1.27 trillion dollars in 2020 and has shown remarkable growth in the past two decades.

The advancement of research and development in the medical field has played a significant role in the growth of the pharmaceutical industry. Also, better production and distribution have changed the way people get medicines.

From online pharmacies to home deliveries, the face of the pharmacy industry has changed and become more convenient.

Also, with the growth of access to information, it has become more competitive too. But if done the right way, the pharmacy business is an extremely profitable one as well.

Say goodbye to boring templates

Build your business plan faster and easier with AI

Plans starting from $7/month

CTA Blue

Things to Consider Before Writing a Pharmacy Store Business Plan

Check your legal requirements.

A pharmacy business requires a fair amount of licenses and permits. It is good to have a checklist of all the required licenses and to see if you have to get any of them.

Research what permits your state requires as well as the ones mandatory for everyone. It helps you stay on the good side of the law.

Pick a good location

A pharmacy setup requires a fixed minimum area. Also, a pharmacy that is easily accessible is more likely to succeed than one which is unreachable during emergencies. Hence, picking a good location is important .

Also, you can pick between starting a physical store or going online. Both business structures would have their pros and cons. You should pick the one that is the best for you.

Have a proper storage facility

Different medicines and formulas have different storage requirements. You’ll keep most of them in cool and dry places though. Bad storage can cost a pharmacy business dearly, even if you do everything else right.

Hence, it is important to have a good and ideal storage facility before you get started.

Check if your staff has the proper technical knowledge

You need technical knowledge and attention to detail to fare well as a pharmacist and so does your staff. As dealing with medicines is quite a critical job and can have consequences if not done right, it is important to find staff who know what they are doing and are well-trained and up to the job.

After you figure out some of the technical requirements, it is essential to figure out the business side of running a pharmacy. Planning, in the beginning, can save you from a lot of trouble later on.

Chalking Out Your Business Plan

A business plan helps you stay prepared for challenges, make better decisions, and formulate better business strategies. A pharmacy business takes a fair amount of legal procedures and competitive strategies, a pharmacy business plan can help you with that.

Reading some sample business plans will give you a good idea of what you’re aiming for. Also, it will show you the different sections that different entrepreneurs include and the language they use to write about themselves and their business plans.

We have created this sample pharmacy business plan for you to get a good idea about how perfect a pharmacy business plan should look and what details you will need to include in your stunning business plan.

Pharmacy Business Plan Outline

This is the standard business plan outline which will cover all important sections that you should include in your business plan.

  • Keys to Success
  • Business Ownership
  • Summary Chart
  • Business Model Description
  • Mail order customers
  • Walk-in customers
  • Target Market Analysis
  • Target Market Segment Strategy
  • Competitive Edge
  • Marketing Strategy
  • Sales Forecast
  • Development Requirements
  • Personnel Plan
  • Important Assumptions
  • Break-even Analysis
  • Projected Profit and Loss
  • Projected Cash Flow
  • Balance Sheet

Let’s understand how you can write each section of the pharmacy business plan.

1. Executive Summary

The executive summary section forms the first page of your business plan. It summarises all that your business stands for.

The executive summary section consists of the following subsegments:

  • Objectives : This segment consists of the reason you started your business in the first place. What is your idea behind it and what problem do you plan on solving with it?
  • Mission : Your mission statement should reflect how your pharmacy business can help people, apart from providing them with medicines. It reflects how your idea can deal with a problem more optimally.
  • Financial Summary : This section would consist of the funding requirements of your business, and how the said funds would be put to use. It serves the main purpose of the executive summary, which is to get your business funded.

As a pharmacy business, your executive summary would consist of the type and size of your pharmacy business, your team, your qualifications and licenses, and a summary of your financial plan.

2. Products and Services

This section consists of a description of all the products and services your pharmacy offers.

For example, apart from your general products, this section can also consist of services your pharmacy offers like home delivery of medicines, subscription packages, online orders, etc.

3. Market Analysis

Market analysis helps you understand what you are getting yourself into. It also helps you make sense of all the research you have done and how you can put it to use for your business.

It consists of the following subsegments:

  • Market Segmentation : Through market segmentation, you separate your target audience from the rest of the market based on their age, gender, income, occupation, medical conditions, etc.
  • Market Positioning : In this segment, you can add an analysis of where you stand in the current market. And what would be the best marketing strategy for you as per your position?
  • Target Market Analysis : In this section, you’ll write down an analysis of your target market, and their tastes and preferences.

As a pharmacy business, you can list down the type of pharmacy you own, your target customer base, the kind of services they like, the location they’ll prefer, and how they buy their medical supplies.

4. Strategy And Implementation

After you carry out market analysis, the next step would be to create a marketing strategy based on the same. This section helps you promote your business to your target audience.

This section consists of the following subsegments:

  • Competitive Edge : Include your competitive advantage in this section. Include how your product is better than your competitor’s and how you’ll use that to your advantage.
  • Marketing Strategy : Your marketing strategy should speak to your target audience. Your campaign should show your customers how your business solves a pressing problem.
  • Sales Strategy : A sales strategy should be formulated after surveying what works best for your specific industry.

As a pharmacy business, you can center your marketing around safe products, better service, and availability. According to various surveys, KAM, clinical sales force, and service rep model are three of the most successful strategies for pharmacies.

5. Web Plan

With everything going online, a website strategy is of utmost importance. With online pharmacies like mail, my prescriptions, and Amazon pharmacy coming up, having an online presence is crucial to being seen by your consumers.

Moreover, an eCommerce website can also serve as a good alternative if you don’t want to go through the hassle of owning a physical store.

Nonetheless, building your online presence can help you in getting noticed. It is also a good method of promoting your brand idea.

6. Financial Plan

This section would consist of everything about your company’s finances. From your financial history to your projected profits, your financial plan would cover it all.

A good financial plan helps your business survive and thrive.

This segment consists of the following subsegments:

  • Financial Resources : This segment would consist of the investment you can put in your business, as well as other resources for meeting your funding requirements.
  • Funding Requirements : This would consist of the funding requirements to set up your pharmacy and keep it going.
  • Projected Cash Flow and Profits : This section would consist of your business’s expected cash flow and profits in the long term.

Download a sample pharmacy business plan

Need help writing your business plan from scratch? Here you go;  download our free pharmacy business plan pdf  to start.

It’s a modern business plan template specifically designed for your pharmacy business. Use the example business plan as a guide for writing your own.

The Quickest Way to turn a Business Idea into a Business Plan

Fill-in-the-blanks and automatic financials make it easy.

crossline

Pharmacy Business Plan Summary

In conclusion, though a pharmacy business might take a lot of work, you can make running your business a lot easier and smoother with a business plan.

A business plan helps you stay organized and updated as per market trends and changing environment of the industry.

After getting started with Upmetrics , you can copy this sample pharmacy business plan template into your business plan and modify the required information and download your pharmacy business plan pdf or doc file.

It’s the fastest and easiest way to start writing your business plan.

Related Posts

Telemedicine Business Plan

Telemedicine Business Plan

Medical Billing Business Plan

Medical Billing Business Plan

400+ business plan example

400+ business plan example

Urgent Care Business Plan

Urgent Care Business Plan

Table of Contents in Business Plan

Table of Contents in Business Plan

Guide for Customer Analysis in Business Plan

Guide for Customer Analysis in Business Plan

About the Author

business plan for pharmaceutical products

Upmetrics Team

Upmetrics is the #1 business planning software that helps entrepreneurs and business owners create investment-ready business plans using AI. We regularly share business planning insights on our blog. Check out the Upmetrics blog for such interesting reads. Read more

Plan your business in the shortest time possible

No Risk – Cancel at Any Time – 15 Day Money Back Guarantee

bpb AI Feature Image

Create a great Business Plan with great price.

  • 400+ Business plan templates & examples
  • AI Assistance & step by step guidance
  • 4.8 Star rating on Trustpilot

Streamline your business planning process with Upmetrics .

Download Pharmacy Business Plan

ProfitableVenture

Pharmaceutical Company Business Plan [Sample Template]

By: Author Tony Martins Ajaero

Home » Business Plans » Medical and Healthcare » Pharmacy

Drug Manufacturing Pharmaceutical Business

Are you about starting a pharmaceutical company? If YES, here is a complete sample pharmaceutical business plan template & feasibility report you can use for FREE .

If you are pharmacist and you are certain that you have a winning formula when it comes to producing effective generic drugs; drugs / medicine that has been tested and proven to meet the requirement for such products, then you should consider launching your own generic pharmaceutical manufacturing company.

It is a business that is still pretty much open for investors to come and compete for the available market in the country you intend launching the business.

A Sample Pharmaceutical Company Business Plan Template

1. industry overview.

The Generic pharmaceutical and medicine manufacturing companies primarily develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals.

Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs.

It is important to mention that the generic pharmaceutical manufacturing industry does not include manufacturers of nutritional supplements, cosmetic beauty products or similar products.

All over the world, the pharmaceutical industry is highly regulated. This is so because the devastating effect of fake drugs or drug abuse can’t be quantified.

As a matter of fact, there are several universal laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.

For example, in the united states, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) as being both safe and effective before they can be allowed to go into the market.

Statistics has it that global spending on prescription drugs grew to a whopping sum of $954 billion in 2011 and The United States accounts for more than a third of the global pharmaceutical market, with an estimate of $340 billion in annual sales

The Generic Pharmaceutical Manufacturing Industry is a thriving sector of the economy of countries like India, China, united kingdom , Germany and the United States of America.

Statistics has it that in the united states alone, the industry generates a whooping sum of well over $66 billion annually from more than 1,203 registered and licensed generic pharmaceutical manufacturing companies scattered all around the United States of America.

The industry is responsible for the employment of well over 67,699 people. Experts project the industry to grow at a 4.1 percent annual rate from 2011 to 2016. Mylan Inc., Sandoz Ltd. and Teva Pharmaceuticals Industries Ltd. have the lion share of the available market in the Generic Pharmaceutical manufacturing industry in the United States of America.

A close study of the Generic Pharmaceutical Manufacturing industry shows that the industry is expanding rapidly. This is due to the demand for the industry’s products by the aging population with more chronic illnesses.

So also, with the regulatory provisions of the Patient Protection and Affordable Care Act expand consumer access to prescription insurance and provide increased opportunities for product development.

Going forward, the industry revenue growth is expected to outpaced revenue growth for the Brand Name Pharmaceutical Manufacturing industry.

A large number of brand name drugs manufacturers lost patent protection for blockbuster drugs beginning in 2010; demand for generics subsequently grew, as consumers demanded affordable versions of these high-profile products. These trends are expected to continue in the next five years.

A recent report published by IBISWORLD shows that the Generic Pharmaceutical Manufacturing industry has a low level of concentration, with the top four companies accounting for 30.2 percent of industry revenue in 2016.

Having a large operation as a generic manufacturer does not offer the same advantages as it does for brand name producers.

The report further stated that generic drug manufacturers can be smaller because the cost of research and development is significantly lower than it is for brand name companies; however, operators can still benefit from economies of scale through savings on administrative and capital costs.

Moreover, a company’s presence in both generic and brand drug markets can buffer company revenue against volatility in price or demand for any one specific drug.

The bottom line is that; the Generic Pharmaceutical Manufacturing industry is still very much open for new entrant; the competition within the industry is not as stiff as similar industry.

If your product is good, it can gain fair share of the available market in any country or region you intend launching the business.

2. Executive Summary

Harry Tancredo® Pharmaceuticals, LLC is a licensed and standard generic pharmaceutical manufacturing company that will be located in an industrial area in Concord – New Hampshire.

We have been able to secure a long-term lease agreement for a facility in a strategic location with an option of a long-term renewal on an agreed terms and conditions that is favorable to us.

The facility has government approval for the kind of production business we want to run and the facility is easily accessible and we are deliberate about that because we want to facilitate easy movement of raw materials (chemicals and packaging containers) and finished products (drugs / medicines).

Harry Tancredo® Pharmaceuticals, LLC is in the generic pharmaceutical manufacturing industry to engage in developing and producing generic drugs, marketing and distributing generic drugs and gaining regulatory approval for generic drugs.

We will manufacture standard and effective pharmaceutical products such as mental health and lipid regulators, anti diabetics and respiratory, pain and antibacterial, nervous system disorders and antihypertensive, antiulcerants and thyroid, dermatological and hormonal contraceptives, and ADHD and anticoagulants.

We are also in business to make profits at the same to give our customers value for their money; we want to give people and businesses who patronize our pharmaceutical products the opportunity to be part of the success story of our brand.

We are aware that there are several big scale and small scale generic pharmaceutical manufacturing companies scattered all around the United States and Canada whose products can be found in every nooks and crannies of The United States and Canada, which is why we spent time and resources to conduct our feasibility studies and market survey so as to enable us locate the business in an area that can easily accept our products and brand.

We ensured that our facility is easy to locate and we have mapped out plans to develop a far-reaching distribution network for wholesalers of pharmaceutical products all around Concord – New Hampshire and throughout the United States of America.

Much more than producing quality, effective and safe generic pharmaceutical products, our customer care is going to be second to none.

We know that our customers are the reason why we are in business which is why we will go the extra mile to get them satisfied when they purchase any of our product and also to become our loyal customers and ambassadors.

Harry Tancredo® Pharmaceuticals, LLC will ensure that all our customers (wholesale distributors) are given first class treatment whenever they visit our factory.

We have a CRM software that will enable us manage a one on one relationship with our customers (wholesale distributors) no matter how large the numbers of our customer base may grow to.

We will ensure that we get our customers involved when making some business decisions that will directly or indirectly affect them. Harry Tancredo® Pharmaceuticals, LLC is family business that will be owned by Harry Tancredo and his immediate family members.

Harry Tancredo who is the Chief Executive Officer of the Company is Graduate of Pharmacology and he holds a Master’s Degree in Business Management (MBA).

He has well over 12 years of experience working in related industry as a senior production manager prior to starting Harry Tancredo® Pharmaceuticals, LLC. He will be working with a team of professionals to build the business and grow it to enviably height.

3. Our Products and Services

Harry Tancredo® Pharmaceuticals, LLC is going to run a standard and licensed generic pharmaceutical manufacturing company whose products will not only be sold in Hartford – Connecticut but also throughout the United States of America and Canada.

We are in the generic pharmaceutical manufacturing industry to make profits and also to give our customers value for their money.

We will ensure that we do all that is permitted by the law in the United States of America to accomplish our business goal and objective. These are some of the products that we will be offering;

  • Developing and producing generic drugs
  • Marketing and distributing generic drugs
  • Gaining regulatory approval for generic drugs
  • Mental health and lipid regulators
  • Anti-diabetics and respiratory
  • Pain and antibacterial
  • Nervous system disorders and antihypertensive
  • Anti-ulcerants and thyroid
  • Dermatological and hormonal contraceptives
  • ADHD and anticoagulants

4. Our Mission and Vision Statement

  • Our vision is to establish a standard generic pharmaceutical manufacturing Company whose products will be not only be sold in Concord – New Hampshire, but also throughout the United States of America and Canada.
  • Our mission is to establish a standard and world class generic pharmaceutical manufacturing Company / brand that in our own capacity will favorably compete with leaders in the industry.
  • We want to build a business that will be listed amongst the top 20 generic pharmaceutical manufacturing brands in the United States of America and Canada.

Our Business Structure

Harry Tancredo® Pharmaceuticals, LLC is a business that is established with the aim of competing favorably with other leading generic pharmaceutical product brands in the industry.

This is why we will ensure that we put the right structure in place that will support the kind of growth that we have in mind while setting up the business.

We will ensure that we only hire people that are qualified, honest, hardworking, customer centric and are ready to work to help us build a prosperous business that will benefit all the stakeholders (the owners, workforce, and customers).

As a matter of fact, profit-sharing arrangement will be made available to all our senior management staff and it will be based on their performance for a period of five years or more depending how fast we meet our set target. In view of that, we have decided to hire qualified and competent hands to occupy the following positions;

  • Chief Executive Officer (Owner)

Production / Plant Manager

Human Resources and Admin Manager

Merchandize Manager

Sales and Marketing Manager

  • Machine Operators
  • Accountants / Cashiers

Distribution Truck Drivers

5. Job Roles and Responsibilities

Chief Executive Officer – CEO (Owner):

  • Increases management’s effectiveness by recruiting, selecting, orienting, training, coaching, counseling, and disciplining managers; communicating values, strategies, and objectives; assigning accountabilities; planning, monitoring, and appraising job results; developing incentives; developing a climate for offering information and opinions; providing educational opportunities.
  • Creates, communicates, and implements the organization’s vision, mission, and overall direction – i.e. leading the development and implementation of the overall organization’s strategy.
  • Responsible for fixing prices and signing business deals
  • Responsible for providing direction for the business
  • Responsible for signing checks and documents on behalf of the company
  • Evaluates the success of the organization.
  • Responsible for overseeing the smooth running of the pharmaceutical production plant
  • Part of the team that determines the quantity and quality of pharmaceutical products that are to be produced
  • Maps out strategy that will lead to efficiency amongst workers in the plant
  • Responsible for training, evaluation and assessment of plant workers
  • Ensures that the steady flow of both raw materials to the plant and easy flow of finished products through wholesale distributors to the market
  • Ensures operation of equipment by completing preventive maintenance requirements; calling for repairs.
  • Ensures that the plant meets the expected safety and health standard at all times.
  • Responsible for overseeing the smooth running of HR and administrative tasks for the organization
  • Updates job knowledge by participating in educational opportunities; reading professional publications; maintaining personal networks; participating in professional organizations.
  • Enhances department and organization reputation by accepting ownership for accomplishing new and different requests; exploring opportunities to add value to job accomplishments.
  • Defines job positions for recruitment and managing interviewing process
  • Carries out staff induction for new team members
  • Responsible for training, evaluation and assessment of employees
  • Oversees the smooth running of the daily office and factory activities.
  • Manages vendor relations, market visits, and the ongoing education and development of the organizations’ buying teams
  • Responsible for the purchase of raw materials and packaging materials
  • Responsible for planning sales, monitoring inventory, selecting the merchandise, and writing and pricing orders to vendors
  • Ensures that the organization operates within stipulated budget.
  • Manages external research and coordinate all the internal sources of information to retain the organizations’ best customers and attract new ones
  • Models demographic information and analyze the volumes of transactional data generated by customer purchases
  • Identifies, prioritizes, and reaches out to new partners, and business opportunities et al
  • Responsible for supervising implementation, advocate for the customer’s needs, and communicate with clients
  • Develops, executes and evaluates new plans for expanding increase sales
  • Documents all customer contact and information
  • Represents the company in strategic meetings
  • Helps to increase sales and growth for the company

Accountant / Cashier

  • Responsible for preparing financial reports, budgets, and financial statements for the organization
  • Provides managements with financial analyses, development budgets, and accounting reports; analyzes financial feasibility for the most complex proposed projects; conducts market research to forecast trends and business conditions.
  • Responsible for financial forecasting and risks analysis.
  • Performs cash management, general ledger accounting, and financial reporting
  • Responsible for developing and managing financial systems and policies
  • Responsible for administering payrolls
  • Ensuring compliance with taxation legislation
  • Handles all financial transactions for the organization
  • Serves as internal auditor for the organization

Client Service Executive

  • Welcomes guests and clients by greeting them in person or on the telephone; answering or directing inquiries.
  • Ensures that all contacts with clients (e-mail, walk-In center, SMS or phone) provides the client with a personalized customer service experience of the highest level
  • Through interaction with clients on the phone, uses every opportunity to build client’s interest in the company’s products and services
  • Manages administrative duties assigned by the manager in an effective and timely manner
  • Consistently stays abreast of any new information on the company’s products, promotional campaigns etc. to ensure accurate and helpful information is supplied to clients
  • Receives parcels / documents for the company
  • Distribute mails in the organization
  • Handles any other duties as assigned by the line manager

Production Workers / Machine Operators:

  • Responsible for preparing, blending, compounding and packaging pharmaceutical products
  • Handle labeling of pharmaceutical products
  • Operate machines used in the manufacturing mental health and lipid regulators, ant diabetics and respiratory, pain and antibacterial, nervous system disorders and antihypertensive, antiulcerants and thyroid, dermatological and hormonal contraceptives, and ADHD and anticoagulants
  • Assist in packaging and loading pharmaceutical products into distribution trucks
  • Assists in loading and unloading pharmaceutical products
  • Maintains a logbook of their driving activities to ensure compliance with federal regulations governing the rest and work periods for operators.
  • Keeps a record of vehicle inspections and make sure the truck is equipped with safety equipment
  • Assists the transport and logistics manager in planning their route according to a delivery schedule.
  • Local-delivery drivers may be required to sell products or services to pharmaceutical stores and businesses on their route, obtain signatures from recipients and collect cash.
  • Transports finished goods and raw materials over land to and from manufacturing plants or retail and distribution centers
  • Inspect vehicles for mechanical items and safety issues and perform preventative maintenance
  • Complies with truck driving rules and regulations (size, weight, route designations, parking, break periods etc.) as well as with company policies and procedures
  • Collects and verifies delivery instructions
  • Reports defects, accidents or violations

6. SWOT Analysis

We are quite aware that there are several generic pharmaceutical manufacturing companies both large and small in the United States of America and Canada which is why we are following the due process of establishing a business so as to compete favorable with them.

We know that if a proper SWOT analysis is conducted for our business, we will be able to position our business to maximize our strength, leverage on the opportunities that will be available to us, mitigate our risks and be welled equipped to confront our threats.

Harry Tancredo® Pharmaceuticals, LLC employed the services of an expert HR and Business Analyst with bias in start – up business to help us conduct a thorough SWOT analysis and to help us create a Business model that will help us achieve our business goals and objectives. This is the summary of the SWOT analysis that was conducted for Harry Tancredo® Pharmaceuticals, LLC;

Part of what is going to count as positives for Harry Tancredo® Pharmaceuticals, LLC is the vast experience of our management team, we have people on board who are highly experienced and understands how to grow business from the scratch to becoming a national phenomenon.

So also, our state of the art machines and equipment, the wide varieties of pharmaceutical products that we produce, our large national distribution network and of course our excellent customer service culture will definitely count as a strong strength for the business.

A major weakness that may count against us is the fact that we are a new generic pharmaceutical manufacturing company in the United States and we don’t have the financial capacity to engage in the kind of publicity that we intend giving the business especially when big names like Mylan Inc., Sandoz Ltd. and Teva Pharmaceuticals Industries Ltd. et al are already determining the direction of the market both in the United States and in the global market.

  • Opportunities:

The opportunities available to generic pharmaceutical manufacturing companies with a wide range of products are enormous. This is due to the fact that almost all Americans and people from all over the world take drugs / medicine for different reasons.

As a result of that, we were able to conduct a thorough market survey and feasibility studies so as to position our business to take advantage of the existing market for pharmaceutical products and also to create our own new market. We know that it is going to requires hard work, and we are determined to achieve it.

We are quite aware that just like any other business, one of the major threats that we are likely going to face are economic downturn and unfavorable government policies . It is a fact that economic downturn affects purchasing power. Another threat that may likely confront us is the arrival of a new generic pharmaceutical manufacturing company in same location where ours is located.

7. MARKET ANALYSIS

  • Market Trends

A close study of the trends in the Generic Pharmaceutical Manufacturing industry shows that the industry is expanding rapidly. This is due to the demand for the industry’s products by the aging population with more chronic illnesses.

So also, with the regulatory provisions of the Patient Protection and Affordable Care Act expand consumer access to prescription insurance and provide increased opportunities for product development. Going forward, the industry revenue growth is expected to outpaced revenue growth for the Brand Name Pharmaceutical Manufacturing industry.

Lastly, the generic pharmaceutical manufacturing industry is the adoption of eco – friendly approach towards the production and packaging of its products. As a matter of fact, the industry’s adoption of eco-friendly practices will likely persuade environmentally conscious consumers to buy its products, while increasing operators’ efficiency.

8. Our Target Market

When it comes to selling pharmaceutical products, there is indeed a wide range of available customers. In essence, our target market can’t be restricted to just a group of people, but all those who resides in our target market locations.

In view of that, we have conducted our market research and we have ideas of what our target market would be expecting from us. We are in business to engage in developing and producing generic drugs, marketing and distributing generic drugs and gaining regulatory approval for generic drugs. Hence our target markets are;

  • Health Facilities
  • Pharmaceutical Products Wholesalers
  • Retail Pharmacy Stores
  • Everybody in our target market location

Our competitive advantage

A close study of the generic pharmaceutical manufacturing industry reveals that the market has become much more intensely competitive over the last decade. As a matter of fact, you have to be highly creative, customer centric and proactive if you must survive in this industry.

We are aware of the stiffer competition and we are well prepared to compete favorably with other generic pharmaceutical manufacturing companies in New Hampshire and throughout the United States and Canada.

Harry Tancredo® Pharmaceuticals, LLC is launching a standard generic pharmaceutical product brand that will indeed become the preferred choice of residence of Concord – New Hampshire and every city where our generic pharmaceutical product will be retailed.

Part of what is going to count as competitive advantage for Harry Tancredo® Pharmaceuticals, LLC is the vast experience of our management team, we have people on board who are highly experienced and understands how to grow business from the scratch to becoming a national phenomenon.

So also, our state of the art pharmaceutical production machines and equipment, the wide varieties of generic pharmaceutical products that we produce our large and far reaching national distribution network and of course our excellent customer service culture will definitely count as a strong strength for the business.

Lastly, our employees will be well taken care of, and their welfare package will be among the best within our category (startups generic pharmaceutical manufacturing companies) in the generic pharmaceutical manufacturing industry, meaning that they will be more than willing to build the business with us and help deliver our set goals and achieve all our aims and objectives.

We will also give good working conditions and commissions to freelance sales agents that we will recruit from time to time.

9. SALES AND MARKETING STRATEGY

  • Sources of Income

Harry Tancredo® Pharmaceuticals, LLC is established with the aim of maximizing profits in the generic pharmaceutical manufacturing industry in both the United States of America and Canada and we are going to go all the way to ensure that we do all it takes to sell a wide range of generic pharmaceutical products to a wide range of customers.

Harry Tancredo® Pharmaceuticals, LLC will generate income by selling the following pharmaceutical products;

  • Antiulcerants and thyroid

10. Sales Forecast

One thing is assured when it comes to generic pharmaceutical manufacturing company, if your products are well – packaged and branded and if your production plant is centrally positioned and easily accessible, you will always attract customers cum sales and that will sure translate to increase in revenue generation for the business.

We are well positioned to take on the available market in Concord – New Hampshire and every city where our generic pharmaceutical products will be sold and we are quite optimistic that we will meet our set target of generating enough income / profits from the first six month of operations and grow the business and our clientele base.

We have been able to critically examine the generic pharmaceutical manufacturing industry and we have analyzed our chances in the industry and we have been able to come up with the following sales forecast. The sales projections are based on information gathered on the field and some assumptions that are peculiar to similar startups in Concord – New Hampshire.

Below is the sales projection for Harry Tancredo® Pharmaceuticals, LLC, it is based on the location of our business and other factors as it relates to small scale and medium scale generic pharmaceutical manufacturing company start – ups in the United States;

  • First Fiscal Year-: $250,000
  • Second Fiscal Year-: $550,000
  • Third Fiscal Year-: $950,000

N.B : This projection is done based on what is obtainable in the industry and with the assumption that there won’t be any major economic meltdown and there won’t be any major competitor manufacturing same generic pharmaceutical products and customer care services as we do within same location. Please note that the above projection might be lower and at the same time it might be higher.

  • Marketing Strategy and Sales Strategy

Before choosing a location for Harry Tancredo® Pharmaceuticals, LLC and also the kind of generic pharmaceutical products we will produce, we conduct a thorough market survey and feasibility studies in order for us to be able to be able to penetrate the available market in our target market locations.

We have detailed information and data that we were able to utilize to structure our business to attract the numbers of customers we want to attract per time and also for our products to favorable compete with other leading generic pharmaceutical manufacturing brands in the United States of America and Canada.

We hired experts who have good understanding of the generic pharmaceutical manufacturing industry to help us develop

In other to continue to be in business and grow, we must continue to sell our generic pharmaceutical products to the available market which is why we will go all out to empower or sales and marketing team to deliver our corporate sales goals.

In summary, Harry Tancredo® Pharmaceuticals, LLC will adopt the following sales and marketing approach to sell our generic pharmaceutical products;

  • Introduce our generic pharmaceutical products brand by sending introductory letters to pharmacy stores, hospitals, residence, pharmaceutical merchants, retailers and other stakeholders in Concord – New Hampshire and other cities both in the United States of America and Canada
  • Open our generic pharmaceutical manufacturing company with a party so as to capture the attention of residence who are our first targets
  • Engage in road show in targeted communities from time to time to sell our products
  • Advertise our products in community based newspapers, local TV and radio stations
  • List our business and products on yellow pages ads (local directories)
  • Leverage on the internet to promote our generic pharmaceutical product brands
  • Engage in direct marketing and sales
  • Encourage the use of Word of mouth marketing (referrals)

11. Publicity and Advertising Strategy

In spite of the fact that our generic pharmaceutical manufacturing plant is a standard one with a wide range of pharmaceutical products that in few years from now will favorably compete with other leading brands in the industry like Mylan Inc., Sandoz Ltd. and Teva Pharmaceuticals Industries Ltd.

We will still go ahead to intensify publicity for all our products and brand. We are going to explore all available means to promote Harry Tancredo® Pharmaceuticals, LLC.

Harry Tancredo® Pharmaceuticals, LLC has a long-term plan of distributing our generic pharmaceutical products in various locations all around the United States of America and Canada which is why we will deliberately build our brand to be well accepted first in Concord – New Hampshire before venturing out.

As a matter of fact, our publicity and advertising strategy is not solely for selling our products but to also effectively communicate our brand. Here are the platforms we intend leveraging on to promote and advertise Harry Tancredo® Pharmaceuticals, LLC;

  • Place adverts on both print (community based newspapers and magazines) and electronic media platforms
  • Sponsor relevant community programs
  • Leverage on the internet and social media platforms like; Instagram, Facebook, twitter, et al to promote our generic pharmaceutical product brand
  • Install our Bill Boards on strategic locations all around major cities in the United States of America and Canada
  • Engage in road show from time to time in targeted communities
  • Distribute our fliers and handbills in target areas
  • Position our Flexi Banners at strategic positions in the location where we intend getting customers to start patronizing our products.
  • Ensure that our products are well branded and that all our staff members wear our customized clothes, and all our official cars and distribution vans are customized and well branded.

12. Our Pricing Strategy

When it comes to pricing for products such as generic pharmaceutical products, there are two sides to the coin. We are aware of the pricing trend in the generic pharmaceutical manufacturing industry which is why we have decided to produce various sizes of pharmaceutical products as regulated by the industry.

In view of that, our prices will conform to what is obtainable in the industry but will ensure that within the first 6 to 12 months our products are sold a little bit below the average prices of various generic pharmaceutical product brands in the United States of America.

We have put in place business strategies that will help us run on low profits for a period of 6 months; it is a way of encouraging people to buy into our generic pharmaceutical product brands.

  • Payment Options

The payment policy adopted by Harry Tancredo® Pharmaceuticals, LLC is all inclusive because we are quite aware that different customers prefer different payment options as it suits them but at the same time, we will ensure that we abide by the financial rules and regulation of the United States of America.

Here are the payment options that Harry Tancredo® Pharmaceuticals, LLC will make available to her clients;

  • Payment via bank transfer
  • Payment with cash
  • Payment via credit cards / Point of Sale Machines (POS Machines)
  • Payment via online bank transfer
  • Payment via check
  • Payment via mobile money transfer
  • Payment via bank draft

In view of the above, we have chosen banking platforms that will enable our client make payment for generic pharmaceutical product purchase without any stress on their part. Our bank account numbers will be made available on our website and promotional materials to clients who may want to deposit cash or make online transfer for the purchase of our products.

13. Startup Expenditure (Budget)

Starting a standard generic pharmaceutical manufacturing company is indeed a capital – intensive business. This is so because the amount required in setting up a generic pharmaceutical production plant is not a piecemeal. The bulk of the start – up capital will be sent on leasing or acquiring a facility and also in purchasing mixing, blending, compounding and packaging equipment.

Aside from that, you are not expected to spend much except for purchase and servicing of distribution trucks, purchasing raw materials, paying of your employees and utility bills. These are the key areas where we will spend our start – up capital;

  • The total fee for registering the Business in the United States of America – $750.
  • Legal expenses for obtaining licenses and permits as well as the accounting services (software, P.O.S machines and other software) – $1,300.
  • Marketing promotion expenses for the grand opening of Harry Tancredo® Pharmaceuticals, LLC in the amount of $3,500 and as well as flyer printing (2,000 flyers at $0.04 per copy) for the total amount of – $3,580.
  • The cost for hiring Business Consultant – $2,500.
  • The cost for insurance (general liability, workers’ compensation and property casualty) coverage at a total premium – $2,400.
  • The cost for payment of rent for 12 months at $1.76 per square feet in the total amount of $105,600.
  • The cost for construction of a standard generic pharmaceutical production plant – $100,000.
  • Other start-up expenses including stationery ( $500 ) and phone and utility deposits ( $2,500 ).
  • Operational cost for the first 3 months (salaries of employees, payments of bills et al) – $100,000
  • The cost for start-up inventory (mixing, blending, compounding and packaging equipment, raw materials, and packaging materials et al) – $80,000
  • Cost for store equipment (cash register, security, ventilation, signage) – $13,750
  • Cost of purchase of distribution vans – $60,000
  • The cost for the purchase of furniture and gadgets (Computers, Printers, Telephone, Fax Machines, tables and chairs et al) – $4,000.
  • The cost of launching a website – $600
  • The cost for our opening party – $10,000
  • Miscellaneous – $10,000

We would need an estimate of $500,000 to successfully set up our generic pharmaceutical manufacturing company in Concord – New Hampshire. Please note that this amount includes the salaries of all the staff for the first 3 month of operation.

Generating Funds / Startup Capital for Harry Tancredo® Pharmaceuticals, LLC

Harry Tancredo® Pharmaceuticals, LLC is a family business that is owned and financed by Harry Tancredo and his immediate family members. They do not intend to welcome any external business partner which is why he has decided to restrict the sourcing of the start – up capital to 3 major sources.

These are the areas we intend generating our start – up capital;

  • Generate part of the start – up capital from personal savings and sell of stocks
  • Source for soft loans from family members and friends
  • Apply for loan from my Bank

N.B: We have been able to generate about $200,000 (Personal savings $150,000 and soft loan from family members $50,000) and we are at the final stages of obtaining a loan facility of $300,000 from our bank. All the papers and document have been signed and submitted, the loan has been approved and any moment from now our account will be credited with the amount.

14. Sustainability and Expansion Strategy

The future of any business lies in the numbers of loyal customers that they have the capacity and competence of the employees, their investment strategy and the business structure. If all of these factors are missing from a business (company), then it won’t be too long before the business close shop.

One of our major goals of starting Harry Tancredo® Pharmaceuticals, LLC is to build a business that will survive off its own cash flow without the need for injecting finance from external sources once the business is officially running.

We know that one of the ways of gaining approval and winning customers over is to retail our generic pharmaceutical products a little bit cheaper than what is obtainable in the market and we are well prepared to survive on lower profit margin for a while.

Harry Tancredo® Pharmaceuticals, LLC will make sure that the right foundation, structures and processes are put in place to ensure that our staff welfare are well taken of. Our company’s corporate culture is designed to drive our business to greater heights and training and retraining of our workforce is at the top burner.

As a matter of fact, profit-sharing arrangement will be made available to all our management staff and it will be based on their performance for a period of three years or more. We know that if that is put in place, we will be able to successfully hire and retain the best hands we can get in the industry; they will be more committed to help us build the business of our dreams.

Check List / Milestone

  • Business Name Availability Check: Completed
  • Business Registration: Completed
  • Opening of Corporate Bank Accounts: Completed
  • Securing Point of Sales (POS) Machines: Completed
  • Opening Mobile Money Accounts: Completed
  • Opening Online Payment Platforms: Completed
  • Application and Obtaining Tax Payer’s ID: In Progress
  • Application for business license and permit: Completed
  • Purchase of Insurance for the Business: Completed
  • Leasing of facility and construction of standard generic pharmaceutical production plant: In Progress
  • Conducting Feasibility Studies: Completed
  • Generating capital from family members and friends: Completed
  • Applications for Loan from the bank: In Progress
  • Writing of Business Plan: Completed
  • Drafting of Employee’s Handbook: Completed
  • Drafting of Contract Documents and other relevant Legal Documents: In Progress
  • Design of the Company’s Logo: Completed
  • Graphic Designs and Printing of Packaging Marketing / Promotional Materials: In Progress
  • Recruitment of employees: In Progress
  • Purchase of the Needed furniture, racks, shelves, computers, electronic appliances, office appliances and CCTV: In progress
  • Creating Official Website for the Company: In Progress
  • Creating Awareness for the business both online and around the community: In Progress
  • Health and Safety and Fire Safety Arrangement (License): Secured
  • Opening party / launching party planning: In Progress
  • Establishing business relationship with vendors – pharmacy stores, hospitals, pharmaceutical products wholesale suppliers / merchants: In Progress

Related Posts:

  • Retail Pharmacy Business Plan [Sample Template]
  • Pharmaceutical Distribution Business Plan [Sample Template]
  • Drug Prescription Delivery Business Plan [Sample Template]

SharpSheets

Pharmacy Business Plan PDF Example

Avatar photo

  • March 19, 2024
  • Business Plan

the business plan template for a pharmacy

Creating a comprehensive business plan is crucial for launching and running a successful pharmacy. This plan serves as your roadmap, detailing your vision, operational strategies, and financial plan. It helps establish your pharmacy’s identity, navigate the competitive market, and secure funding for growth.

This article not only breaks down the critical components of a pharmacy business plan, but also provides an example of a business plan to help you craft your own.

Whether you’re an experienced entrepreneur or new to the healthcare industry, this guide, complete with a business plan example, lays the groundwork for turning your pharmacy concept into reality. Let’s dive in!

Our pharmacy business plan is constructed to encompass all critical facets required for a robust strategy. It details the pharmacy’s operational processes, marketing approaches, market conditions, competitive landscape, management hierarchy, and financial predictions.

  • Executive Summary : Provides a concise overview of the Pharmacy’s business concept, market analysis , management team, and financial strategy, setting the stage for the detailed plan.
  • Pharmacy & Location: Details the pharmacy’s layout, amenities, and the strategic significance of its location to attract customers.
  • Services & Pricing: Lists the pharmaceutical services and products available, including pricing strategy and how it caters to the target market .
  • Key Stats: Shares important statistics on the pharmacy industry, highlighting the market size and growth trends.
  • Key Trends: Discusses current trends affecting the pharmaceutical industry and how the Pharmacy aligns with these trends.
  • Key Competitors : Evaluates main competitors in the vicinity, showcasing the Pharmacy’s unique advantages.
  • SWOT: Strengths, weaknesses, opportunities, and threats analysis tailored to the Pharmacy.
  • Marketing Plan : Outlines strategies for marketing, customer engagement, and loyalty building.
  • Timeline : Key milestones and objectives from the Pharmacy’s startup phase through its first year of operation.
  • Management: Information about the management team, their expertise, and their roles in the Pharmacy.
  • Financial Plan: Projects the Pharmacy’s financial performance over the next five years, including revenue, profit margins, and significant expenses.

the business plan template for a pharmacy

Pharmacy Business Plan

business plan for pharmaceutical products

Fully editable 30+ slides Powerpoint presentation business plan template.

Download an expert-built 30+ slides Powerpoint business plan template

Executive Summary

The Executive Summary introduces your pharmacy’s business plan, providing a concise overview of your pharmacy and its offerings. It should detail your market positioning, the range of pharmaceutical products and health services you offer, its location, size, and an outline of day-to-day operations.

This section should also explore how your pharmacy will integrate into the local market, including the number of direct competitors within the area, identifying who they are, along with your pharmacy’s unique selling points that differentiate it from these competitors.

Furthermore, you should include information about the management and co-founding team, detailing their roles and contributions to the pharmacy’s success. Additionally, a summary of your financial projections, including revenue and profits over the next five years, should be presented here to provide a clear picture of your pharmacy’s financial plan.

Make sure to cover here _ Business Overview _ Market Overview _ Management Team _ Financial Plan

Pharmacy Business Plan exec summary

Dive deeper into Executive Summary

Business Overview

For a Pharmacy, the Business Overview section can be concisely divided into 2 main aspects:

Pharmacy & Location

Briefly describe the pharmacy’s physical setup, focusing on its layout, ease of navigation, and the welcoming atmosphere for customers. Mention the pharmacy’s location, highlighting its accessibility and convenience to customers, such as proximity to medical centers, residential areas, or ease of parking. Explain why this location is strategically chosen to attract your target customer base.

Products & Pricing

Detail the range of products and services offered, from prescription medications and over-the-counter drugs to health supplements and wellness products. Include any specialized services such as pharmaceutical consultations, immunizations, health screenings, or medication management programs. Outline your pricing strategy, ensuring it is competitive yet reflects the quality and value of the products and services offered. Highlight any discount programs, insurance collaborations, or loyalty schemes that provide added value to your customers, encouraging repeat visits and customer loyalty.

Make sure to cover here _ Pharmacy & Location _ Products & Prices

business plan for pharmaceutical products

Market Overview

Industry size & growth.

In the Market Overview of your pharmacy business plan, start by examining the size of the pharmaceutical industry and its growth potential. This analysis is crucial for understanding the market’s scope and identifying expansion opportunities.

Key Market Trends

Proceed to discuss recent market trends , such as the increasing consumer interest in health and wellness products, the growth in demand for prescription and over-the-counter medications, and the expansion of pharmacy services like immunizations and health screenings. For example, highlight the demand for pharmacies that offer comprehensive health management solutions and personalized medication consultations, alongside the rising popularity of digital health services and telepharmacy.

Key Competitors

Then, consider the competitive landscape, which includes a range of pharmacies from large chains to local independents, as well as online pharmacies and health tech startups. For example, emphasize what makes your pharmacy distinctive, whether it’s through superior customer service, a wide range of health and wellness products, or specialization in certain medical areas. This section will help articulate the demand for pharmacy services, the competitive environment, and how your pharmacy is positioned to thrive within this dynamic market.

Make sure to cover here _ Industry size & growth _ Key competitors _ Key market trends

Pharmacy Business Plan market overview

Dive deeper into Key competitors

First, conduct a SWOT analysis for the pharmacy , highlighting Strengths (such as a comprehensive range of health products and services, knowledgeable pharmacists), Weaknesses (including potential inventory management issues or strong competition from large chains), Opportunities (for example, an increasing focus on healthcare and preventive measures in the community), and Threats (such as regulatory changes or online pharmacies cutting into market share).

Marketing Plan

Next, develop a marketing strategy that outlines how to attract and retain customers through targeted health and wellness campaigns, promotional discounts on wellness products, an engaging online presence that includes health tips and advice, and involvement in community health events.

Finally, create a detailed timeline that outlines critical milestones for the pharmacy’s opening, marketing initiatives, customer base growth, and potential service expansion objectives, ensuring the business progresses with clear direction and purpose.

Make sure to cover here _ SWOT _ Marketing Plan _ Timeline

Pharmacy Business Plan strategy

Dive deeper into SWOT

Dive deeper into Marketing Plan

The Management section focuses on the pharmacy’s management and their direct roles in daily operations and strategic direction. This part is crucial for understanding who is responsible for making key decisions and driving the pharmacy toward its financial and operational goals.

For your pharmacy business plan, list the core team members, their specific responsibilities, and how their expertise supports the business.

Pharmacy Business Plan management

Financial Plan

The Financial Plan section is a comprehensive analysis of your financial projections for revenue, expenses, and profitability. It lays out your pharmacy’s approach to securing funding, managing cash flow, and achieving breakeven.

This section typically includes detailed forecasts for the first 5 years of operation, highlighting expected revenue, operating costs and capital expenditures.

For your pharmacy business plan, provide a snapshot of your financial statement (profit and loss, balance sheet, cash flow statement), as well as your key assumptions (e.g. number of customers and prices, expenses, etc.).

Make sure to cover here _ Profit and Loss _ Cash Flow Statement _ Balance Sheet _ Use of Funds

Pharmacy Business Plan financial plan

Related Posts

The business plan template of an optician

Optician Business Plan PDF Example

Avatar photo

  • May 10, 2024

Executive Summary of an Optician business plan

Executive Summary of an Optician: Template & Example

  • May 9, 2024
  • Business Plan , Executive Summary

Competitive Analysis for an Optician business plan

Competitive Analysis for an Optician (Example)

  • Business Plan , Competitive Analysis

Privacy Overview

Process Street

Pharmacy Business Plan

Identify and study the market needs for pharmaceuticals.

  • 1 Hospitals and clinics
  • 2 Individual consumers
  • 3 Long-term care facilities
  • 4 Healthcare organizations
  • 5 Pharmaceutical wholesalers
  • 1 Strong competition
  • 2 Changing regulations
  • 3 Limited access to medication
  • 4 Lack of awareness
  • 5 Logistics challenges

Research on the regulatory requirements for setting up a pharmacy business

  • 1 Complex licensing process
  • 2 Cost of obtaining permits
  • 3 Stringent security measures
  • 4 Regular inspections and audits
  • 5 Maintaining accurate recordkeeping

Prepare a business model and revenue plan

  • 1 Prescription medications
  • 2 Over-the-counter medications
  • 3 Healthcare products and supplements
  • 4 Consultations and services
  • 5 Compounding medications

Create a detailed marketing and sales strategy

  • 1 Digital marketing (website, social media)
  • 2 Print advertisements
  • 3 Radio and television ads
  • 4 Direct mail campaigns
  • 5 Partnerships with healthcare providers
  • 1 Brochures
  • 4 Business cards
  • 5 Digital advertisements

Draft a detailed organizational structure

  • 1 Pharmacist
  • 2 Pharmacy technician
  • 3 Front-end staff
  • 4 Inventory manager
  • 5 Marketing manager
  • 1 Communication gaps
  • 2 Staff turnover
  • 3 Employee conflicts
  • 4 Performance management
  • 5 Training and development

Approval: Organizational Structure

  • Draft a detailed organizational structure Will be submitted

Develop a business operation plan

  • 1 Ordering and receiving medication
  • 2 Storing and organizing inventory
  • 3 Monitoring and restocking inventory
  • 4 Managing expiration dates
  • 5 Implementing quality control measures
  • 1 Inventory shortages
  • 2 Medication errors
  • 3 Supply chain disruptions
  • 4 Unforeseen emergencies
  • 5 Staff scheduling conflicts

Research and decide on an ideal location

  • 1 High rental costs
  • 2 Limited availability of commercial spaces
  • 3 Zoning restrictions
  • 4 Competition from existing pharmacies
  • 5 Accessibility issues for customers

Estimate initial setup and ongoing operating costs

  • 1 Negotiating bulk purchase discounts
  • 2 Energy-efficient lighting and appliances
  • 3 Automation of manual processes
  • 4 Staff cross-training for multi-functional roles
  • 5 Optimizing inventory management

Identify potential sources for investment

  • 1 Business plan
  • 2 Financial projections
  • 3 Market analysis
  • 4 Legal and regulatory compliance documentation
  • 5 Track record of the management team
  • 1 Limited access to capital
  • 2 Competitive investment landscape
  • 3 Uncertainty in the healthcare market
  • 4 Regulatory changes impacting investment decisions
  • 5 Market saturation in the pharmacy industry

Approval: Investment Sources

  • Identify potential sources for investment Will be submitted

Create a detailed risk management plan

  • 1 Limited resources for risk mitigation
  • 2 Complex regulatory requirements
  • 3 Resistance to change from staff or stakeholders
  • 4 Inadequate risk monitoring and reporting systems
  • 5 Emerging risks in the healthcare industry

Draft a proposal for partnership with pharmaceutical suppliers

  • 1 Price fluctuations in the pharmaceutical market
  • 2 Dependence on a single supplier
  • 3 Quality control issues
  • 4 Supply chain disruptions
  • 5 Maintaining competitive pricing for customers

Approval: Pharmaceutical Suppliers Proposal

  • Draft a proposal for partnership with pharmaceutical suppliers Will be submitted

Develop a training plan for employees

  • 1 Limited resources for training programs
  • 2 High staff turnover impacting training effectiveness
  • 3 Keeping up with changing regulations and industry standards
  • 4 Practical application of training concepts
  • 5 Staff resistance to training initiatives

Create a customer service and retention strategy

  • 1 In-person interactions
  • 4 Website chat support
  • 5 Social media platforms
  • 1 Long wait times
  • 2 Communication barriers with non-native language speakers
  • 3 Patient confidentiality concerns
  • 4 Managing customer complaints and queries
  • 5 Ensuring accurate medication information

Plan for the pharmacy layout

  • 1 Accessibility for customers with disabilities
  • 2 Space constraints
  • 3 Ergonomic design for staff
  • 4 Compliance with building codes
  • 5 Effective utilization of retail space

Develop a digital strategy including e-prescriptions, home delivery, etc

  • 1 E-prescriptions
  • 2 Online ordering
  • 3 Home delivery
  • 4 Mobile app for medication reminders
  • 5 Virtual consultations
  • 1 Technological infrastructure requirements
  • 2 Integration with existing systems
  • 3 Training staff on digital platforms
  • 4 Protecting customer information from cyber threats
  • 5 Managing customer expectations and feedback

Outline a plan for future growth and expansion

  • 1 Competitive landscape in new markets
  • 2 Acquiring adequate funding for expansion
  • 3 Managing increased operational complexities
  • 4 Adapting to changing industry regulations
  • 5 Maintaining consistent quality across multiple locations

Create a final draft of pharmacy business plan

  • 1 Executive summary
  • 2 Company overview
  • 4 Marketing and sales strategies
  • 5 Organizational structure
  • 6 Operational plan
  • 7 Financial projections
  • 8 Risk management plan
  • 9 Partnership and supplier strategies
  • 10 Training and development plans
  • 11 Customer service and retention strategies
  • 12 Digital strategy
  • 13 Growth and expansion plan

Email Subject: Final Draft of Pharmacy Business Plan

Approval: Pharmacy Business Plan

  • Create a final draft of pharmacy business plan Will be submitted

Take control of your workflows today.

More templates like this.

Preview of the downloaded sample plan asset

Free Download

Pharmacy Business Plan Template

Download this free pharmacy business plan template, with pre-filled examples, to create your own plan..

Or plan with professional support in LivePlan. Save 50% today

Available formats:

Word Icon

What you get with this template

A complete business plan.

Text and financials are already filled out and ready for you to update.

  • SBA-lender approved format

Your plan is formatted the way lenders and investors expect.

Edit to your needs

Download as a Word document and edit your business plan right away.

  • Detailed instructions

Features clear and simple instructions from expert business plan writers.

Money-Back Guarantee

All 100% free. We're here to help you succeed in business, no strings attached.

Get the most out of your business plan example

Follow these tips to quickly develop a working business plan from this sample.

1. Don't worry about finding an exact match

We have over 550 sample business plan templates . So, make sure the plan is a close match, but don't get hung up on the details.

Your business is unique and will differ from any example or template you come across. So, use this example as a starting point and customize it to your needs.

2. Remember it's just an example

Our sample business plans are examples of what one business owner did. That doesn't make them perfect or require you to cram your business idea to fit the plan structure.

Use the information, financials, and formatting for inspiration. It will speed up and guide the plan writing process.

3. Know why you're writing a business plan

To create a plan that fits your needs , you need to know what you intend to do with it.

Are you planning to use your plan to apply for a loan or pitch to investors? Then it's worth following the format from your chosen sample plan to ensure you cover all necessary information.

But, if you don't plan to share your plan with anyone outside of your business—you likely don't need everything.

More business planning resources

Group of business people

How to Write a Business Plan for Investors

Industrial building

Industry Business Planning Guides

Variety of books

How to Start a Business With No Money

Variety of icons

10 Qualities of a Good Business Plan

Woman climbing mountain

How to Write a Business Plan

Stacks of boxes

Simple Business Plan Outline

Man stacking bricks

How to Create a Business Plan Presentation

Business Plan Template example

Business Plan Template

Download your template now

Need to validate your idea, secure funding, or grow your business this template is for you..

  • Fill-in-the-blank simplicity
  • Expert tips & tricks

We care about your privacy. See our privacy policy .

Not ready to download right now? We'll email you the link so you can download it whenever you're ready.

Download as Docx

Download as PDF

LivePlan on a computer

Finish your business plan with confidence

Step-by-step guidance and world-class support from the #1 business planning software

LivePlan screen shots

From template to plan in 30 minutes

  • Step-by-step guidance
  • Crystal clear financials
  • Expert advice at your fingertips
  • Funding & lender ready formats
  • PLUS all the tools to manage & grow

Garrett's Bike Shop

The quickest way to turn a business idea into a business plan

Fill-in-the-blanks and automatic financials make it easy.

No thanks, I prefer writing 40-page documents.

LivePlan pitch example

Discover the world’s #1 plan building software

business plan for pharmaceutical products

PlanBuildr Logo

Pharmacy Business Plan Template

Written by Dave Lavinsky

Pharmacy Business Plan

You’ve come to the right place to create your pharmacy business plan.

We have helped over 10,000 entrepreneurs and business owners create business plans and many have used them to start or grow their pharmacies.

Pharmacy Business Plan Example

Below is a sample pharmacy business plan and template to help you create each section of your pharmacy business plan.

Executive Summary

Business overview.

Healthy1 Pharmacy is a new independent retail pharmacy located in Charleston, South Carolina. The company is founded by Stephen Harris, a licensed pharmacist who has spent more than fifteen years working in the pharmacy industry. Stephen is confident that his strong communication skills combined with his keen attention to detail when preparing prescriptions will help him quickly grow a loyal customer base for his new pharmacy. Stephen has recruited a team of highly qualified professionals to help manage the day-to-day complexities of running a retail pharmacy including marketing, sales, customer service, financial reporting, and operations management.

Healthy1 Pharmacy will provide all of the products and services that are available at large retail chains, only with a better price and a small-town atmosphere. At Healthy1, sales associates and pharmacy technicians will get to know each customer by name and be able to offer a more personalized service not typically offered at larger pharmacies. Healthy1 Pharmacy will be a one-stop shop for any customer in need of a prescription, flu shot, OTC medication, and more.

Product Offering

The following are the services that Healthy1 Pharmacy will provide:

  • Over-the-counter (OTC) medications
  • Prescription medications
  • Immunizations
  • Travel medications
  • Point-of-Care (POC) Tests
  • Compounding

Customer Focus

Healthy1 Pharmacy will target all individuals in Charleston. The pharmacy will target multiple age groups from pediatric to geriatric. Healthy1 will also target patients needing prescriptions filled on a regular basis. No matter the customer, Healthy1 Pharmacy will deliver the best communication, service, and prices.

Management Team

Healthy1 Pharmacy will be owned and operated by Stephen Harris. He has recruited Emily Jackson, an experienced retail pharmacy manager to be his Store Manager and help to supervise the staff and run the day-to-day retail operations.

Stephen Harris is a licensed pharmacist with a Doctor of Pharmacy (PharmD) degree and more than fifteen years of experience working in the pharmacy industry. Stephen has been recognized by his former employer as a top performing pharmacist for five years in a row.

Emily Jackson has been a store manager at a local retail pharmacy for over a decade and has garnered a positive reputation for her exceptional organizational skills and leadership. Emily has worked in the pharmacy industry for so long, she understands all aspects required in running a successful retail pharmacy.

Success Factors

Healthy1 Pharmacy will be able to achieve success by offering the following competitive advantages:

  • Friendly, knowledgeable, and highly qualified team of sales associates and pharmacy technicians who will assist customers, answer questions, and provide a personalized approach not found in larger pharmacies.
  • Comprehensive array of products and services that includes everything you would expect from a large pharmacy, only with attentive customer service and lower prices.
  • Healthy1 Pharmacy offers the best pricing in Charleston. The pharmacy’s pricing structure is the most cost effective compared to the competition.

Financial Highlights

Healthy1 Pharmacy is seeking $400,000 in debt financing to launch its new pharmacy. The funding will be dedicated towards securing the retail space and purchasing equipment, inventory, and supplies. Funding will also be dedicated towards three months of overhead costs to include payroll of the staff, rent, and marketing costs. The breakout of the funding is below:

  • Pharmacy and retail space build-out: $100,000
  • Equipment, supplies, inventory, and materials: $100,000
  • Three months of overhead expenses (payroll, rent, utilities): $160,000
  • Marketing costs: $25,000
  • Working capital: $15,000

The following graph below outlines the pro forma financial projections for Healthy1 Pharmacy.

pharmacy financial plan

Company Overview

Who is healthy1 pharmacy.

Healthy1 Pharmacy is a newly established independent retail pharmacy located in Charleston, South Carolina. Healthy1 Pharmacy will provide all of the products and services that are available at large retail chains, only with lower prices and a small-town atmosphere. At Healthy1, sales associates and pharmacy technicians will get to know each customer by name and be able to offer a more personalized service not typically offered at larger pharmacies. Healthy1 Pharmacy will be a one-stop shop for any customer in need of a prescription, flu shot, OTC medication, and more. Healthy1 Pharmacy will be able to provide Charleson customers with the experience of a friendly, neighborhood drugstore while ensuring each prescription is handled with the highest standards of quality and care. The team of pharmacy technicians and sales associates will be highly qualified and experienced in helping customers find the right over-the-counter solutions for their individual needs as well as ensuring each prescription is filled accurately and efficiently.

Healthy1 Pharmacy History

Healthy1 is owned and operated by Stephen Harris, a licensed pharmacist with over fifteen years of experience working in the pharmacy industry. Stephen has worked for a large pharmacy chain and managed a team of pharmacy technicians for several years. Stephen’s tenure with the pharmacy chain combined with his pharmaceutical education has given him the skills and knowledge required to start his own pharmacy.

Since incorporation, Healthy1 Pharmacy has achieved the following milestones:

  • Registered Healthy1 Pharmacy, LLC to transact business in the state of South Carolina.
  • Has a contract in place to lease the retail storefront he will use for his pharmacy.
  • Reached out to numerous contacts to include experienced pharmacy technicians and sales associates to advise them of the upcoming opportunities at his new pharmacy.
  • Began recruiting the management team members including a store manager, an accountant/bookkeeper, and a marketing director.

Healthy1 Pharmacy Services

The following are the pharmacy products and services that Healthy1 Pharmacy will provide:

Industry Analysis

The pharmacy industry in the United States is valued at $534.2B and is projected to grow to $862B by 2028. Major market drivers include a growing number of types of diseases, an increasing percentage of people with chronic illnesses, an aging population, and higher healthcare costs.

There are more prescription medications being developed, and the demand for more prescriptions is growing faster than ever before. In 2020, there were an estimated 860M medications prescribed by physicians and 336M prescribed by hospitals. This prescription demand is resulting in more pharmacies opening across the U.S. The National Council for Prescription Drug Programs (NCPDP) reports an estimated 20,400 independent pharmacies in 2010. This number has grown to over 23,000 by 2019, a 12.9% increase in the number of independent pharmacies for that time period.

Industry operators in the pharmaceutical market can benefit from providing above average customer service, lower prices than competitors, and products or services that aren’t being offered elsewhere.

Customer Analysis

Demographic profile of target market.

Healthy1 Pharmacy will target all individuals in Charleston, South Carolina. The pharmacy will target multiple age groups from pediatric to geriatric. Healthy1 will also target patients needing prescriptions filled on a regular basis.

The precise demographics for Charleston, South Carolina are:

Customer Segmentation

Healthy1 will primarily target the following customer profiles:

  • Parents of pediatric patients
  • Geriatric patients
  • People taking medications on a regular basis
  • People needing compounding services
  • People looking for vaccines or immunizations
  • People who need lab tests

Competitive Analysis

Direct and indirect competitors.

Healthy1 Pharmacy will face competition from other companies with similar business profiles. A description of each competitor company is below.

Charleston Care Pharmacy

Charleston Care Pharmacy provides a wide variety of pharmacy products and services including OTC medications, lab testing, and compounding. Located in a senior neighborhood, Charleston Care Pharmacy specializes in serving the geriatric population, but welcomes customers of all ages. Charleston Care Pharmacy’s promise is to deliver effective communication, honesty, and integrity in every transaction. Charleston Care Pharmacy’s team of experienced pharmacy technicians assures customers are well taken care of and prescriptions are filled quickly and correctly.

FeelBetterNow Pharmacy

FeelBetterNowPharmacy is a Charleston-based neighborhood pharmacy that provides a full suite of services including compounding, vaccines, lab testing, local delivery, and more. The owners of FeelBetterNowPharmacy are licensed pharmacists who have extensive experience working for independent retail pharmacies so they understand what customers are looking for in a neighborhood pharmacy. Customers who choose FeelBetterNowPharmacy can rest assured they are getting the best quality products at reasonable prices.

Care Better Pharmacy

Care Better Pharmacy is a trusted Charleston pharmacy that is known for providing superior customer service. They are able to provide a one-stop shop for customers looking for convenient OTC and prescription medications, durable medical equipment, vaccines, and immunizations. Care Better Pharmacy is also able to serve customers in need of compounding, recurring prescriptions, and lab testing. They have expert pharmacy technicians to provide information about each medication and answer all of their customers’ questions.

Competitive Advantage

Healthy1 Pharmacy will be able to offer the following advantages over their competition:

  • Healthy1 Pharmacy offers the best pricing in Charleston. The pharmacy offers its customers low prices on all of its products and services compared to the competition.

Marketing Plan

Brand & value proposition.

Healthy1 Pharmacy will offer the unique value proposition to its customers:

  • Highly-qualified team of skilled pharmacy technicians and sales associates will be able to provide personalized customer service and ensure all prescriptions are handled with care.
  • Unbeatable pricing to its clients – Healthy1 Pharmacy does not mark up its products and services at a large percentage. The pharmacy will offer the lowest prices guaranteed. If a customer finds a cheaper price elsewhere, Healthy1 Pharmacy will give the customer a better price.

Promotions Strategy

The promotions strategy for Healthy1 Pharmacy is as follows:

Healthy1 Pharmacy will create and maintain a company website that is well organized, informative, and lists all the products and services that Healthy1 is able to provide. The website will also list promotions and discounts, informative healthcare articles, and pharmacy-sponsored community events.

SEO/Google Marketing

The company’s marketing director will manage Healthy1’s website presence with SEO marketing tactics so that any time someone types in the Google or Bing search engine “Charleston pharmacy” or “pharmacy near me”, Healthy1 Pharmacy will be listed at the top of the search results.

Social Media Marketing

Healthy1 Pharmacy’s marketing director will also manage the company’s social media presence on several platforms including Instagram, Facebook, Twitter, YouTube, TikTok, and LinkedIn. The goal of the social media strategy is to attract new customers while engaging with current customers to encourage referrals, reviews, and feedback.

Content Marketing/Email Marketing

The company will post blogs and other promotional content on a regular basis with informative health and wellness information to keep people coming back. Healthy1 will post informative content on the website, social media platforms, and through email newsletters.

Professional Associations/Networking

Healthy1 Pharmacy will become a member of professional associations such as the Independent Retail Pharmacy Association, the National Community Pharmacists Association, and the Tennessee Pharmacists Association. The company will focus networking efforts on expanding its customer base.

Print Advertising

Healthy1 Pharmacy will invest in professionally designed print ads to display in programs or flyers at industry networking events, in magazines, direct mailers, and in local newspapers.

The pricing will be lower than competitors so customers feel they receive value when they choose Healthy1 products and services.

Operations Plan

The following will be the operations plan for Healthy1 Pharmacy.

Operation Functions:

  • Stephen Harris will be the Owner and Lead Pharmacist. He will oversee pharmacy technicians. Stephen has spent the past year recruiting the following staff:
  • Emily Jackson – Store Manager who will oversee all retail operations, sales associates, supplier relations, and inventory management.
  • Jessica Johnson – Staff Accountant/Bookkeeper who will provide budgeting, tax payments, and financial reporting.
  • Tim Thompson – Marketing Director who will provide marketing and sales campaigns for Healthy1 Pharmacy.

Milestones:

Healthy1 Pharmacy will have the following milestones complete in the next six months.

9/1/2022 – Finalize contract to lease the retail space.

9/15/2022 – Finalize personnel and staff employment contracts for the Healthy1 Pharmacy team.

10/1/2022 – Finalize contracts with suppliers.

10/15/2022 – Network at industry events and initiate the marketing and promotional campaign.

10/22/2022 – Begin moving into the Healthy1 Pharmacy storefront.

11/1/2022 – Healthy1 Pharmacy opens for business.

Stephen Harris is a licensed pharmacist with a Doctor of Pharmacy (PharmD) degree and more than fifteen years of experience working in the pharmacy industry. Stephen has been recognized for his commitment to excellence in filling prescriptions accurately and efficiently as well as his communication skills and positive rapport with customers.

Emily Jackson has been a store manager at another retail pharmacy for over a decade and has garnered a positive reputation for her exceptional organizational skills and leadership. Emily has worked in the pharmacy industry for so long, she understands all aspects required in running a successful retail pharmacy.

Financial Plan

Key revenue & costs.

The revenue drivers for Healthy1 Pharmacy are the fees charged to customers in exchange for the pharmacy’s products and services.

The cost drivers will be the overhead costs required in order to staff a pharmacy. The expenses will be the payroll cost, rent, utilities, inventory, supplies, and marketing materials.

Funding Requirements and Use of Funds

Healthy1 Pharmacy is seeking $400,000 in debt financing to launch its pharmacy business. The funding will be dedicated towards securing the retail space and purchasing equipment, inventory, and supplies. Funding will also be dedicated towards three months of overhead costs to include payroll of the staff, rent, and marketing costs. The breakout of the funding is below:

Key Assumptions

The following outlines the key assumptions required in order to achieve the revenue and cost numbers in the financials and in order to pay off the startup business loan.

  • Number of prescriptions filled per month: 2,000
  • Average fees collected each month: $50,000
  • Retail lease per year: $100,000

Financial Projections

Income statement, balance sheet, cash flow statement, what is a pharmacy business plan.

A pharmacy business plan is a plan to start and/or grow your pharmacy  business. Among other things, it outlines your business concept, identifies your target customers, presents your marketing plan and details your financial projections.

You can easily complete your pharmacy business plan using our Pharmacy Business Plan Template here .

What are the Main Types of Pharmacy Businesses?

There are a number of different kinds of self storage business , some examples include: Pharmacy, Home Care Pharmacy, Mail Order Pharmacy and Compounding Pharmacy.

How Do You Get Funding for Your Pharmacy Business Plan?

Pharmacy businesses are often funded through small business loans. Personal savings, credit card financing and angel investors are also popular forms of funding.

What are the Steps To Start a Pharmacy Business?

Starting a pharmacy business can be an exciting endeavor. Having a clear roadmap of the steps to start a business will help you stay focused on your goals and get started faster.

1. Develop A Pharmacy Business Plan - The first step in starting a business is to create a detailed pharmacy business plan that outlines all aspects of the venture. This should include potential market size and target customers, the services or products you will offer, pricing strategies and a detailed financial forecast.  

2. Choose Your Legal Structure - It's important to select an appropriate legal entity for your pharmacy business. This could be a limited liability company (LLC), corporation, partnership, or sole proprietorship. Each type has its own benefits and drawbacks so it’s important to do research and choose wisely so that your pharmacy business is in compliance with local laws.

3. Register Your Pharmacy Business - Once you have chosen a legal structure, the next step is to register your pharmacy business with the government or state where you’re operating from. This includes obtaining licenses and permits as required by federal, state, and local laws. 

4. Identify Financing Options - It’s likely that you’ll need some capital to start your pharmacy business, so take some time to identify what financing options are available such as bank loans, investor funding, grants, or crowdfunding platforms. 

5. Choose a Location - Whether you plan on operating out of a physical location or not, you should always have an idea of where you’ll be based should it become necessary in the future as well as what kind of space would be suitable for your operations. 

6. Hire Employees - There are several ways to find qualified employees including job boards like LinkedIn or Indeed as well as hiring agencies if needed – depending on what type of employees you need it might also be more effective to reach out directly through networking events. 

7. Acquire Necessary Pharmacy Equipment & Supplies - In order to start your pharmacy business, you'll need to purchase all of the necessary equipment and supplies to run a successful operation. 

8. Market & Promote Your Business - Once you have all the necessary pieces in place, it’s time to start promoting and marketing your pharmacy business. This includes creating a website, utilizing social media platforms like Facebook or Twitter, and having an effective Search Engine Optimization (SEO) strategy. You should also consider traditional marketing techniques such as radio or print advertising.

Learn more about how to start a successful pharmacy business:

  • How to Start a Pharmacy Business

Where Can I Get a Pharmacy Business Plan PDF?

You can download our free pharmacy business plan template PDF here . This is a sample pharmacy business plan template you can use in PDF format.

404 Not found

Newly Launched - World's Most Advanced AI Powered Platform to Generate Stunning Presentations that are Editable in PowerPoint

SlideTeam

Researched by Consultants from Top-Tier Management Companies

Banner Image

Powerpoint Templates

Icon Bundle

Kpi Dashboard

Professional

Business Plans

Swot Analysis

Gantt Chart

Business Proposal

Marketing Plan

Project Management

Business Case

Business Model

Cyber Security

Business PPT

Digital Marketing

Digital Transformation

Human Resources

Product Management

Artificial Intelligence

Company Profile

Acknowledgement PPT

PPT Presentation

Reports Brochures

One Page Pitch

Interview PPT

All Categories

Top 5 Pharmacy Business Plan Templates with Samples and Examples (PDF and Editable Word Doc Included)

Top 5 Pharmacy Business Plan Templates with Samples and Examples (PDF and Editable Word Doc Included)

Lakshya Khurana

author-user

As a business, as you scan the horizon for opportunities today, it is inevitable that the next big project you zero in on is the neighborhood pharmacy. After all, a pharmacy is more than a drug store where customers pick up their prescriptions. It is a safe space where people buy medicines and have a confidant in the form of the pharmacist, someone they implicitly come to trust with their vulnerable state of health and personal information.

As you begin building this business, you must consider everything in the supply chain, from the products to the vendors and, certainly, the customers. You know you must take care of every minute detail before taking the first step. The tool that will help you in every aspect is a Pharmacy Business Plan from SlideTeam.

We have created a content-ready Pharmacy Business Plan and curated the Top 5 PPT Templates to help you succeed. The business plan comes in the form of a PDF and an editable Word document as well. This operations plan will guide you to positive, result-oriented action in every scenario. In fact, the PPT Templates are content-ready and 100% customizable and editable.

These tools from SlideTeam, available in all major formats, give you the framework to begin making your pharmacy a real, profitable corporation, and this blog will take you through the business plan.

Pharmacy Business Plan Including Market Size Prescription Drugs and OTC

Access the Pharmacy Business Plan Here

The business plan is divided into the following parts, represented in the Table of Contents below:

   1. Executive Summary                                                                          8. Marketing Plan

   2. Company Overview                                                                           9. Operational Plan

   3. Industry Analysis                                                                              10. Financial Plan

   4. Customer Analysis                                                                            11. Graphical Representation of Financials

   5. Competitor Analysis                                                                         12. Management Summary

   6. SWOT Analysis                                                                                   13. Exit Strategy

   7. Porter’s Competitive Analysis

Here’s a detailed look at each of these parts and the templates on offer.

1. Executive Summary

According to the Journal of the American Pharmacists Association, every 9 of 10 people in the US live within five miles of a community pharmacy. This is a point that pharmacies should play a big role in public health efforts, like providing vaccinations and medicines.

However, in some areas, 8% of counties have roughly half of their residents living over 10 miles from a pharmacy. This presents an opportunity for pharmacy businesses to open shop in those places and serve the community.

Executive Summary

The executive summary serves as a concise overview of the pharmacy business plan, summarizing key points for potential stakeholders. It highlights the pharmacy’s unique value proposition (as we did in the previous paragraph), target market, and revenue projections. The summary also emphasizes the management team’s expertise and the business’s competitive advantage. Investors can grasp the business’s potential and decide whether to buy into the plan based on the specifics outlined.

2. Company Overview

This section presents the pharmacy’s background, history, and legal structure. The company overview highlights its mission, vision, and core values, giving a glimpse into its corporate culture. It details the pharmacy’s location, facilities, and the range of pharmaceutical products and services on offer. This plan never misses critical details like the business’s goals and objectives, and a start-up summary is presented through figures and charts.

Company Overview

The need for the pharmacy is emphasized with a market gap analysis, a study that the business statement also serves to boost. With the base built, the services that the business offers are also documented. These include prescription refills, new prescriptions, mail-order delivery, immunizations, etc.

3. Industry Analysis 

The industry analysis delves into the pharmaceutical market, examining factors like the market size, growth trends, and regulatory landscape. It outlines key opportunities and challenges, providing insights into the pharmacy’s potential for success.

This section of the plan begins with a market analysis of the pharmaceutical industry. The analysis is current and considers the influence of the Covid-19 pandemic on the industry. Some figures and charts showcase the pharmaceutical industry as it is, with a look at its rate of growth and the factors that influence it.

Industry Analysis

This segment also addresses the impact of emerging technologies and innovations in the healthcare sector. Although the report begins with insights into global trends, we focus on insights relevant to the US, such as pharmacy retail stores and pharma spending.

Let us review the first PowerPoint Presentation chosen to aid this pharmacy business plan.

Template 1: Emerging Business Model of a Pharmaceutical Company

This exhaustive PowerPoint Deck delivers on the intricacies of running a pharmacy. Use this PPT Template Bundle to present a comprehensive report on verticals like company financials, problems related to production, solutions for the same, potential business partners, etc. This PPT Set has got you covered, so download it now!

Emerging Business Model Of A Pharmaceutical Company Case Competition Complete Deck

Download now

4. Customer Analysis

Understanding the pharmacy’s target market is essential for tailoring marketing strategies. This section identifies the pharmacy’s primary customer segments with an analysis of the geographics, demographics, psychographics, and behavior. This allows you to create and deliver the buyer persona and identify customers by classifications, such as the elderly, athletes, chronic disease patients, and more.

Customer Analysis

5. Competitor Analysis

What makes this the best pharmacy business plan on the Internet today is that it comes with a current competitor analysis of the major players in the US today. These competitors include CVS, Walgreens, Rite Aide, and more. The product delivers a tabulated rate comparing these businesses on revenue, number of locations, services offered, etc.

6. SWOT Analysis

The SWOT analysis assesses the pharmacy's internal strengths, such as a skilled team and advanced technology, and weaknesses, such as limited brand awareness. It also evaluates external opportunities, like an aging population, and threats, like new regulatory requirements. The template presents a detailed overview of these four areas as they relate to the market in the US today.

SWOT Analysis

7. Porter’s Competitive Analysis

Porter's Five Forces analysis helps evaluate the pharmacy industry's competitiveness. It examines the bargaining power of suppliers and buyers, the threat of new entrants, substitutes, and the intensity of competition. The product delivers the analysis in the case of these matrices being high, medium, and low and how it influences your business.

8. Marketing Plan

The marketing plan outlines a comprehensive strategy to attract and retain customers. It includes a mix of sales strategy, promotional strategy, pricing strategy, and a sales funnel template. Along with the details of each of these four methods, it provides recommendations to consider when employing these methodologies.

Marketing Plan

Template 2: Pharmaceutical Marketing PowerPoint Presentation Slides

This PPT Deck is the ultimate guide to executing marketing strategies for your pharmacy. Use this PPT Set to analyze and deliver important tasks, ranging from product introduction and launch plan to life cycle management and GAP analysis. Employ this PPT Template bundle to create the perfect marketing plan, execute it, and track its progress and outcomes. Download now.

Pharmaceutical marketing powerpoint presentation slides

Download Now

Template 3: Pharmaceutical Sales Plan PowerPoint Template Bundles

This PPT Set is the presentation your sales team needs to create and execute their plans. Use this PPT Deck to boost your sales with slides focused on comparative analysis, 30-60-90-day plans, revenue forecasting, and more. Grab this now from the link below.

Pharmaceutical Sales Plan Powerpoint Ppt Template Bundles

9. Operational Plan

The operational plan details the day-to-day operations of the pharmacy as we enter the execution phase of the business plan. This section provides you with a ready-made table that classifies tasks into phases and financial quarters. The appropriate task is added in the right row and column; with that, you are ready to implement!

Template 4: Pharmaceutical Manufacturing Research Process Products Laboratory Analysis in a Pharmacy Business Plan

Use this PowerPoint Deck to boost the appeal of your pharmacy business plan using images and relevant icons. Some amazing slides within this PowerPoint Set are on test tubes and beakers, clinical research, drug testing, viral analysis, and other concepts. Download this PPT Template Bundle from the link below to grab the attraction of stakeholders and potential investors.

Pharmaceutical Manufacturing Research Process Products Laboratory Analysis

Download This Template Now

10. Financial Plan

Finances are hard to control and harder to present. This part of the product presents a tabulated analysis for financial analyses such as financial assumptions, revenue model & sales forecast, break-even analysis, projected profit and loss account, and more. The editable Word doc is ready for your own financial data to be inserted and analyzed accordingly.

11. Graphical Representation of Financials

Visual aids narrowly beat tables regarding ease of delivery. This section delivers the charts and graphs you need to represent your finances visually. Use this business plan to deliver pictograms on total revenue from operations, earnings before taxes, gross profit, cash flow, and more.

Graphical Representation of Financials

12. Management Summary

We begin to bring the plan to a close with a management summary. Use this section to present details on the organizational structure, professional summary, and job roles & responsibilities.

Template 5: Strategies To Achieve Sustainable Development in a Pharmacy Business Plan

You’re in it for the long haul, and this PPT Layout will help you set anchor and build a profitable business. Use this PPT Deck to showcase the strategies you have in mind to make your pharmacy business sustainable. This includes everything from the company’s finances and business partnerships to the environmental impact of your operations. Download this PPT Set to convert your business into a landmark of the community where you decide to open a shop.

Strategies To Achieve Sustainable Development In Pharmaceutical Company Case Competition Complete Deck

13. Exit Strategy

The exit strategy outlines options for investors or business owners to divest their interests in the pharmacy. Many methods can be used. These can be an initial public offer (IPO), mergers, acquisitions, public offerings, or venture capital.

With our Pharmacy Business Plan Templates, you will be ready to face hurdles entrepreneurs face and, more importantly, overcome these with ease and finesse. TOGETHER, the PDF and the PPT Templates are an exhaustive self-sufficient ecosystem that will help you create your business with tranquillity and answer all these questions.

FAQs on Pharmacy Business Plan

How can i start my pharmacy business.

Starting your pharmacy business in the United States can be rewarding but requires careful planning and compliance with relevant regulations. Here are some steps to consider:

  • Education and Licensing: Ensure you have the educational background and licenses to operate a pharmacy. This typically involves obtaining a Doctor of Pharmacy (PharmD) degree and passing state licensing exams.
  • Business Plan: Develop a detailed business plan outlining your pharmacy's target market, services offered, competitive analysis, marketing strategy, and financial projections. Use SlideTeam’s Pharmacy Business Plan Templates .
  • Location and Premises: Choose a strategic location for your pharmacy, considering factors such as population density, competition, and proximity to medical facilities. Ensure that the premises meet regulatory requirements and are designed to accommodate pharmacy operations.
  • Legal and Regulatory Compliance: Comply with federal, state, and local regulations governing the operation of pharmacies, including obtaining necessary permits and licenses.
  • Inventory and Suppliers: Establish relationships with pharmaceutical wholesalers and manufacturers to ensure the supply of medications and products.
  • Staffing: Hire qualified and licensed pharmacists and pharmacy technicians to run day-to-day operations.
  • Obtain appropriate insurance coverage to protect your business from potential liabilities.

Is the pharmacy business profitable?

The profitability of a pharmacy business can vary depending on location, competition, pricing, and services offered. Pharmacies can generate revenue by selling prescription and over-the-counter medications, medical equipment, and other healthcare-related products. Some pharmacies offer services like immunizations, medication therapy management, and compounding, which can contribute to profitability.

How much money do I need to start a pharmacy business?

Starting a pharmacy business can cost between $400,000 and $600,000 for an average location and reasonable revenue expectations. Remember that pharmacies can be set up for $250,000 as well. The major contributors to the cost are:

  • Licensing and permits fees
  • Rent or purchase of the premises
  • Initial inventory
  • Staff salaries and benefits
  • Technology and equipment (POS systems, pharmacy software, etc.)
  • Marketing and advertising expenses
  • Insurance costs
  • Security measures
  • Professional fees (legal, accounting, etc.)

What is the monthly income of the pharmacy business?

As for the monthly income of the pharmacy business, it also varies widely. A successful and well-established pharmacy in a busy location can generate significant monthly revenue. In contrast, a newer or less-established pharmacy may have lower income during the initial months or years of operation. Monthly income can be influenced by factors such as sales volume, prescription pricing, insurance reimbursements, and the range of services offered.

To get more accurate and up-to-date information, it is advisable to conduct thorough market research and seek guidance from industry experts or business consultants familiar with the pharmaceutical industry in your area. Additionally, networking with other pharmacy owners can provide valuable insights into the financial aspects of running a pharmacy business.

Related posts:

  • Salon Business Plan – Download Free PPT and PDF
  • How to Design the Perfect Service Launch Presentation [Custom Launch Deck Included]
  • Quarterly Business Review Presentation: All the Essential Slides You Need in Your Deck
  • [Updated 2023] How to Design The Perfect Product Launch Presentation [Best Templates Included]

Liked this blog? Please recommend us

business plan for pharmaceutical products

Must-Have Social Media Business Plan Templates with Examples and Samples

Top 5 Nonprofit Business Plan Templates with Examples and Samples

Top 5 Nonprofit Business Plan Templates with Examples and Samples

This form is protected by reCAPTCHA - the Google Privacy Policy and Terms of Service apply.

digital_revolution_powerpoint_presentation_slides_Slide01

Digital revolution powerpoint presentation slides

sales_funnel_results_presentation_layouts_Slide01

Sales funnel results presentation layouts

3d_men_joinning_circular_jigsaw_puzzles_ppt_graphics_icons_Slide01

3d men joinning circular jigsaw puzzles ppt graphics icons

Business Strategic Planning Template For Organizations Powerpoint Presentation Slides

Business Strategic Planning Template For Organizations Powerpoint Presentation Slides

Future plan powerpoint template slide

Future plan powerpoint template slide

project_management_team_powerpoint_presentation_slides_Slide01

Project Management Team Powerpoint Presentation Slides

Brand marketing powerpoint presentation slides

Brand marketing powerpoint presentation slides

Launching a new service powerpoint presentation with slides go to market

Launching a new service powerpoint presentation with slides go to market

agenda_powerpoint_slide_show_Slide01

Agenda powerpoint slide show

Four key metrics donut chart with percentage

Four key metrics donut chart with percentage

Engineering and technology ppt inspiration example introduction continuous process improvement

Engineering and technology ppt inspiration example introduction continuous process improvement

Meet our team representing in circular format

Meet our team representing in circular format

Google Reviews

Building-Effective-Business-Development-in-Pharma-rectangle.jpg

/ Article

Building effective business development in pharma.

By  Mark Lubkeman ,  André Kronimus , and  Filip Hansen

At a time of rapidly evolving scientific breakthroughs and, coincidentally, of the expiration of many blockbuster drug patents, the key to innovation and revenue growth is pharmaceutical business development. While some innovation and new revenue can come from internal pipelines and assets, business development teams are under intense pressure at most companies to supplement internal efforts with external licensing agreements and M&A. Unfortunately, those teams are frequently unable to deliver the transactions needed for innovation and growth.

Often a major reason for this shortfall is that executive team members are not fully aligned on the role of business development in achieving the company’s strategic priorities. They may agree in theory that business development should pursue partnerships, ecosystems, and collaborations, but that consensus falls apart when it comes to making decisions about specific deals.

We have identified six success factors that enable more rapid and effective decision making, which, in turn, will lead to substantially enhanced business development performance.

Subscribe to our Biopharma E-Alert.

Biopharma m&a and licensing remain strong.

Biopharma M&A deal value more than doubled between 2017 and 2019, from $138 billion to $336 billion, and valuations reached all-time highs. Most of those deals involved midsized biotech companies, for which the average premium paid was close to 70%, with an average EV/sales multiple of nearly 8x. All in all, close to 60% of new therapeutic drugs in the last five years have been externally sourced.

The COVID-19 pandemic slowed biopharma M&A activity in 2020, especially in the first half of the year. But since the core drivers of deals remain intact—scientific breakthroughs, expiring patents, and an increasing focus on key therapeutic areas or on modalities such as cell and gene therapy—deal activity will continue to rebound. A recent example is AstraZeneca’s acquisition in late December of Alexion for $39 billion.

Moreover, biopharma companies can finance transactions cheaply with today’s very low interest rates. They also have significant financial resources to pursue business development. BCG’s ValueScience team estimates that the top 20 biopharma companies have more than $700 billion in cash, short-term investments, and additional debt capacity. But as a result, many companies are pursuing the same assets, driving up valuations and the risk of overpaying.

Six Success Factors for Pharma Business Development While we focus here on M&A, the six success factors we have identified will enable business development teams to create value through both M&A and licensing. (See Exhibit 1.)

business plan for pharmaceutical products

1. Prioritize what business development needs to accomplish for the company. Executive team members often have differing views about how to prioritize business units, technology areas, and technology platforms and what types of deals to pursue (early- versus late-stage R&D deals, for example, or transformative versus tuck-in acquisitions). To ensure alignment, it’s critical that team members agree on how and where they want to create value. Will they use business development to generate near-term revenues or to build the pipeline for future innovation? Will they seek to maximize the core, expand into adjacent markets, or explore new frontiers? (See Exhibit 2.)

business plan for pharmaceutical products

As part of this prioritization process, the executive team needs to regularly review and agree on how much revenue growth the current internal portfolio or pipeline will deliver. Only then can it determine the revenue gaps that business development needs to address in which specific therapeutic areas or modalities—and with what urgency. It’s astonishing how often management teams are misaligned on this simple setting of objectives, which often results in business development teams wasting time assessing opportunities that are fundamentally unattractive to the executive team and will never get approved. To avoid such situations, the team should ask itself two key questions about every transaction early on: What revenue gap will the transaction fill? And who on the executive committee will champion the transaction from start to finish? By forcing these decisions early, the team can avoid a lot of wasted time.

2. Build relationships with prospective targets. Executive teams should commit to building relationships with potential partners or acquisition targets for two or three years. Proactive sourcing, screening, and relationship building are far better for deal execution than simply showing up at the target’s headquarters with a banker and an offer. An established relationship will give a prospective buyer an edge over other bidders, perhaps even preempting the bidding process altogether. Such relationships can also accelerate due diligence.

Active engagement with potential targets over several years also gives companies a better grasp of the range of potential deals available. It might, for example, make a pharmaceutical company more likely to take small equity stakes in a number of promising biotechs, perhaps supporting Phase 1 trials with its own clinical and regulatory expertise.

3. Agree on how to assess value. Depending on one’s assumptions when valuing a target, the same transaction may seem spectacularly attractive or exceptionally unattractive. So teams need to agree about how they will value all aspects of each deal and then apply that valuation with discipline. Too often, companies end up redoing their analysis and engaging in repetitive decision making because they haven’t agreed on valuation approaches or metrics from the start.

One common valuation pitfall is to focus only on core asset value, that is, the value of the cash flow generated by current and future products in the market. Valuation models need a wider lens, encompassing multiple dimensions of value, including the following:

  • Synergies. What is the value of cost, revenue, and capability synergies across the value chain—for example, in R&D, manufacturing, and sales?
  • Platform Value. What is the value of the future products a technology platform might make possible?
  • Strategic Value. What is the value of preempting a competitor from acquiring an asset, gaining access to a large proprietary data set, or being recognized as a leader in an emerging field?

Because these advantages are less tangible than core assets, large swings in valuation are possible depending on the underlying assumptions. We have found that companies with a clearly defined and endorsed valuation approach are able to use a common “language” in their deliberations, leading to better, faster decision making. These advantages are amplified when the company is highly transparent about the underlying assumptions and entertains a range of scenarios and associated probabilities.

4. Define integration issues early. Executive and business development teams are frequently so focused on due diligence and valuation that they don’t consider the integration process until after a term sheet has been signed. Integration issues should be considered at the outset, when assessing the deal’s attractiveness and viability, and in parallel with due diligence. Teams should ask such questions as: Will the acquired company be a distinct entity or be integrated into the acquiring company? What governance will be applied to the acquired assets? How will cost synergies factor into the valuation?

Knowing the answers to these questions early on is critical to realizing the full potential of the transaction. Our research shows that successful integration can drive 8% to 10% more value compared with the average transaction. Planning for that success right from the start is essential.

5. Enable agile business development teaming and governance. Even when a company has a clear vision for the transaction, it still needs an agile process and governance to execute the deal quickly and effectively. But because the business development process is highly cross-functional (and often involves many junior-level people), it can be unclear who has the authority to make decisions and who will provide the necessary analytical resources. In addition, preexisting governance committees (such as executive committees) often meet too infrequently to keep up with the fast pace of business development decision making.

To address these challenges, we recommend three best practices:

  • Designate resources. Within each function, several senior staff members with business development experience and authority should be on call. This will help build continuity and organizational learning.
  • Establish clear processes and responsibilities. All members of a business development project team should be aligned on processes, deliverables, and timelines. That should include who is responsible for what and who has what decision rights. For example, who in R&D will calculate the probability of success of a specific asset under review?
  • Create nimble governance. A few members of key governance committees should meet more frequently than the entire group (perhaps even on a weekly basis, depending on deal volume) and have the authority to mobilize the entire committee within 24 or 48 hours if there’s an urgent issue to be addressed.

6. Design an organizational structure suited to strategic priorities. Because companies have different revenue gaps and objectives and use business development in different ways, there is no single “right” organizational structure. One company might focus on early-stage and another on late-stage acquisitions. One company might be looking for deals to strengthen the core business, another to build up new therapeutic areas. A company’s business development organization must be suited to its strategic purpose, whatever that may be. There are three main approaches (with various permutations) to consider:

  • Centralize business development in one group. A central function maximizes scale, alignment of activities, and resource prioritization. This setup works well for companies looking to make relatively few late-stage or transformative acquisitions.
  • Separate R&D and commercial transactions. Assessing an early-stage R&D acquisition requires a different mix of expertise than assessing a late-stage, commercial acquisition. When a company intends to pursue both types of transactions, it’s best to keep at least some of these due diligence activities separate. But such companies can still centralize certain functions—valuation modeling, for example—in order to maximize scale.
  • Separate by business lines or therapeutic areas. It can be sensible to separate business development activities by business lines or therapeutic areas at different levels of maturity. This arrangement works well if a company has a mature business area looking for transformative deals and a smaller business unit looking for technology platform acquisitions. Here again, certain aspects of the business development process, such as valuation modeling, can be centralized for scale and efficiency.

Current market conditions present unique opportunities to tap into external innovation and drive revenue growth, but the inherently complex and cross-functional nature of business development makes it difficult for many pharmaceutical companies to execute effectively. As a result, these companies are not winning the transactions necessary for future success. We believe that the six success factors described above can significantly improve business development capabilities and are worth serious consideration by management teams.

mark-lubkeman-tcm9-221603.jpg

Managing Director & Senior Partner

Filip-Hansen.jpg

ABOUT BOSTON CONSULTING GROUP

Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.

Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.

© Boston Consulting Group 2024. All rights reserved.

For information or permission to reprint, please contact BCG at [email protected] . To find the latest BCG content and register to receive e-alerts on this topic or others, please visit bcg.com . Follow Boston Consulting Group on Facebook and X (formerly Twitter) .

What Is Next

Read more insights from BCG’s teams of experts.

489-unlocking-acquisitive-growth-1694x950-tcm9-62154.jpg

Lessons from Successful Serial Acquirers

Successful serial acquirers deliver more growth and create more value from acquisitions than their peers. What explains their success?

Most-Tech-Deals-Focus-on-Growth.-Most-Post-Merger-Integrations-Dont-hero-rectangle (1).jpg

Most Tech Deals Focus on Growth. Most Post-Merger Integrations Don’t.

A survey of dealmakers shows that technology companies can maximize the value from M&A by aligning their predeal strategy with their postdeal priorities.

cultivating-the-pearl-1694x950-tcm9-62276.jpg

Creating Value from Midsize Biopharma Acquisitions

Although small in scale relative to the acquiring company, midsize acquisitions are becoming important to creating value in the biopharmaceutical industry.

pmi-retail-1694x950-tcm9-65131.jpg

Post-Merger Integration in Retail

How to boost the odds that your M&A deal delivers the value you’re counting on? Start planning early for success—using a proven five-step process.

Ready for launch: Reshaping pharma’s strategy in the next normal

As COVID-19 cases continue to spread across the globe, the repercussions in healthcare extend across the value chain from patients and families to clinicians and pharmaceutical companies.

The industry faces a dual challenge. As well as helping to tackle COVID-19 spread by developing and distributing new vaccines and tests, it must continue to deliver innovative therapies and diagnos­tics to clinicians, patients, and healthcare systems—even as R&D, manufacturing, and supply chains are struggling to maintain business as usual.

An earlier McKinsey article considered how pharma companies can reorient their commercial model to respond to the new environment. Below, we focus on launch activities and identify five success factors to consider for commercial launches in the next normal.

Familiar challenges and new complications

Even before the COVID-19 outbreak, launching a new drug was far from straightforward. Forty percent of worldwide drug launches between 2009 and 2017 failed to meet their two-year sales forecasts. 1 McKinsey analysis of pharmaceutical-industry data from Evaluate, August 2020. A successful launch must overcome a series of barriers, including intensifying competition, increasing pricing pressure, growing access challenges, and rising expectations among caregivers and patients. The pandemic and its economic consequences have added further complications to what was already a risky launch environment.

We analyzed 86 launches scheduled for 2018 onward with expected sales in excess of $300 million. We found that between February and August 2020, all of these launches were disrupted through delays, lost revenues, or both. Companies chose to delay launches in 45 percent of cases, regulatory delays affected another 40 percent, and other external factors such as supply-chain problems accounted for the remaining 15 percent of delays. 2 This article draws on insights from a global survey conducted by McKinsey in June 2020 among 101 managers with recently launched drugs that had not reached their peak sales or drugs scheduled for launch between January and June 2020 that had been delayed. In the United States, for instance, the median interval between approval and first scripts had increased more than threefold by May 2020, from 17 to 58 days, although it shrunk back to 21 days by September. 3 McKinsey analyzed products launched from March 2020 or awaiting launch, using data from PHAST (Pharmaceutical Audit Suite) and Evaluate. For products not yet launched, the interval between the FDA-approval date and September 2020 was used as a proxy for the interval between approval and launch.

The pandemic also had a marked impact on the financial performance of the launches we analyzed. In 50 out of the 86 disrupted launches, companies lowered their expectations by more than 25 percent. Overall, we estimate that the changes in analyst consensus expectations between March and August 2020 represent a 9 percent decline in the net present value of the 86 drugs—the equivalent of a total loss of some $10 billion globally. 4 McKinsey used August 2020 data from Evaluate and estimates from March 2020 or earlier to calculate how the net present value of the 86 drugs changed in the months following the outbreak of COVID-19.

Why the traditional launch model is losing effectiveness

It is too soon to evaluate the full impact of the COVID-19 pandemic on drug launches. However, it is clear that major shifts in the way that healthcare professionals (HCPs) interact with pharma companies will present a challenge for the traditional launch model, with its reliance on face-to-face meetings with physicians and its “one size fits all” approach to engagement.

One immediate consequence of the pandemic has been a drastic reduction in pharma companies’ visits to HCPs. A survey conducted by McKinsey in Europe shows that the average number of in-person contacts between HCPs and pharma sales reps was 70 percent lower in September 2020 than before the pandemic. 5 McKinsey COVID-19 Survey: EU Physician Experiences, Expectations, and Perspectives on Pharma Engagement; survey in the field in May and September 2020. In parallel, HCPs’ adoption of digital channels and telemedicine has accelerated for interactions with patients and pharma reps alike. In the same survey, the HCPs who are highly open to remote engagement with sales reps report conducting almost half of their patient consultations remotely as well.

However, this broad overview masks considerable differences in HCPs’ preferences and expectations. A McKinsey survey conducted in May and September 2020 to assess sentiment among more than 900 physicians in five European countries yielded a patchwork of responses (Exhibit 1).

Only 18 percent of the physicians surveyed in May were willing to accept reps’ visits, but by September, that percentage had risen to 31 percent, suggesting that preferences shift over time as infection rates change and HCPs adjust to new circumstances. 6 McKinsey COVID-19 Survey: EU Physician Experiences, Expectations, and Perspectives on Pharma Engagement; survey in the field in May and September 2020. Preferences also vary by country. In the September survey, more than 50 percent of HCPs in France, Germany, and Italy expressed a willingness to accept regular face-to-face visits from reps, but only 11 percent of their UK peers felt the same way.

These findings suggest that the traditional pharma commercial model will likely struggle to adapt to a different world. When reps venture back into the field, they will need to address the plurality and access challenges of the new interaction landscape. To do that, they will need to consider a new approach to launches: one that is digital, local, and personalized.

What next? Five success factors to consider for a launch strategy

For a pharma company looking to reinvent its commercial model, the launch of new products is a golden opportunity to try out new techniques and gauge their impact before rolling them out more widely. Given the uncertainties triggered by the pandemic and the radical changes in physicians’ preferences and behaviors, replicating successful launch strategies from the past is no longer a safe option. Our work with pharma companies indicates that leaders designing a new strategy should consider paying close attention to five success factors: rapidly personalized content, analytics-enabled engagement, innovative patient channels and services, nimble frontline operations, and closed-loop execution (Exhibit 2). We outline each of these five factors in greater detail below.

Rapidly personalized content

With HCPs’ preferences so variable and changeable, pharma companies need clear, up-to-date per­spectives on each physician’s interests and wishes so they can gear messages to individual needs and concerns. Basing communications on an undifferentiated aggregate view of physicians or segments will no longer suffice. For each new product launch, best-practice companies compile a set of marketing and medical modules to cover the full spectrum of HCP needs and then ask reps to use their insight into individual physicians to select the modules that best meet their needs.

While this approach has been true for many years, the difference is that today those new modules need to be created quickly to be relevant. A better way to stay relevant is to engage HCPs on the current hot topics in their field—for example, what best practices are emerging in telemedicine? How are HCPs managing COVID-19 infection risk for patients? What do key opinion leaders think about the potential for drug-to-drug interactions with COVID-19 vaccines?

Familiar product-oriented and company-centered approaches to content may also need rethinking. To reduce development cycles, content creation and review processes need to be streamlined and simplified. With agile approaches, companies can book a meeting with an HCP, gather feedback, and capture it immediately in the next iteration of content development. In that way, content can be approved and refined within approval cycles of no more than two to four weeks.

For a pharma company looking to reinvent its commercial model, the launch of new products is a golden opportunity to try out new techniques and gauge their impact before rolling them out more widely.

Analytics-enabled engagement

If a universal approach is no longer an option for content, the same is true of engagement. The days of casual appointments and conversations in hallways are over. Whether an interaction is face to face or remote, it needs to be scheduled and an agenda shared in advance. A rep needs to have something new and compelling to discuss or risks that the meeting might never happen.

To understand individual physicians’ preferences for interaction frequency and channels, innovative companies are creating data lakes, building predic­tive models, and drawing on unfamiliar data sources—not only customer-relationship-management (CRM) systems, sales records, and quantitative surveys, say, but also claims data for providers at a physician’s office. Innovative approaches can yield surprising results. In the United States, for instance, some pharma com­panies found they can predict physicians’ willingness to engage with reps more accurately from foot traffic and credit-card spend in a given zip code than from local state restrictions or COVID-19 infection rates.

Since relevant historical data on physician prefer­ences on interactions with sales reps is seldom available at launch, the process of generating insights typically begins with field reps reporting on the impressions they gained of HCPs’ preferences during prelaunch interactions with them. As the product launch progresses, important factors such as physi­cian feedback, field insights, and prescription volume are used to flesh out and update this prelimi­nary picture. Through a continual process of refinement, the predictive model on launch success becomes more powerful and its output better aligned with the realities of the market. As a physician’s preferences evolve—both in response to the new product as well as in engagement channels—the model adjusts its recommendations, enabling reps to fine-tune content and channel choices for an audience of one to provide an optimal personalized experience at launch.

To implement an analytics-based approach to engagement, pharma leaders also need to ensure that two critical enablers are in place: a tech and data backbone to enable seamless integration across channels and data sources, and a platform for run­ning advanced-analytics models to enable leaders to distinguish signals from noise, improve deci­sion making in real time, and optimize messages, channels, and timing in individual HCP interactions.

Innovative patient channels and services

In a McKinsey survey of 300 physicians in September 2020, 74 percent of respondents reported noticing their patients delaying necessary care, with conse­quences including an increase in complications from injury or disease, a loss of income from missing work, and a rise in the costs of care. For new product launches, this finding is significant, since patients who have yet to be treated for a new medical condition are often the ones most interested in a new product for treat­ment. However, as patients delay care due to the COVID-19 pandemic, the pool of new patients that may have benefited from being treated with a new product is declining as well. The new hurdles created by the COVID-19 pandemic call for innovative services from pharma companies, as well as from healthcare systems and professionals, to stay connected with patients.

As the survey indicates, the perceived risk of engag­ing with health systems has made many patients wary of face-to-face interactions in all but the most serious cases. Those suffering from nonurgent conditions, such as migraines, insomnia, and depres­sion, are less likely to request appointments with primary-care physicians. Responsive companies have been stepping in to facilitate inter­actions with HCPs by offering telemedicine diagnostic platforms in app form or through the integration of web, text, and voice.

Maintaining or adjusting treatment can also be dif­ficult in today’s circumstances, especially for infusions, injections, and other therapies that require attendance at a hospital or clinic. Innovative companies are developing alternative infusion sites, enabling “at home” infusion, and offering guidance on how to minimize risk when visiting health facilities.

Nimble frontline operations

As pharma companies gear up for remote launch activities, they can help their sales reps build new capabilities that can enhance their impact on launch success. As virtual calls replace in-person visits, reps can foster a sense of proximity with HCPs by learning to make the most of cameras, screen sharing, and other interaction tools. Soft skills such as deep listening will help sales reps gather insights on physicians’ unmet needs and sources of dissatisfaction. Feeding these insights back into CRM systems will enhance their predictive power and enable the organization to rapidly correct course where needed.

As the use of video, interactive content, and multi­person interactions increases, companies will also need to rethink marketing materials so that they are effective in remote settings. Meanwhile, marketing staff will need to further develop their ability to optimize marketing campaigns based on HCP engagement, as well as using CRM data and dashboards to assess the effectiveness of past and future actions. Capability-building programs will equip staff with the soft and hard skills— from empathy to proficiency with advanced digital tools—required for success in a rapidly changing launch environment.

Capabilities aside, launch programs give companies an opportunity to reassess the setup of their field force. With less time spent traveling and waiting to see HCPs, reps have more capacity to pursue value-added opportunities. One example might be expanding physician engagement beyond the treatment network—through referral networks, for instance—especially now that location is no longer a constraint. Building a fuller view of customer-facing roles and interactions should allow launch leaders to allocate frontline capacity in a more effective and granular manner.

Closed-loop execution

Today’s environment makes agile ways of working a necessity. With launches no longer following a common regional or national strategy but tailored to suit local contexts, each initiative must be tracked and redirected in real time as early feedback and results on sales tactics are gathered. This kind of closed-loop execution requires changes in governance and in how decisions are made.

For instance, regional leads should be empowered to fine-tune targeting philosophy and product positioning in response to the feedback they gather locally. Meanwhile, central launch teams can share best practices or make suggestions by aggregating the success rate of different approaches across various target segments and regions. Campaigns that prove effective can be scaled up across broader geographies, while ineffective campaigns can be replaced with new campaigns that are tested and, in turn, refined or replaced as needed based on their results. Consequently, launch plans are updated in rapid iterations at national and regional levels to ensure that insights and opportunities are fully captured. To manage this process and experiment with new methods and ways of working, some companies set up launch situation rooms  that pull together data on sales, volume uptake, and other standard metrics with field insights garnered through rep apps to analyze launch performance in real time. Adopting an agile operating model with processes that support cross-functional collaboration enables launch teams to rapidly create campaigns to address shifting customer needs.

The turbulence of the past few months has made pharma companies keenly aware of the need to rethink their medical education, engagement channels, and platforms—but it has also left some of them paralyzed by uncertainty. Should they invest now in transforming their commercial model or wait to see how things play out? As com­mercial leaders consider their go-to-market plans for new drugs, they have a unique opportunity to experiment with new approaches without disrupting their entire business model. Innovations developed for new drugs that prove valuable for commercial success will reshape the commercial strategy of the whole company.

Arafat Mlika is an associate partner in McKinsey’s Geneva office, Jennifer Mong is a consultant in the Silicon Valley office, Nils Peters  is a partner in the Zurich office, and Pablo Salazar is a partner in the Stamford office.

Explore a career with us

Related articles.

COVID-19 and commercial pharma: Navigating an uneven recovery

COVID-19 and commercial pharma: Navigating an uneven recovery

Winning against COVID-19: The implications for biopharma

Winning against COVID-19: The implications for biopharma

  • Business Plans Handbook
  • Business Plans - Volume 03
  • Pharmaceutical Company Business Plan

Pharmaceutical Company

Pharmaceutical Company 432

BUSINESS PLAN

PAIN AWAY LTD.

1117 High St. Poughkeepsie, NY 13495

The company described in this plan has moved beyond the initial start-up phase and is now seeking investors to finance its growth. Much of the plan, therefore, is geared toward persuading, explaining, and reassuring potential investors that the company (which produces a therapeutic, topical pain cream), is well-managed and stable. The in-depth analysis of the company's competitors is an outstanding feature of this plan, as is its market research.

EXECUTIVE SUMMARY/OVERVIEW

Competition.

  • PROPERTY & FACILITIES
  • PATENTS & TRADEMARKS
  • RESEARCH & DEVELOPMENT

GOVERNMENT REGULATIONS

Insurance and taxes, corporate structure, risk factors.

  • RETURN ON INVESTMENT AND EXIT
  • ANALYSIS OF OPERATIONS & PROJECTIONS

FINANCIAL STATEMENTS

Type of business.

Non-prescription drug wholesalers; US SIC Code - 2834 Pharmaceutical Preparations.

Company Summary

Pain Away Ltd. is a going concern, a Delaware corporation formed in January 1995 to manufacture and sell its premier launch product Pain Away, a topical pain remedy using FDA-approved homeopathic ingredients developed for the simple purpose of relieving pain. The company was formed by its parent S-corporation, Peale, Inc. in order to market products nationally and internationally. Peale, Inc. was formed in February 1994 to complete the development of the launch product. The formation of the company was a significant step in a 9-year process of refining and testing a homeopathic formula first used by company founder and CEO Robert Peale to alleviate his pain from carpal tunnel syndrome. The R&D phase of this product began when Mr. Peale purchased the original formula, did a thorough study of homeopathy, and refined the formula to its present marketable state. From the beginning of R&D, Mr. Peale worked within FDA guidelines in order to secure FDA registration. Then, in February 1994, the company was formed to finally manufacture and sell the product. Starting with only a handful of customers, including some professionals, chiropractors, physical therapists, etc., only 19 months of operation have yielded 12,000 individual customers with an 80% reorder rate. The current customer base now includes medical doctors from different specialties, sports trainers, and athletes, both professional and amateur. The company expects to show a profit in 1996 and estimates that it will be very profitable in 3 years.

Mr. Peale is 49 years old and has a 25-year history in sales, sales management, and marketing for a tool distribution company. His deep study of homeopathic medicines started in 1985 and included studies in nutritional supplements. Mr. Peale has been invited to sit on a newly-formed FDA committee addressing the growing national interest in natural medicines.

Curtis Company president, Ms. Alana has 25 years of experience in retail and direct sales. She has been a senior sales director and sales trainer for Beautiful You Cosmetics, has owned and operated a retail sporting goods store, and has managed a 15 person, $1 million department for a major chain retailer. She also has some banking experience.

Vice-president of marketing, Ryan Lemon has 32 years of experience as production manager, buyer, sales manager, and marketing manager. He was director of marketing for Pilgrim Health and was responsible for their first launch into New Jersey which led to their first $18MM in sales (in 3 years). He has a BS degree in textile engineering and has also done independent marketing consulting.

Product and Competition

The R&D mission was to develop a greaseless, odorless, topical cream which was measurably more effective at relieving pain than any other OTC (over the counter) topical product. This mission has been accomplished. The company has collected anecdotal, testimonial, and uncontrolled medical study evidence that Pain Away is more effective than the leading topical analgesics such as Arthritin and others. The product's effectiveness in relieving pain is its most powerful benefit, besides the added benefits of it being greaseless and odorless. What distinguishes Pain Away from any other topical analgesic in this still-growing $402.1MM market is its advanced homeopathic formula - a refined blend of 11 FDA approved pure and natural ingredients. The typical OTC topical analgesic works to either block the sensation of pain or distract perception of deep pain by "counterirritating" another localized area near the pain. Pain Away's formula is different. Pain Away treats pain at its source. It stimulates improved circulation in the micro-capillary system in the ligaments and tendons, where most pain is felt. Pain-relief from Pain Away is the result of the body's own self-healing. It also can be applied several times a day because it is odorless and greaseless. The US pain management market ($15.2 billion by 1997) is a mature market with intense, established competition ("The Market for Pain Management Products in the US - Introduction, Drugs, Devices, Trends, and Market Structure," in FIND-SVP). With future pharmaceutical market growth dependent upon new and innovative product additions, Pain Away is entering the field at the right time. The company will distinguish itself and its market position by dedication to the development of only natural-ingredient products. Since its unique formula of ingredients already has FDA approval, the company aims to penetrate the OTC pharmaceutical market, where new products traditionally find success. Here Pain Away will compete with topical as well as internal analgesics, including aspirin, acetaminophin and ibuprofen. An estimated 4,000 people a year die from aspirin overdose. A condition known as "analgesic neuropathy" can result from extended or inappropriate use of analgesics. Medical studies linking heavy usage to health problems have affected aspirin, acetaminophin, and ibuprofen. Pain Away can be marketed as a substitute for (reducing overdose risk with internal analgesics), or as a supplement to (using Pain Away can reduce needed dosage of internal analgesics) internal analgesics when used for certain pain relief. Furthermore, Pain Away is not contraindicated for use with any other medication. This broad-based appeal is built upon the reliability of Pain Away's effectiveness in relieving pain, inflammation, and spasm associated with arthritis, bursitis, sciatic spasm, neck/back pain, tendonitis, tennis elbow, tension headache, achilles tendonitis, and carpal tunnel syndrome.

A second product, a natural anti-inflammatory nutritional support system formula known as "Pain Away Plus," will soon be marketed as a companion product to Pain Away. This multistaged formula is a combination of trace minerals, herbs, and a natural cartilage-derived substance. The company has long-term plans to develop more health-related products.

Funds Requested

Company principals have invested all available personal assets into the product development and operations to date. The need for capital is in the context of the readiness of the product for mass marketing. Management is seeking a $1,500,000 equity investment in exchange for a suggested 30% ownership of the company. All terms of financing are negotiable in order to meet the financial requirements of the investor.

Use of Proceeds

Advertising & promotion campaign - $1,200,000 (see below); Market research - $300,000. The company anticipates the need for follow-on financing after 24 months of business.

Pharmaceutical Company: Pain Away Ltd.

Financial History

Pharmaceutical Company: Pain Away Ltd.

Sales were first made in 5/94 under Peale Inc. ($143,881). As sales expanded nationally, Pain Away Ltd was formed in January 1995. All sales since then have been under Pain Away Ltd.

Financial Projections

Pharmaceutical Company: Pain Away Ltd.

With capital request accomodated, the company believes that Pain Away will jump in sales starting in 1996.

The company will attempt a public offering based on year 2000 earnings. If there is no public market and no prospect for a public market in the near future, then the company will offer to buy back the stock owned by the venture capitalist. A predetermined price could be set ahead of time, if desired by the venture capitalist.

The product effectiveness, evidenced largely through anecdotal evidence, personal testimonials, and repeat sales, has formed the basis for the future growth of the company. Together with a second, complementary product (nearly ready for market), the launch product will be aggressively mass marketed as a pain management system for the next five to ten years. Past and current sales have been to end-users, health professionals, and to some retail chains. The company and product are now poised for first stage expansion. Over 30 target wholesale markets have been identified. While the company uses its marketing strategy to enter these wholesale markets, simultaneous efforts will be made to develop research protocols. Management is confident that the anecdotal evidence and personal testimonials will be strengthened by controlled studies, designed to test the effectiveness of the product and demonstrate the physiological healing activity stimulated by the formula. With scientific credibility, the product will not only build its position in the $150 million homeopathic product category but will also strengthen its transition into the formidable mainstream topical analgesic category.

Future research is planned, based upon inquiry, in order to adapt the formula for animal use (Pain Away currently being tested on thoroughbred horses).

At the end of five years, the company intends to have at least one additional health product and should be able to go public off its revenues. The long-term goal for the company is to become an entrepreneurial leader in the development of natural products for various segments of the health care market. The company plans to capture enough share of the topical analgesic market to become either a viable joint venture partner or an acquisition candidate.

The product formula and delivery system are proprietary. The formula is uniquely advanced and is nearly immediately effective in relieving pain. Homeopathy and immunization have much in common, namely the principle of similars, which states that whatever a substance causes in a large dose, it can stimulate an immune response to defend against it in a small dose. It works by the principles of stimulation to the body's own self-healing mechanism and by the scientific balancing of its natural active ingredients through a dilution process called micro-dosing. Micro-dosing has given homeopathy its 200-year history of safety with no known side effects or toxicity. This self-healing process is in contrast to the majority of commercially successful topical analgesics, which contain counter-irritants, including the newer capsaicin-based products. These ingredients cause a superficial inflammation on the skin which masks pain by deadening the sensation of pain in the epidermal nerve endings only, or by distracting from the perception of pain by irritating an area near the pain source. The Pain Away formula has been developed with precision and balance and is a product that is effective and safe for use on all skin types. Pain Away's eleven active ingredients stimulate improved circulation in the micro-capillary system to ligaments and tendons, where most pain is felt. Pain relief is the result of the body's self-healing.

The manufacturing is sub-contracted out to a highly respected FDA-licensed manufacturer of homeopathic products.

An important unique feature of Pain Away which distinguishes it from other homeopathic remedies is that Pain Away is a topical treatment and is not a systemic treatment. As such, it requires little knowledge to use and is conducive to cross-merchandising in the mainstream analgesic category. Furthermore, since Pain Away is a formula of ingredients, it provides a broad spectrum of effects as compared to single remedies.

The personal commitment of the founder to relieve his own pain also adds a unique value to the story of this product - a story which can enhance marketability - to anyone who is in pain or anyone who knows someone in pain.

Although Pain Away is an homeopathic product, the company will position itself as a natural ingredients company - not necessarily homeopathic. All the company principals plan to engage both septics and advocates of complementary medicine by applying rigorous scientific standards equally across the board, for both conventional and unconventional treatments. Contacts have already been made with the National Institute of Health regarding future research.

Product Description

The product is a specialty consumer good carrying a suggested retail price of $19.95 for a 3.7 oz. jar (1.9 oz. jar also available at $12.95). The jar is designed with a medical appearance. The jar is easy to ship in multiples, is easy to stack on a shelf, is aesthetically pleasing, and has an easy-to-handle screw cap. The actual cream is greaseless, easy and pleasant to apply, and is odorless. Pain Away has, to date, largely been sold directly to end-users, and wholesale to retailers, distributors, and catalogues. The markets have supported the suggested retail price, which was arrived at by surveying market research supporting the $19.95 price along with the perceived value of the product compared to similar products at about the same price. This price also yielded a gross profit of $3.75 per jar and allowed for 100% markup from wholesale.

The eleven ingredients are readily available through top-quality labs which control for purity and authenticity. The cream is compatible with any medication being taken. The product carries a money-back 30-day guarantee.

Purchasers of the Product

Preliminary studies done by independent treatment professionals (no control group used) have shown that Pain Away has been effective for relieving the pain, inflammation, and spasm associated with arthritis, bursitis, sciatic spasm, neck and back pain, tendonitis, tennis elbow, tension headache, achilles tendonitis, and carpal tunnel syndrome. Anyone suffering these ailments, treating these ailments, or caring about anyone suffering these ailments is a potential purchaser of the product. A New Jersey hockey team uses Pain Away prior to workouts, competition, and for pain relief. The head trainer for the team says, "There's no product better for contusion of the quadriceps." He has reported shorter recovery times as a result of using Pain Away. Reports from athletes are that using Pain Away before and after workouts yields less cramping, fatigue, and soreness.

Top purchasers of TPR to date:

Pharmaceutical Company: Pain Away Ltd.

The total market for OTC internal and topical analgesics is estimated at $3.6 billion for 1995 and is projected to be $4 billion by 1997. With over 400 brands saturating this mature market, growth is still occurring through new products and product innovations. Driving this growth are:

  • increasing use of pain management products for the over-50 population segment, whose numbers are increasing
  • increasing awareness that pain does not have to be tolerated and can be treated
  • price increases

Body/Muscle Pain Market

The market is dominated by internal analgesics:

Pharmaceutical Company: Pain Away Ltd.

Pain Away is a new product to this sizable OTC pain-relief market. It will enter this large arena riding on its effectiveness and coming from the new and growing alternative health care market segment. As a new OTC product, Pain Away has such a broad-based appeal that it will be sold to a large portion of the total OTC pain-relief market (both internal & topical), estimated to be 84% of all US adults and growing as the baby boom population ages and concerns regarding age-related ailments, such as arthritis, increase. Of this 84%, about 25% alone use pain-relief products for body/muscle pain for which Pain Away is especially suited. Just this one type of ailment offers a substantial market potential:

Pharmaceutical Company: Pain Away Ltd.

If only 40.3 million Americans (25% of 84% of adults) use an OTC pain-relief product three times a week for body/muscle pain alone, then the market potential is 6.3 billion uses of a pain-relieving product per year. Past use of Pain Away has indicated that a minimum of 3 applications per week would use about one 3.7 oz. jar per month. A conservative yearly estimate would be 10 jars per year, with consistent use. In order to reach a five-year sales goal of $50 million (6.7 MM jars), 667 MM consistent purchasers (10 jars/yr.) are needed. Product history has indicated a consistent 80% reorder rate, so at this rate, 833,000 original purchasers are required. This figure is 2.07% of just this one market segment. The company is very confident that it can capture 2.07% of this market segment within five years, especially considering that the roughly 40 million Americans who exercise on a regular basis, and who are aging, are included in this segment. Anecdotal reports from athletes who use Pain Away are that it can prevent injuries by "warming up" vulnerable muscles and joints prior to a workout. The product has wide applicability within this segment. The table below shows the percentage of the body/muscle pain market segment required to meet the next 5 years of sales projections.

Pharmaceutical Company: Pain Away Ltd.

These numbers are based upon a wholesale price of $7.50 per jar and a usage rate of 10 jars/year with a segment population of 40.3 million potential purchasers.

The prescription pain relief market is a distinct market which Pain Away will not attempt to penetrate. Pain Away can, however, compete directly with nearly all pain-relief products because of its unique identity of being both a substitute and a supplement to ail competing products. This uniqueness fits a projected market shift from internal to topical analgesic use as the population ages, and derives from 2 factors: 1) Use of Pain Away can reduce the needed dosage of any pain-relieving medication and 2) Pain Away is already part of a rapidly growing segment (25%-30%/year) of consumers who use alternative health care because of a disenchantment with OTC drugs and a concern about side effects with adverse reactions. Use of Pain Away can reduce needed dosage of other pain-relieving medications. As stated earlier, Pain Away's effectiveness is based upon the homeopathic principle of microdosing. While it promotes self-healing by stimulating blood flow to micro-capillaries, it remains safe for all skin types and with use of any other medication. Anecdotal evidence (from hospitals, some doctors, and occupational rehab center) has indicated that use of Pain Away alone has yielded positive results and use of Pain Away, along with other treatments, has seemed to accelerate recovery. As always, this kind of evidence will be scientifically studied. The salient point is that Pain Away can be a substitute and/or a supplement in pain management, and thereby reduce needed dosages of other medications.

Alternative Health Care Segment

Homeopathy, being an established (officially recognized by UK National Health Service) and significant alternative mode of treatment, is gaining increasing acceptance in mainstream American health care. The National Institute of Health has even awarded grant money for research in alternative treatments, including homeopathy. Drug retailers report that homeopathy may be the fastest-growing category in the trade class of drug chains. Since homeopathy is gaining acceptance as an alternative treatment, the market segments which are already embracing these alternatives will continue to be targeted in the company's initial expansion. These segments include people ages 25-elderly, who seek improved quality in life, and whose lifestyle values involve "newness." This segment includes most of the "baby-boomer" population, estimated at over 75 million. The market of alternative health care seekers is characterized by patients who can and will pay for their own care. As much as 70% of alternative medical treatments are still paid for by patients themselves rather than insurers. This kind of purchasing indicates a willingness to try an alternative product and continue purchasing based upon perceived value of the product's effectiveness. Company management has been encouraged by the consistent 80% reorder rate and knows sales will be sustained once initial purchases are made. The alternative health care market is of respectable proportion. According to the New England Journal of Medicine (1/28/93), 34% of Americans spend $13 billion/year on alternative treatments such as chiropractic, acupuncture, massage, and homeopathy. Pain Away is already marketed to all of these treatment specialties so it will reach the spectrum of alternative treatment. This 34% of Americans are familiar with the term "homeopathic," so there's a consumer predisposition to being further educated about homeopathy as a value-added natural ingredient alternative.

The company will build an early market position on the alternative health-care market and will join the growth of the homeopathic segment as it moves from the fringes to the mainstream of the OTC pharmaceutical market.

Alternative Market Potential:

Pharmaceutical Company: Pain Away Ltd.

If only about one third of Americans use an an alternative pain-reliever just twice per month, then the market potential is 2 trillion uses of an alternative pain-relieving product per year. Market indicators are that both the number of users and the frequency of use will increase as the population ages. The use rate of 2 times per month converts to 2 jars of Pain Away per year with consistent use. Again, in order to reach the 6.7 million jar sales goal ($50 MM), at the re-order rate of 80%, Pain Away would have to make 4.2 million initial sales in order to sustain 3.3 million consistent purchasers. This size customer base comprises 4.71% of the growing alternative health care market. The company believes that this sales goal is attainable within the next five years. The table below shows the percentage of the alternative health care market segment required to meet projected sales.

Pharmaceutical Company: Pain Away Ltd.

These numbers are based upon a wholesale price of $7.50 per jar and a usage rate of 2 jars/year with a segment population of 89.1 million potential purchasers.

Narrowing the Market Focus 2X

The market potential for pain relief products is huge. By narrowing the focus to product category sales, the potential becomes more exact. Pain Away's product category is within the topical analgesic market, estimated at $402.1 MM annually with a projected $522.7 MM market in 1996 (30% growth) and $692.6 in 1997 (32.5% growth). Starting with $522.7 as the base market volume, and with 30% growth per year for the next 5 years, Pain Away would have to capture 3.33% of the year 2000 market volume to make its sales goal of $50MM. Management believes that these goals are attainable.

The table below shows what percentage of the topical analgesic market will meet Pain Away's sales projections.

Pharmaceutical Company: Pain Away Ltd.

The focus can be narrowed further to the homeopathic product category, which is growing at a rapid rate at this time. The dollar volume of this segment is estimated at present to be between $150 million and $215 million and expected to grow at a rate of 25% to 30% a year. Some market-trackers say that retail sales haven't grown enough to support the existing number of homeopathic manufacturers and that a shakeout will consolidate sales in the hands of fewer manufacturers. The forseeable trend, however, is progressive growth from the fringes to mainstream markets, and at a rapid rate. The table below again shows percentages of this dollar volume required to meet sales projections.

Pharmaceutical Company: Pain Away Ltd.

These numbers are based upon a 1996 volume mid-point between the projected volume range of $150 MM and $215 MM. Growth rate is 25% a year. At first glance these percentages may seem daunting. However, the manufacturers supplying this niche are relatively few in number and therefore hold significant market shares A new player can get a reasonable market share with the right product and marketing plan. The mainstream merchandising of homeopathic products started in the early '90's and has been tested as a lucrative direction. Company management is very confident that Pain Away will gain enough share points to capitalize on the rapid growth of this product category. Pain Away will not remain in the homeopathic niche. Its effectiveness will make it competitive with mainstream topical angalgesics.

International Markets

The company will also develop an international market. A 10,000-unit order has already been received from a distribution company in Hungary and is awaiting final approval from the Hungarian State Department of Pharmacy. A small order was also sent to well-known sports figure in Spain. Discussions are underway for this individual to start large-scale distribution. The homeopathy market in the UK is estimated at 18M pounds and in Germany at 120M pounds, so European marketing could be strengthened by the homeopathic identity alone. In Germany, an independent division of the German Federal Health Agency publishes monographs on the safety and efficacy of herbal medicines. The company believes that Pain Away would fare excellently under such review and will carefully research and plan when and how to reach such markets.

There are many companies competing for shares of the 3.6 billion dollar OTC analgesic market. The major players are the internal analgesic manufacturers:

Pharmaceutical Company: Pain Away Ltd.

The balance of the OTC internal analgesic market is held by private label companies and "others." The major strengths of this level of competition are obvious in comparison to Pain Away's present market position. The major players have:

  • a manufacturing cost advantage,
  • sophisticated market knowledge and access,
  • established sales capability,
  • strong R&D capacity,
  • and of course, brand name loyalty.

An important competitive strength of Pain Away is that it is topical - pain relief is accomplished without risk of overdose and consequent risk of serious side effects. This competitive strength derives from a previously noted shift in the market from internal to topical analgesic use. This shift in consumer preference, along with Pain Away's effectiveness, can position the product as a substitute/supplement among these large competitors. Management is ever mindful that mainstream pharmaceutical companies are watchful of the homeopathic market and will act accordingly should market share be lost to homeopathic remedies. Becoming a viable acquisition candidate to any one of its major competitors is a realistic goal. Pain Away management is committed to quality product development and is also open to strategic alliances which would enhance its market capability.

The competition in the topical analgesic market is head-to-head. The top competitors are:

Pharmaceutical Company: Pain Away Ltd.

The basis for the competitive analysis is Pain Away's most competitive feature:

  • It doesn't have any of the aforementioned advantages held by the major, well-known players in this market - yet.
  • It doesn't have widespread brand name recognition - yet.
  • It doesn't have appreciable market share in topical analgesics, alternative health, or homeopathy - yet.
  • It does have a unique formula of safe and effective ingredients which none of the above products have.

All topical analgesics contain counter-irritants, including camphor, menthol, methyl salicylate, eucalyptus, wintergreen, and even the popular capsaicin. These ingredients, even when blended, act primarily to cause a superficial inflammation on the skin. This inflammation serves to hide the pain by deadening pain receptors in the skin.

What distinguishes Pain Away from all of the above products is that the eleven active homeopathic ingredients stimulate the blood flow in the body's micro-capillaries and act synergistically with the body tissue. This stimulates the body's own self-healing. Pain is treated at its source. Company management believes that the unique effectiveness of Pain Away will give it competitive clout. The issue then becomes how to compete.

Although Pepperub (Pepper) and Vapol (Athens) enjoy the largest market share, they are vulnerable to new product introductions. Menthol Plus (Lucia) held the top position in this category last year until Pepperub was re-packaged and relaunched with line extensions. That relaunch along with a relaunch of Zanprin boosted sales of both brands and put Pepperub back on top. Pepperub, Vapol, and Mentholplus are all menthol-based products. Zanprin is a capsaicin-based product and has boosted usage of its relatively new ingredient. Other relatively new capsaicin products are Capcreme (Bioderm) and Capthol (Men-Thol Co.).

Company management believes that Pain Away is generally more effective than Pepperub and Vapol. However, these venerated brand names, large advertising budgets, and consumer loyalty are formidable competitive advantages. Pain Away will focus on other competitors in order to gain a market position.

The key competitors are Menthol Plus, made by Lucia and Zanprin, made by Skin Care Corp.. Menthol Plus is a menthol-based product which Pain Away has encountered head to head in the sports market. Menthol Plus has a retail price advantage in the mass market, selling for $4 for a 2 oz. tube. This price difference is of little concern because Pain Away will promote itself as a high value product. The topical analgesic, alternative health, and homeopathic markets all support pricing based on perceived product value. Menthol Plus' manufacturer has reduced the advertising budget for this product (about $2 million) recognizing from a 21% decrease in 1994 sales that the product has matured. The company plans to acquire other brands (no topical analgesics) and extend its other lines in order to generate sales growth. The company sells another topical analgesic which is doing well in sales but has not reached the same position as Menthol Plus. Pain Away will monitor the life cycle of Menthol Plus and move to gain any market share it might lose.

Zanprin, made by Skin Care Corp., is gaining market share because Zanprin (.025%) and Zanprin- X (.075%) are capsaicin-based products. Capsaicin, derived from cayenne peppers, has created a new segment in the market and is very popular. Other companies are making capsaic in products but Skin Care Corp. attracted market attention by relaunching Zanprin as an OTC consumer product. It had been marketed for seven years to physicians and kept behind the counter, carrying the credibility of a prescription product. In early 1995, the product was re-packaged for shelf space and supported by TV ads. Despite commanding premium prices ($19.95/2oz of Zanprin-X), the product has done dramatically well.

Skin Care Corp. claims that Zanprin is the "only brand with physician endorsement and specific clinical support." This is a credible claim, cultivated for seven years, and obviously contributing to sales of the product.

Skin Care claims to be the first in the industry to develop their highly purified version of capsaicin for a pharmaceutical base. Zanprin distinguishes itself by promoting controlled clinical studies which have supported its effectiveness. Skin Care claims that such clinical trials don't apply to other, less pure, capsaicin formulas. This scientific feature enhances product credibility among physicians and pharmacists.

The management of Pain Away Ltd. recognizes the effective marketing strategy used by Skin Care because it is similar to their own strategy. Advertising and promotion expense is critical. With proper capitalization, Pain Away can compete because the Pain Away homeopathic formula is unique and effective. Many capsaicin users, including Zanprin users, have complained about the burning sensation caused by capsaicin. Pain Away will stand up to any topical analgesic on the market and do very well with comfort, safety, and effectiveness. The company needs to get this message out. The seven-year product life of Zanprin, supported by unique and heavy TV advertising, gives Zanprin quite an edge. Zanprin is now a "new" growth product and Pain Away can grow behind it, by comparing ingredients and effectiveness at every turn. Pain Away is also in the same price range as Zanprin, doing slightly better with $19.95 for a 3.7 oz. jar or $12.95 for a 1.9 oz. jar.

Zanprin is not the "only brand with physician endorsement and specific clinical support." Pain Away has been cultivating health professional support since the R&D phase. The product is heavily endorsed, and more medical support is developing. Many of Pain Away's sales to date have been to health professionals. Regarding clinical support, Skin Care's success with this strategy underscores the strategic importance of Pain Away's plans for controlled clinical studies.

Speaking of "highly purified" formulas, Pain Away can compete strongly with any formula on the market, especially capsaicin-based. The company wants to discuss purity of ingredients and formula and will do so in all promotional efforts.

The remainder of the products listed in the top competitor list have of course the same advantages that any established company with significant market share has. Beyond these immediate competitive advantages, Pain Away can compete, again, on the ingredient effectiveness basis.

Aspratin, an odorless rub which contains Salycin, sold well when it was introduced in 1992. It held third place among topical analgesics at the end of 1993. It has since been surpassed by capsaicin-based Zanprin. Bioderm developed Capcreme and lowered its price when Zanprin was relaunched.

Capthol was recently developed by the long-established Men-Thol Co. and is a capsaicin-menthol blend designed to compensate for the sometimes delayed pain relief when using capsaicin alone.

Salicreme is a methylsalicylate product which has shown flat growth and has lost market share.

Lyptum was a rapid-growth product in 1990-1991 but has since lost market share. Besides the well-established brands like Pepperub, the products which are gaining in this market are the capsaicin-based. This product category is known to be affected by product innovation and development. With proper support, Pain Away will take a respectable market share.

Homeopathic Competition

The competition takes place in the drug chain arena. Homeopathy may well be the fastest-growing category in the trade class of drug chains (20% of all homeopathic product sales). Among the growing number of drug chains which are giving shelf space to homeopathic products are: Walgreens, Medicine Shoppes International, Thrifty Payless, Eckerd Corp., Edgehill Drugs, Genovese and FEDCO, a California supermarket chain. Research published in the Journal of Clinical Pharmacy and Therapeutics states that 27% of US pharmacists consider homeopathic medicines helpful while only 18% consider them useless. The crossover of homeopathy from health food stores, where sales are still strong, to mass markets is gaining momentum.

As mentioned earlier, there are relatively few companies supplying homeopathic products to the mass market. There are five major producers/distributors of homeopathic products.

Pharmaceutical Company: Pain Away Ltd.

Health System, Homeopathic Co., and Life-Right pioneered the distribution of homeopathic products to chain drug stores in the early 1990's and are now market leaders, although more companies are entering this lucrative market. Health System Products now has about 40% market share. Homeopathic Co. and Del Sol are aggressively developing the crossover into mass marketing with line development and heavy TV advertising.

All the topical analgesics listed above are arnica-based, with few other ingredients. Arnica Montana is the premier homeopathic medicine for the treatment of shock and trauma to the muscle. These formulas come the closest to Pain Away's because they contain some of the essential homeopathic pain-reducing ingredients. Pain Away's formula, however, blends more ingredients than any other homeopathic topical analgesic on the market. This more inclusive formula gives the product wider applicability. Price-wise, Pain Away is more expensive than most of the competing homeopathic products, where prices are in the $5-$10 range for 2oz.-4oz. sizes. But, this is a value-priced market, so price is not a critical variable. Since Pain Away is very competitive on an ingredient/effectiveness basis, the critical factor is having the resources to promote the product.

Future Competition

As has been noted, the topical analgesic category, including natural ingredient, is rapidly influenced by new clinical studies and product innovations. There are three main sources of new competition:

  • New ingredients and/or new innovations of existing ingredients. Examples are new products which employ the medicinal benefits of ammonium compounds. These products are designed to provide pain relief without the objectionable training room smells, burning sensations and stinging of abraded skin that are often caused by the majority of topical analgesics that contain menthol, methyl salicylate or capsaicin as active ingredients. Pain Away's formula has solved this sensation problem and is a less "high-tech" product, for which consumers are showing a preference.
  • Companies currently in this market who could increase market share and become major players. Pain Away Ltd. is in this category.
  • Chain drug companies may produce their own private label homeopathic products and corral a significant share of this growing market - much as they did in the non-homeopathic analgesic market. This scenario is more likely to happen as homeopathic companies expand the sales volume in this market and there are share points to be taken away by private labeling.

Pain Away Ltd. can be very competitive with the right promotional support.

Marketing Strategies

Increase market share by reducing market share of competitors. This strategy will capitalize on the market development to date and capture a share of markets held by existing pain-relieving topical applications. The key benefit is that conventional pain-relievers mask pain while Pain Away stimulates the body's own healing ability to directly battle an ailment. Another benefit is that homeopathic remedies have no known side effects while many pain-relievers, especially those ingested, have side effects. Neither will Pain Away interfere with any medication. This strategy requires extensive advertising in mainstream media, including infomercial, QVC (Pain Away already under review), 60 second commercial, cable TV, interactive TV, direct mail, independent sales reps, POP displays, and educational inserts/newsletters. One objective of planned controlled studies on the effectiveness of Pain Away is to use scientific evidence to help bridge the narrowing gap between natural and conventional medicine. Product studies will support this marketing strategy. In this context, the company will pursue preliminary inquiries from a favored vendor to use Pain Away in the workplace to study any reduction of lost work time and/or medical costs precipitated by repetitive stress injuries.

Expand a growing new market for alternative health care by positioning to lead this growing market. This strategy involves specialty catalogues (placed in 5 currently), placement on retail shelves of health food stores, educational product inserts/newsletters, media appearances discussing product, and independent sales reps. This strategy addresses the 89.1 million users of alternative health care.

The company has already been approached by two large Multi-Level Marketing companies. This strategy would involve creating private labels for a large customer. Of utmost consideration with this strategy is product identity and how this channel of distribution would affect it. This channel of distribution usually requires more price mark-up than the product would tolerate.

The company will create its own "competition" by developing private labels and/or separate companies to market to different niches.

Keep capital outlay to a minimum by licensing/franchising Pain Away to a brand-name company. This strategy would add value to the product in the form of brand name loyalty, manufacturing strength, and a strong sales/service force already in place. The company envisions its role in this type of strategic alliance as conducting scientific studies to increase the credibility of TPR and in developing new products. This strategy remains an option which could preclude other strategies under mutually acceptable terms.

Building on an initial order from a health product distribution company in Hungary, Pain Away Ltd. will penetrate the European market by targeting England and Germany, where homeopathy is an accepted form of treatment. This strategy would be developed only after a US market position was established.

Marketing Plan

The company is moving from start-up stage into its first growth stage. Market strategy to date can be succinctly described as selling "one jar at a time." Direct personal selling has been the mainstay in sales growth. This strategy has targeted any end-user willing to try the product. These early customers were reached through health care professionals and direct selling through state/county fairs, shopping mall space, health food store chains, and most recently lifestyle catalogues. As the company moves away from direct selling, a strategy which proved to be an excellent market test, into mass-marketing, identified market segments are being matched with appropriate distribution channels. The plan now is to expand and concentrate more on helping the consumer develop product preference by heavy advertising of the brand name, the benefits of the product, the ease of use, and the guarantee. Company expectations are that all advertising will be enhanced by results of controlled studies of product effectiveness.

The company intends to expand regionally, based on existing markets and consumer profiles (e.g., households from the South are likely heavy users of analgesics). The national market will only be tested by placement in catalogues with a distribution of 200 million. As regional sales grow and as the product gains recognition, then a national marketing strategy will take shape. Company management have begun discussions with a major marketing communications agency (Fortune 500 client list) who themselves approached Pain Away. The marketing and sales outline is as follows.

Marketing Function

  • A complete review and analysis of the topical analgesic market.
  • Utilization of Triad Groups conducted with the professional community and general consumers. Purpose is to identify professional and consumer preferences.
  • Based on research, create a product identity.
  • From product identity, establish professional and consumer strategic directions, which would affect product design, packaging, advertising, consumer promotion, and product publicity.
  • Test both professional and consumer strategic direction via two more Triad Groups.
  • Develop launch marketing plan with all elements and budget for both professional and consumer.
  • Actual implementation of the plan to include product design changes, packaging, advertising, consumer promotion, display, and product publicity.

Sales Function

Utilize a sales organization enabling direct-call coverage on the top 25 customers, which generally account for 80% of retail sales, and broker-managed coverage for the remainder. Launch plan would include a national sales meeting and all necessary materials.

Professional

Concentrate on the pharmacist community via co-op direct mail. Pharmacist recommendation at the purchase counter does affect sales.

The production process takes place in a standard homeopathic laboratory where raw materials are blended. There are no significant health or safety risks involved. Production orders are processed by purchase order for finished product. Some raw materials are usually on hand but more are ordered against purchase order requirements. Jars are ordered from a separate manufacturer and sent to the homeopathic laboratory to be filled, packaged, and shipped to Pain Away Ltd., where fulfillment is done.

The homeopathic laboratory has the capacity to fill all projected orders. As orders increase, Pain Away management will consider using a fulfillment service and more drop-shipping to wholesale customers. Cost of goods is estimated at 18% of gross sales. This figure has been consistent throughout production to date and is based on the complete production cycle.

There is no backlog.

Production Characteristics

The production process does not require any specialized or proprietary machinery. The critical factors in the production process are the highest quality of raw materials and the incubation process, which assures a stable finished product. Water is added to a base of vegetable/plant emollients. The eleven active ingredients are then mixed into the emulsion, which incubates for about 48 hours in large vats, while monitored for any fungal invasion. The finished product is then lab-tested for potency, which is done by lot number (the company gets lot samples). Filling is currently done by gravity-feed. The manufacturer might advance to computerized filling. One batch is 500 gallons. Lead time from order to packaged product is 4 weeks. Only a skilled and experienced manufacturer can produce the formula. Even other homeopathic manufacturers not familiar with a cream-based product would have difficulty with the production process. General topical analgesic manufacturers would need to become familiar with the raw materials and the production process in order to blend Pain Away's eleven active and ten inert ingredients. The company currently has one back-up manufacturer, which has never been used.

Labor Force and Employees

The company administrative staff consists of 5 people (recently reduced by 3) including the 3 officers. The two employees are paid an hourly wage. The staff are not unionized and there is no expectation of such. The labor supply in the region is more than sufficient to meet all future staffing needs. The sales force is comprised of independent agents who are paid on commission.

Pharmaceutical Company: Pain Away Ltd.

Currently, the laboratory procures all production materials. There are no shortages of key components, and multiple sources are available.

Subcontractors

All production is sub contracted out. Only fulfillment and shipping are done in-house. The company has formed a strong working relationship with Herbal Laboratories, which is the key subcontractor. Although management has selected a back-up manufacturer, the existing relationship with Herbal Labs has been more than satisfactory, so no change is foreseen. Other subcontractors supplying jars, labels, and boxes are used based upon price and service and can be replaced.

Standard office equipment is used for administrative functions. All production equipment at Herbal Laboratories is new and there is nothing that would cause production to be stopped for any appreciable time.

PROPERTY AND FACILITIES

The company facility is a single-story 1,950 square foot, cement block structure on about a two-acre cleared lot that is leased in one-year increments. The facility is located in northern Dutchess County, NY. All necessary commercial and industrial infrastructure is in place. The facility is easily accessible from major thoroughfares. The general area has been and is recovering from the closing of 2 large industrial facilities, so there's been anoticeable decline in property values. There is, however, a regional effort to re-direct the area to rely more upon small and entrepreneurial business. Management plans to purchase the building in order to add an appreciable fixed asset and to reduce expenses. The structure is easily expandable, so the company will not have to move during its critical growth stage.

PATENTS AND TRADEMARKS

Active homeopathics are not patentable. Management is exploring establishing a trademark and a formula patent.

RESEARCH AND DEVELOPMENT

The three principals have invested collectively $100,000, which has been capitalized. Plans for the immediate future include forming a research alliance with a university, hospital, or research group in order to develop a protocol for applying the "rigorous scientific standards" against which the effectiveness of Pain Away can be proven. Management has projected R&D expenses at $ 30,000 for the next 12-month period. These expenditures are intended for controlled studies proving effectiveness, and for continuation of developing applications for animals. Management is sales-marketing oriented and does not want to develop only a research lab. Any R&D will be designed to enhance sales and profits. Company management is currently investigating an SBIR grant.

There are no particular federal, state or local laws/regulations that affect the conduct of business. The manufacturer meets OSHA requirements, as does the Pain Away administrative facility. The FDA regulates homeopathy as an OTC non-prescription medicine. Pain Away's ingredients are in total compliance with FDA standards. Mr. Peale cultivated a working relationship with FDA representatives during the initial research and wisely intends to sustain such.

Product liability insurance is underwritten. A buy-sell agreement among officers exists but is not yet backed by insurance. Key employee insurance is also yet to be written.

All taxes are current. The company pays standard payroll, Social Security, and corporate taxes. The product is sales tax exempt in many states.

Company principals first formed an S-corporation under the name Peale Inc. The realization of the likelihood of international sales prompted management to form Pain Away Ltd. as the operational company. Peale Inc. serves a limited partnership which was formed to attract investors. Both companies are run by the same management team. All R&D is done through Peale Inc. There is comingling of funds. This proposal seeks financing for Pain Away Ltd. Return on the investment will derive from the sale of the product Pain Away itself and any other products which the company sells.

Pain Away Ltd. is a member of the Homeopathic Manufacturers Association. The officers were invited to participate in an annual meeting of the newly formed FDA committee on natural medicines. This committee works on the bases for regulations, compliance, and claims for the natural ingredient industry, covering vitamins, herbs, and homeopathy.

Management subscribes to the following publications:

  • Homeopathy Today
  • Natural Foods Merchandiser
  • American Health
  • Prevention Magazine
  • Let's Live
  • New England Journal of Medicine letter

Directors and Officers

A board of directors will be developed in the near future. There is interest from the medical, nutritional, and professional sports communities, as well as from a local bank. Officers are:

Robert Peale - CEO Alana Curtis - President Ryan Lemon - Vice-President, Marketing

Profit and loss responsibilities are shared by the officers.

The officers are primary key employees (backgrounds in executive summary). Other key employees include:

Key Employees

Leslie Ottaviani - bookkeeper and office manager - known by management for 5 years and described as "a dedicated innovator with a true grasp for details." She has experience supervising 20 employees in the accounting department of Worldwide Airlines and has worked as an independent bookkeeper for several companies in Hudson Valley, NY.

Julia Allen - administrative assistant - known by management for 6 years and described as "having people and problem-solving skills and works incredibly well under pressure." Her background includes sales in a successful business which included business consulting.

Remuneration

Pharmaceutical Company: Pain Away Ltd.

Accountant and Banker

Pharmaceutical Company: Pain Away Ltd.

All other fees paid on an ad hoc basis. Different attorneys have been used on an ad hoc basis (finance closing fees will be paid by the company).

Principal Shareholders

Pharmaceutical Company: Pain Away Ltd.

Proposed Financing

Management is willing to negotiate any structure which suits the investor. The company is seeking an equity investor. Management will provide a seat on the company's board of directors. Ongoing reports of key ratios, profit-loss statements, balance sheets, and annual audits would be provided to the investor. It is management's intent that the investor will enjoy returns on investment in excess of that of alternative investments, as a privately held company, while providing investor liquidity of his investment by taking the company public at its earliest opportunity.

Capital Structure

The existing capital structure includes a $50,000 unsecured line of credit with Poughkeepsie National Savings Bank. This line of credit was just brought to maturity in 1/96 for a 30-day period, at which time the line was renewed. If the current financing proposal is accomodated, then the line of credit can be increased.

Additional financing to date has derived from the sale of limited partnerships offering $.01 per 3.7 oz. jar royalty for every $1,000 invested. Each limited partner has been given the right to convert his/her capital investment into common stock when the company goes public, or, to receive back his/her original capital investment when the company goes public. Total amount of financing raised through the limited partnership is $100,000.

As mentioned earlier, officers have collectively invested about $100,000 in the company, mostly through the R&D phase. Officers' "sweat equity" is immeasurable.

As stated in the executive summary: Advertising & promotion campaign - $1,200,000 (see below); Market research - $300,000. The company anticipates the need for follow-on financing after 24 months of business.

Pharmaceutical Company: Pain Away Ltd.

Management intends to preserve cash flow by factoring much of the receivables. With the current lead time of 4 weeks, however, some capital may be used to increase merchandising inventory in order to fulfill initial large orders. It is hoped that any follow-on financing can and will be debt financing, serviced by cash flow.

The following table sets forth the capitalization of Pain Away Ltd. as of 12/31/95 and as adjusted to reflect the proposed sale of common stock.

Pharmaceutical Company: Pain Away Ltd.

Dilution: The net tangible book value of the company as of 12/31/95 was minus $1,673 per share. Without taking into account any other changes in such net tangible book value after 12/31/96, other than to give effect to the sale of 60 shares (proposed 30% equity share) hereby, the pro forma net tangible book value of the company on 12/31/95 will be $5,827 per share, representing an immediate dilution of $13,597 per share to new investors.

Pharmaceutical Company: Pain Away Ltd.

Management recognizes that this proposed financing implies a large premium value on the existing equity and so will negotiate any other conditions which would induce the investor to make the investment.

At the time of the company's IPO, limited partners who opt for common stock will receive their shares from the officers' share of owned stock. The negotiated ownership held by the investor will not be further diluted.

Investor Involvement

Management seeks a close working relationship with the investor. The investor will be given one seat on the board of directors. Management would solicit consultations (for a fee) on financial matters, or any other area of investor expertise (e.g., planning, management development), but voting power is not an option. Fees will also be paid for any future financing and/or profitable business connections arranged by the investor.

Limited Operating History

Even though management feels that the company is at first-stage expansion, it is definitely still an early-stage company. Two obvious risks inherent in early-stage companies are undercapitalization and poor liquidity. Management has capitalized the business operations to date well enough to have developed the product and identified penetrable market segments. The current proposed financing will provide enough capital to handle the anticipated growth.

Limited Resources

Management believes that it has the resources to continue at the present pace of business. An anticipated increase in sales through advertising media such as QVC , regional/national catalogues, retail outlets, and some European distribution can be financed by factoring. These "bootstrapping" approaches have sustained the company to date and will accommodate slow growth. Management believes, however, that more rapid expansion is desirable in order to penetrate its identified market segments. More rapid expansion requires more resources.

Limited Management Experience

All officers have successful backgrounds in marketing. Additional experience in manufacturing/distribution has been gained in the past nine years of product development. Management has consistently shown a willingness to leverage themselves with accomplished professional consulting relationships. The company culture is one which reinforces sharing of expertise with mutual benefit to all concerned.

Market Uncertainties

Any consumer product business is subject to the changing preferences of the marketplace. As presented in the marketing section of this proposal, the target markets are showing substantial growth, which limits uncertainty. There is currently a growing consumer preference for homeopathic topical remedies. More uncertainty is evident when considering competition, but can be made tolerable by on-going research and analysis.

Production Uncertainties

The only uncertainty at present is whether or not the lead time (4 weeks) from purchase order to finished product can consistently be reduced. This uncertainty is of material concern as sales increase. Herbal Laboratories is a sound company with a promising long-term future and has always been customer-friendly, so no more serious uncertainties exist at present. Management believes that vertical integration of manufacturing is feasible in the long-term but is not practical in the near-term.

Liquidation

In the event that liquidation becomes necessary, management believes that the most value could be realized from the sale of the product formula itself. The formula is not patented, so valuation remains uncertain. However, the sales history, along with the testimonials attesting to the effectiveness of this "ready-made" product, should determine value. Office equipment would yield limited value, and unless the company building was purchased prior to liquidation, no value would be realized. Management believes that the company can and will generate increasing value in the near future, evidenced by increasing sales.

Dependence on Key Management

At present, CEO Robert Peale is considered the primary key manager/officer. His knowledge of the product ingredients, his history of public appearances promoting the product, his increasing recognition by the health community as an expert in natural medicine, and his charisma as a business professional highlight his key role. Managerially, the other officers are thoroughly competent and could manage the company and market its products without Mr. Peale. At this critical early stage, however, the product needs an identity and a market position before the loss of any key managers could be overcome. Once the premier product is securely launched and the product line is expanded, the loss of any officer could be absorbed by continued proper management of the company. Management believes that such a development is not far off, once the company is properly capitalized. Until such time, key person life insurance will be purchased.

What Could Go Wrong?

Upgraded advertising campaigns could not lead to any substantial increase in sales. This problem can be avoided by using experienced advertising/marketing consultants who have familiarity with the targeted markets. Furthermore, properly designed test runs on any advertising campaign would provide objective indicators of expected returns. Capital investment in advertising should be gradual and progressively based upon certain expected levels of return.

Stronger competition could capitalize on and stall Pain Away's early success by replicating the product and its marketing strategy. This problem can be solved in two ways: First, with proper capitalization, Pain Away can make an entry into targeted markets rapidly and with enough strength to grab market share. Keeping market share can be easier than getting it. This market requires extensive advertising. Increasing market share could mean an increasing advertising budget. An increasing advertising budget can easily reduce profit margin, so strategic planning is required. The second way to solve the competition problem is in the formula itself. Management will seek to patent the formula. The nature of the homeopathic ingredients is likely to inhibit any mainstream non-homeopathic company from replicating the product. Acquisition of a homeopathic company would make more sense. Narrowing the competition, then, to other homeopathic companies gives Pain Away more of a fighting chance, since its formula is more sophisticated and user-friendly than any homeopathic topical analgesic on the market.

Governmental controls could conceivably impede sales. This problem is unlikely because the ingredients are already FDA-approved. Furthermore, management's participation in the FDA committee to develop regulatory standards for the natural medicine field would provide early warnings of any such prohibitory controls.

The company could be controlled by non-investor stockholders. This problem is not likely to develop because the management team would hold a majority. Management is dedicated to the principles of increasing value and profits and is confident that its efforts will be in concert with those of the investor.

RETURN ON INVESTMENT ANDEXIT

Public offering.

Management plans for an IPO in 5-7 years. The investor's shares would be sold to provide the targeted return on investment. Should there be no public market, then a buy back would occur.

Management will negotiate a buy back formula with the investor and will target milestones in planning for this possibility. Management aims for returning 6 times the original investment in five years.

ANALYSIS OF OPERATIONS AND PROJECTIONS

The business has not shown a profit since sales activity began in May 1994. This lack of profit is not unusual for an early-stage company. Losses were incurred in the start-up phase, where the objective was to get consumers to try the product. Gross profit margins have remained stable, however. Management focus was targeted on getting professionals and consumers to try the product in order to collect anecdotal evidence and testimonials of its effectiveness. Not enough focus was on asset management, as evidenced by a low return on assets ratio (p.32). Now that the product has gotten some recognition, especially in professional circles, the focus will shift toward mass marketing. Management intends to improve inventory management by using factoring of receivables in conjunction with JIT inventory control. As sales volume increases, drop-shipping from plant to wholesale customer, will also be arranged.

Balance Sheet

Pharmaceutical Company: Pain Away Ltd.

Monthly Income Statements 1995

Pharmaceutical Company: Pain Away Ltd.

Income Statement - 12/31/95

Pharmaceutical Company: Pain Away Ltd.

Key Ratio Analysis

Pharmaceutical Company: Pain Away Ltd.

THIS PORTION OF PAGE INTENTIONALLY LEFT BLANK SEE NEXT PAGE FOR PROJECTED CASH FLOW TABLE

Projected Cash Flow

Pharmaceutical Company: Pain Away Ltd.

Projected Annual Financial Statements

Pharmaceutical Company: Pain Away Ltd.

Assumptions

Pharmaceutical Company: Pain Away Ltd.

User Contributions:

Comment about this article, ask questions, or add new information about this topic:.

Business Plan Template for Pharmaceutical Sales Representatives

  • Great for beginners
  • Ready-to-use, fully customizable Subcategory
  • Get started in seconds

slide 1

Selling pharmaceutical products in a competitive market requires a well-thought-out plan. That's where ClickUp's Business Plan Template for Pharmaceutical Sales Representatives comes in! This template is specifically designed for pharmaceutical companies and sales reps to outline their sales goals, target customers, and strategies for success.

With this template, you can:

  • Develop a comprehensive approach to selling pharmaceutical products
  • Identify key performance indicators to measure success
  • Collaborate with your team to align sales efforts and maximize results

Whether you're launching a new drug or expanding your market presence, this template will help you create a winning business plan and achieve your sales targets. Get started on ClickUp today and make your pharmaceutical sales soar!

Business Plan Template for Pharmaceutical Sales Representatives Benefits

When using the Business Plan Template for Pharmaceutical Sales Representatives, you can expect the following benefits:

  • Streamline your sales process and improve efficiency by having a clear plan in place
  • Set realistic and achievable sales goals that align with your company's objectives
  • Identify and target the right customers for your pharmaceutical products
  • Develop effective strategies to promote and sell your products in the market
  • Track and measure key performance indicators to assess your sales performance
  • Stay organized and focused on your sales objectives with a comprehensive approach

Main Elements of Pharmaceutical Sales Representatives Business Plan Template

ClickUp's Business Plan Template for Pharmaceutical Sales Representatives provides a structured approach to sales planning and strategy. Here are the main elements of this template:

  • Custom Statuses: Track the progress of your business plan with statuses like Complete, In Progress, Needs Revision, and To Do, ensuring clear visibility and accountability.
  • Custom Fields: Utilize custom fields such as Reference, Approved, and Section to organize and categorize important information within your business plan.
  • Custom Views: Access different views like Topics, Status, Timeline, Business Plan, and Getting Started Guide to gain a comprehensive overview of your sales goals, strategies, and progress.
  • Document Collaboration: Collaborate with your team in real-time by utilizing ClickUp's Docs feature, allowing you to create, edit, and share your business plan seamlessly.
  • Task Management: Break down your business plan into actionable tasks, assign them to team members, set due dates, and track progress using ClickUp's tasks feature.

With ClickUp's Business Plan Template, pharmaceutical sales representatives can streamline their sales planning process and effectively sell pharmaceutical products in the market.

How To Use Business Plan Template for Pharmaceutical Sales Representatives

If you're a pharmaceutical sales representative looking to create a comprehensive business plan, follow these four steps using the Business Plan Template in ClickUp:

1. Define your target market

Start by identifying your target market. Determine the specific healthcare professionals and institutions that are most likely to prescribe or use your products. Consider factors such as geography, specialty, and patient demographics.

Use custom fields in ClickUp to categorize and track your target market data, including key contacts and prescribing habits.

2. Set strategic objectives

Next, establish your strategic objectives for the year. These objectives should align with your company's overall sales and marketing goals. Think about what you want to achieve in terms of market share, sales growth, and customer relationships.

Create tasks in ClickUp to outline your strategic objectives and assign responsibilities to team members.

3. Develop your sales tactics

Once you have your objectives in place, it's time to develop your sales tactics. These are the specific actions and strategies you will implement to achieve your objectives. Consider tactics such as product presentations, educational events, relationship-building activities, and promotional campaigns.

Use the Board view in ClickUp to create columns for each sales tactic and move tasks across the board as they progress.

4. Monitor performance and adjust

As you execute your business plan, it's crucial to monitor your performance and make adjustments as needed. Regularly review your sales data, track the success of your tactics, and gather feedback from healthcare professionals.

Use Dashboards in ClickUp to visualize your sales performance, track key metrics, and identify areas for improvement. Set up Automations to receive real-time alerts and notifications based on specific performance thresholds.

By following these steps and utilizing the Business Plan Template in ClickUp, you'll be well-equipped to create and execute an effective business plan as a pharmaceutical sales representative.

Get Started with ClickUp’s Business Plan Template for Pharmaceutical Sales Representatives

Pharmaceutical sales representatives can use this Business Plan Template for Pharmaceutical Sales to help them outline their sales goals and strategies, track progress, and stay organized.

First, hit “Add Template” to sign up for ClickUp and add the template to your Workspace. Make sure you designate which Space or location in your Workspace you’d like this template applied.

Next, invite relevant members or guests to your Workspace to start collaborating.

Now you can take advantage of the full potential of this template to create a comprehensive business plan:

  • Use the Topics View to organize your business plan into different sections, such as market analysis, sales strategies, and target audience.
  • The Status View will help you track the progress of each section, whether it's complete, in progress, needs revision, or still to do.
  • The Timeline View will allow you to set deadlines for each section and visualize the overall timeline of your business plan.
  • Use the Business Plan View to get a holistic view of your entire plan, including all sections and their statuses.
  • The Getting Started Guide View will provide you with step-by-step instructions on how to use the template effectively.
  • Create custom fields like Reference, Approved, and Section to add additional information and categorize your business plan.
  • Update statuses and custom fields as you work on each section to keep track of progress and approvals.
  • Monitor and analyze your business plan to ensure it aligns with your sales goals and objectives.
  • Business Plan Template for Hair Salon
  • Business Plan Template for Marketplace Sellers
  • Business Plan Template for Machine Operators
  • Business Plan Template for QA Engineer
  • Business Plan Template for Ui Designers

Template details

Free forever with 100mb storage.

Free training & 24-hours support

Serious about security & privacy

Highest levels of uptime the last 12 months

  • Product Roadmap
  • Affiliate & Referrals
  • On-Demand Demo
  • Integrations
  • Consultants
  • Gantt Chart
  • Native Time Tracking
  • Automations
  • Kanban Board
  • vs Airtable
  • vs Basecamp
  • vs MS Project
  • vs Smartsheet
  • Software Team Hub
  • PM Software Guide

Google Play Store

Goodness Care

Crafting a Pharmaceutical Distribution Business Plan

Goodness Care

  • Pharmaceutical Industry

pharmaceutical distribution business plan

In the dynamic landscape of the pharmaceutical industry , a well-thought-out business plan is the foundation for success in the distribution sector. Whether entering the field or looking to revamp your existing operations, a pharmaceutical distribution business plan is essential for outlining your goals, strategies, and the path to sustainable growth. This guide delves into the key components that should be included in a pharmaceutical distribution business plan.

1. Executive Summary: Setting the Stage

The executive summary is a concise yet impactful overview that is the gateway to your pharmaceutical distribution business plan. In this section, you aim to capture readers’ attention, including potential investors, partners, and stakeholders, by presenting a compelling snapshot of your business.

Mission, Vision, and Core Values

Begin the executive summary by articulating your company’s mission, vision, and core values. Clearly define the purpose of your pharmaceutical distribution business, the long-term aspirations encapsulated in your vision, and the guiding principles that underpin your operations. This sets the tone for the entire business plan, providing a foundation that aligns with the broader goals of the healthcare industry.

Key Objectives

Outline the primary objectives that your pharmaceutical distribution business aims to achieve. Whether it’s expanding market reach, optimizing supply chain efficiency, or introducing innovative distribution solutions, clearly articulate the specific goals that define your business trajectory.

Target Markets

Identify and describe your target markets. Specify the geographical regions you operate in, the demographics of your intended customer base, and any niche markets you plan to serve. This provides readers with a clear understanding of the scope and potential of your pharmaceutical distribution business.

Unique Value Proposition (UVP)

Highlight the unique value proposition that distinguishes your pharmaceutical distribution business from competitors. Communicate the benefits you bring to clients, emphasizing what sets you apart regarding service quality, innovation, or other factors contributing to your competitive edge.

2. Company Description: Defining Your Identity

The Company Description section of your pharmaceutical distribution business plan provides a detailed exploration of the fundamental aspects that define your company’s identity. This section offers readers an in-depth understanding of your business’s history, mission, values, product offerings, geographical reach, and strategic collaborations.

Company History

Commence the Company Description by providing a historical overview of your pharmaceutical distribution business. Share key milestones, significant achievements, and pivotal moments that have shaped the trajectory of your company. This offers insight into your business’s evolution and establishes a narrative that connects with readers.

Mission and Values

Articulate your company’s mission and values, delving into the core principles that guide your operations. Communicate the purpose of your pharmaceutical distribution business and the ethical framework that underlies your decision-making processes.

Product Offerings

Provide a comprehensive overview of your distribution business’s pharmaceutical products and services. Detail the range of products you distribute, including prescription medications, over-the-counter drugs, vaccines, and any specialized healthcare products. Highlight any unique features or attributes that set your product portfolio apart.

Geographical Reach

Specify the geographical areas your pharmaceutical distribution business serves. Whether you operate locally, nationally, or internationally, clarify the regions you cover. Discuss any expansion plans or strategic considerations related to your geographical reach.

Key Partnerships and Collaborations

Highlight any key partnerships, collaborations, or alliances that contribute to the success of your pharmaceutical distribution business. This may involve collaborations with pharmaceutical manufacturers, technology providers, or other entities that enhance the efficiency and effectiveness of your operations.

3. Market Analysis: Understanding the Landscape

The Market Analysis section of your pharmaceutical distribution business plan is a critical component that thoroughly examines the external factors shaping the industry. This in-depth analysis aids in identifying opportunities, anticipating challenges, and strategically positioning your business within the pharmaceutical distribution landscape.

Industry Overview

Initiate the Market Analysis by presenting a comprehensive overview of the pharmaceutical distribution industry. Discuss the industry’s current state, including its size, growth trends, and key drivers. This section sets the stage for a nuanced understanding of the broader landscape in which your business operates.

Market Trends

Examine the prevailing trends within the pharmaceutical distribution industry. This involves an analysis of emerging patterns, technological advancements, and shifts in consumer behavior. Identifying and adapting to these trends is crucial for staying ahead of the curve and aligning your business strategies with industry dynamics.

Competitor Landscape

Conduct a thorough analysis of your competitors within the pharmaceutical distribution space. Identify key players, their market share, distribution strategies, and areas of specialization. This assessment helps you understand the competitive dynamics and formulate strategies to differentiate your business.

Regulatory Environment

Explore the regulatory landscape governing pharmaceutical distribution. Highlight any recent or anticipated changes in regulations that may impact your business. Understanding and complying with regulatory requirements is vital for ensuring the legality and sustainability of your operations.

Target Customer Base

Define your target customer base within the pharmaceutical distribution market. This involves identifying the types of healthcare providers, pharmacies, or other entities you aim to serve. Understanding your target customers’ needs, preferences, and expectations is crucial for tailoring your distribution strategies.

SWOT Analysis

Conduct a SWOT analysis (Strengths, Weaknesses, Opportunities, Threats) to assess the internal and external factors influencing your pharmaceutical distribution business. This analysis provides a holistic perspective, helping you capitalize on strengths, address weaknesses, seize opportunities, and mitigate potential threats.

4. Organization and Management: Building a Strong Foundation

The Organization and Management section of your pharmaceutical distribution business plan is a crucial segment that provides an in-depth exploration of the structure and leadership of your company. This section offers readers insights into the key players steering your pharmaceutical distribution operations, emphasizing their experience, expertise, and contributions to the business’s overall success.

Organizational Structure

Commence this section by outlining the organizational structure of your pharmaceutical distribution business. Clearly define your company’s hierarchy, departmental divisions, and reporting lines. This offers readers a visual representation of how your business is organized and how various components collaborate to achieve common goals.

Key Roles and Responsibilities

Specify the key roles and responsibilities within your pharmaceutical distribution business. This involves detailing the functions of each department and the specific responsibilities of key positions. Clarifying roles helps establish accountability and ensures that every aspect of your distribution operations is well-defined.

Management Team

Introduce your management team, emphasizing their professional backgrounds, qualifications, and relevant experience. Highlight key executives and their respective roles in steering the company toward success. This is an opportunity to showcase the strength and diversity of your leadership, instilling confidence in readers about the capabilities of your management team.

Biographies of Key Executives

Provide detailed biographies of key executives, highlighting their professional achievements, educational backgrounds, and specific contributions to the pharmaceutical distribution industry. This personalized touch adds credibility to your management team, allowing readers to connect with the individuals driving your business forward.

Experience and Expertise

Emphasize the collective experience and expertise of your management team. Discuss any industry-specific knowledge, certifications, or accolades that demonstrate the competency of your leadership. This section is an opportunity to reassure readers that your team possesses the necessary skills to navigate the complexities of pharmaceutical distribution.

5. Products and Services: Showcasing Your Portfolio

The Products and Services section of your pharmaceutical distribution business plan is a pivotal segment that offers a comprehensive view of the range of pharmaceutical products and services your distribution business provides. This section serves as a platform to highlight the unique aspects of your portfolio, emphasizing how your offerings align with market demand and contribute to emerging healthcare trends.

Overview of Pharmaceutical Products

Initiate this section by providing a detailed overview of the pharmaceutical products your distribution business offers. This includes prescription drugs, over-the-counter medications, vaccines, medical devices, and other healthcare products within your portfolio. Clearly define the scope of your product range to give readers a holistic understanding of your offerings.

Specialization Areas

Highlight any specific areas of specialization within your product portfolio. This could involve focusing on particular therapeutic categories, specialized medications, or niche healthcare segments. Emphasizing your specialization areas showcases expertise and allows you to position your distribution business as a go-to source for specific healthcare needs.

Exclusive Partnerships

Discuss any exclusive partnerships your distribution business has established with pharmaceutical manufacturers. Exclusive partnerships can contribute to the uniqueness of your product portfolio, giving you a competitive edge. Highlighting these collaborations demonstrates your ability to secure premium products and reinforces your credibility within the industry.

Unique Selling Points (USPs)

Identify and emphasize the unique selling points that distinguish your pharmaceutical products and services. This could include features such as superior quality, innovative formulations, special packaging, or any other factors that set your offerings apart from competitors. Clearly articulating your USPs helps create a compelling value proposition for your customers.

Alignment with Market Demand

Demonstrate how your product portfolio aligns with current market demand. This involves an analysis of industry trends, consumer preferences, and healthcare needs. Illustrate how your distribution business proactively responds to market dynamics, ensuring that your offerings address the evolving requirements of healthcare providers and end consumers.

Contribution to Emerging Healthcare Trends

Discuss how your products and services contribute to or align with emerging healthcare trends. This could involve advancements in personalized medicine, digital health solutions, or any other transformative trends shaping the pharmaceutical industry. Positioning your distribution business as a contributor to healthcare innovation enhances your industry standing.

6. Marketing and Sales Strategy: Reaching Your Audience

The Marketing and Sales Strategy section of your pharmaceutical distribution business plan is a critical component that outlines the methodologies you’ll employ to promote and sell your products and services effectively. This section serves as a roadmap, defining your target audience, elucidating marketing strategies, and detailing sales tactics to secure and retain clients.

Target Audience Definition

Begin by clearly defining your target audience. Identify the specific demographic, geographic, and psychographic characteristics of the individuals and organizations you aim to reach. Understanding your target audience is fundamental to tailoring your marketing and sales approaches to meet their needs effectively.

Marketing Strategies

Elaborate on the marketing strategies you’ll employ to reach your target audience. This may encompass digital marketing, traditional advertising, content marketing, and participation in industry events. Detail how each strategy contributes to brand visibility, lead generation, and engagement with potential clients.

Digital Marketing Approach

If applicable, provide details about your digital marketing approach. This could involve strategies for online visibility, content creation, social media engagement, and email marketing. Articulate how your digital presence will be leveraged to communicate your brand message and attract potential clients.

Traditional Advertising Channels

Discuss your approach to traditional advertising channels like print media, television, or radio. Clarify how these channels complement your overall marketing strategy and contribute to brand recognition among your target audience.

Partnerships with Healthcare Providers

Detail any partnerships or collaborations with healthcare providers contributing to your marketing strategy. These partnerships can enhance credibility and create avenues for direct engagement with potential clients.

Sales Tactics

Shift the focus to your sales tactics, outlining how to secure and retain clients. Discuss your approach to lead generation, client acquisition, and strategies for building long-term customer relationships.

Client Retention Strategies

Highlight strategies for client retention. This may involve after-sales support, loyalty programs, and ongoing communication to ensure customer satisfaction and foster long-term relationships.

7. Funding Request: Securing Resources

The Funding Request section of your pharmaceutical distribution business plan is a crucial segment where you clearly articulate your financial requirements should you seek external funding. This section serves as a detailed proposal, specifying the amount needed, the purpose behind the funding, and how the investment will be utilized to propel your pharmaceutical distribution business forward.

Amount Required

Start by explicitly stating the amount of funding you are seeking. This figure should be based on thoroughly assessing your business needs, considering expansion plans, operational requirements, technology investments, and marketing initiatives.

Purpose of the Funding

Clearly outline the purpose behind the funding request. Specify how the funds will be utilized and the key areas of your pharmaceutical distribution business that will benefit from the investment. This provides transparency and demonstrates a thoughtful consideration of your business needs.

Expected Return on Investment (ROI)

Discuss the expected return on investment that the funding is anticipated to generate. Provide a realistic projection of how the infusion of capital will contribute to the growth and profitability of your pharmaceutical distribution business over a defined period.

Utilization Breakdown

Offer a comprehensive breakdown of how the funds will be utilized. This involves providing a detailed list of expenses, investments, and allocations to different aspects of your business. This breakdown enhances transparency and instills confidence in potential investors or lenders.

Financial Projections

Support your funding request with financial projections that illustrate the anticipated impact of the investment on your business’s financial performance. Include projections for revenue growth, profit margins, and other key financial metrics over the period covered by the funding.

Risk Mitigation Strategies

Acknowledge potential risks associated with using funds and present strategies for mitigating these risks. This demonstrates foresight and a proactive approach to addressing challenges that may arise while implementing your business plan.

8. Financial Projections: Painting the Financial Landscape

The Financial Projections section of your pharmaceutical distribution business plan is a critical component that paints a comprehensive picture of your company’s anticipated financial performance. This section gives potential investors or lenders detailed insights into your revenue streams, expected expenses, profit margins, and overall financial health. Realistic, data-backed financial projections are crucial for instilling confidence and demonstrating the viability and profitability of your pharmaceutical distribution business.

Income Statements

Present detailed income statements forecasting your revenue streams and expenses over a defined period. Clearly outline your sources of revenue, including product sales, distribution services, or any other income-generating activities. Provide a breakdown of direct costs, operating expenses, and taxes to show your company’s profitability clearly.

Balance Sheets

Include balance sheets that showcase your company’s financial position at specific times. Highlight your assets, liabilities, and shareholders’ equity to provide a comprehensive overview of your financial stability and the resources available for your pharmaceutical distribution business.

Cash Flow Statements

Present detailed cash flow statements that illustrate the inflow and outflow of cash within your pharmaceutical distribution business. This includes operating activities, investing activities, and financing activities. Positive cash flow indicates your ability to meet financial obligations and reinvest in business growth.

Revenue Streams and Profit Margins

Provide a breakdown of your various revenue streams, emphasizing the diversity and stability of your income sources—detail profit margins for each revenue stream to showcase the financial viability of your pharmaceutical distribution business.

Expense Projections

Anticipate and detail your expected expenses, including operational costs, marketing expenditures, technology investments, and other relevant costs. A thorough breakdown of expenses demonstrates your understanding of the financial intricacies of your pharmaceutical distribution business.

Assumptions and Methodology

Clearly outline the assumptions and methodology underlying your financial projections. This is essential for transparency and helps potential investors or lenders understand the basis on which your projections have been formulated.

Sensitivity Analysis

Conduct sensitivity analysis to assess how changes in key variables may impact your financial projections. This demonstrates a proactive approach to risk management and provides insight into the robustness of your financial forecasts.

9. Risk Analysis: Identifying and Mitigating Challenges

The Risk Analysis section of your pharmaceutical distribution business plan is a crucial component that aims to foresee potential challenges and uncertainties your business may encounter. By acknowledging these risks and presenting well-thought-out mitigation strategies, you demonstrate a proactive approach to challenges, instilling confidence in potential investors or lenders regarding your ability to navigate uncertainties and ensure business continuity.

Regulatory Risks

Identify potential regulatory risks that may impact your pharmaceutical distribution business. Changes in pharmaceutical regulations, licensing requirements, or compliance standards can significantly influence operations. Clearly outline how your business plans to stay abreast of regulatory changes and adapt to evolving legal landscapes.

Supply Chain Disruptions

Anticipate challenges related to supply chain disruptions, including issues with product availability, transportation delays, or disruptions in manufacturing. Develop strategies to ensure a resilient supply chain, such as diversifying suppliers, implementing advanced inventory management systems, and fostering strong relationships with key suppliers.

Market Dynamics and Competition

Evaluate potential risks arising from changes in market dynamics or increased competition. Shifts in consumer preferences, entry of new competitors, or fluctuations in market demand can impact your business. Demonstrate a thorough understanding of market trends and articulate strategies to maintain a competitive edge.

Technological Advancements

Acknowledge risks related to technological advancements and the need for constant innovation. Failure to adapt to emerging technologies or changes in digital platforms can impact operational efficiency. Present strategies for incorporating new technologies and staying at the forefront of industry advancements.

Economic Conditions

Consider risks associated with economic fluctuations, currency exchange rates, or financial downturns. Economic uncertainties can impact consumer spending and overall market conditions. Showcase your understanding of economic factors and outline strategies to mitigate potential financial risks.

Cybersecurity and Data Privacy

Acknowledge the increasing importance of cybersecurity and data privacy in the digital age. Risks related to data breaches or cyber-attacks can have severe consequences. Present comprehensive cybersecurity measures and data protection protocols to safeguard sensitive information.

10. Implementation Plan: Turning Plans into Action

The Implementation Plan section of your pharmaceutical distribution business plan bridges strategic vision and tangible actions. It outlines the steps, timelines, and responsibilities required to bring your business strategy to life. This section is crucial for demonstrating the practicality and feasibility of your plans, providing stakeholders with a clear roadmap for the execution of key initiatives.

Strategic Milestones

Outline the major milestones that mark the implementation of your pharmaceutical distribution business plan. These milestones may include the expansion of distribution networks, the introduction of new product lines, the launch of marketing campaigns, or the integration of advanced technologies. Clearly define these objectives to give a comprehensive overview of your business trajectory.

Timeline and Phases

Develop a detailed timeline that outlines each milestone’s specific phases and durations. Break down the implementation process into manageable phases, providing a realistic overview of when each objective will be achieved. This timeline serves as a visual representation of the sequential progression of your business plan.

Responsibilities and Roles

Clearly define the responsibilities and roles of each team member involved in the implementation process. This section emphasizes the importance of a collaborative and coordinated effort. Highlight the specific skills and expertise each team member brings to the table, showcasing how their contributions align with the successful execution of the business plan.

Performance Metrics and Monitoring

Establish clear performance metrics for each milestone to assess the effectiveness of your implementation efforts. Define key performance indicators (KPIs) that align with your business objectives. Additionally, outline a monitoring and evaluation process to regularly assess progress, identify challenges, and make necessary adjustments to stay on course.

Contingency Plans

Anticipate potential challenges or deviations from the planned implementation and develop contingency plans. Addressing unforeseen circumstances with predefined alternative strategies demonstrates your readiness to adapt and ensures that your business plan remains resilient amid uncertainties.

11. Monitoring and Evaluation: Assessing Progress

The Monitoring and Evaluation section of your pharmaceutical distribution business plan is essential for gauging the success of your strategies, identifying areas for improvement, and ensuring ongoing adaptability in the dynamic business landscape. It involves establishing key performance indicators (KPIs), defining robust monitoring processes, and outlining an evaluation framework that aligns with your business objectives.

Key Performance Indicators (KPIs)

Identify and define key performance indicators that directly align with your pharmaceutical distribution business objectives. These indicators serve as quantifiable metrics to measure the success of your operations. KPIs provide insights into critical areas such as sales performance, customer satisfaction, supply chain efficiency, and market penetration.

Monitoring Processes

Detail the processes and tools you will employ to monitor ongoing activities and performance against the established KPIs. Whether through advanced analytics software, regular team meetings, or real-time dashboards, a well-defined monitoring process enables continuous visibility into the various facets of your pharmaceutical distribution business.

Regular Review Meetings

Schedule regular review meetings to assess the progress of your pharmaceutical distribution business. These meetings are opportunities to discuss performance metrics, share insights, and collectively address any challenges that may arise. The collaborative nature of these sessions fosters a proactive approach to problem-solving and continuous improvement.

Adaptive Strategies

Highlight your commitment to adaptability by emphasizing how you will adjust strategies based on the insights gathered through monitoring processes and review meetings. The ability to swiftly adapt to changing market conditions, consumer preferences, or operational challenges is crucial for long-term success in the pharmaceutical distribution industry.

Continuous Improvement Initiatives

Demonstrate your commitment to continuous improvement by outlining specific initiatives or actions that will be taken based on the findings of your monitoring and evaluation processes. Whether it’s refining operational workflows, enhancing customer service protocols, or optimizing supply chain logistics, continuous improvement ensures sustained growth and competitiveness.

12. Appendices: Supporting Documentation

The Appendices section of your pharmaceutical distribution business plan serves as a repository for supplementary materials that provide depth and credibility to the assertions and plans outlined in the document’s main body. While the core of the business plan remains concise and focused, the appendices offer an opportunity to include detailed documentation that enhances the understanding and confidence of stakeholders, whether they be investors, partners, or regulatory authorities.

Resumes of Key Personnel

Include detailed resumes of key personnel involved in the leadership and management of your pharmaceutical distribution business. Resumes should highlight relevant experience, qualifications, and achievements that position your team as capable and well-equipped to execute the outlined business strategies.

Market Research Data

If your market analysis in the main body of the business plan includes summarized data, the appendices offer an opportunity to include more extensive market research materials. This could include detailed reports, surveys, or other relevant data supporting your understanding of market trends, customer behavior, and competitive landscapes.

Legal Documents

Include any legal documents that are relevant to the operation of your pharmaceutical distribution business. This may encompass licensing agreements, permits, contracts, or any other legal documentation that assures stakeholders of your compliance with regulatory requirements and industry standards.

Financial Information

While the main body of the business plan includes financial projections, the appendices can house additional financial information for those stakeholders who seek more detailed insights. This could include historical financial statements, detailed breakdowns of expenses, or any other financial documentation supporting your projections’ credibility.

Supporting Visuals

If visuals such as charts, graphs, or images contribute to a better understanding of your business plan, consider placing them in the appendices. While the main body should remain focused, the appendices can accommodate supplementary visuals that enhance clarity and illustrate key points.

Conclusion: Guiding Your Path to Success

Crafting a pharmaceutical distribution business plan is a strategic exercise that requires careful consideration of various factors influencing the industry. A well-articulated plan serves as a roadmap for your business and demonstrates your commitment to success, instilling confidence in potential investors, partners, and stakeholders. Regularly revisit and update your business plan to adapt to evolving market dynamics, ensuring that your pharmaceutical distribution business remains agile, competitive, and positioned for sustained growth in the ever-evolving healthcare landscape.

Related Content

Cleaning validation

Cleaning Validation Training

good distribution practice

Good Distribution Practices (GDP)

AI for healthcare

Impact of ChatGPT on Pharmaceutical Sales and Marketing

cosmetics advertising

Cosmetics Advertising

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to  upgrade your browser .

Enter the email address you signed up with and we'll email you a reset link.

  • We're Hiring!
  • Help Center

paper cover thumbnail

Pharmaceutical Business Plan

Profile image of Kamal Rajput

Related Papers

mahmoud abdalla

business plan for pharmaceutical products

Jose Luis Valverde Lopez

Health spending accounted for 9.3% of GDP on average across OECD countries in 2011. The Pharmaceutical expenditure, as a percentage of total expenditure on health, accounted for 15%. The pharmaceutical sector is highly regulated. On describe the major characteristics of the world pharmaceutical industry as one increased globalization, changing structure of competition and increased competitiveness. This are growing pressures on discovery and development. Drug liabilities become more frequent and more costly. The pharmaceutical industry is under immense pressure by external and internal stakeholders. Government and National Health Services are monopsonic practices. Pharmaceutical companies are criticised for high prices, over-intensive sales and marketing activities, presents to medical doctors, clinical trials and industry – government alliances. Lawyers, medical journals, physicians, politicians, and the media use product liabilities and marketing activities to denounce pharmaceutical companies as culprits. The pharmaceutical sector needs to demonstrate responsibility and take steps to increase awareness. Transparency would increase the credibility of the pharmaceutical industry. Corporate governance will prevent corruption by being in compliance with the legislation and establishing their own internal policies designed to prevent corruption. All firms will act more responsibly. In order to rebuild the trust the industry needs to work together and quickly.

Continuous innovation is one of the pharmaceutical industry's most defi ning characteristics. New medications can be crucial for maintaining the quality of human life, and may even affect its duration. The sales potential is staggering: the global pharmaceutical market is expected to reach $1.1 trillion by 2015. The pressure to succeed is tremendous. Yet, pharmaceutical innovation is hardly an orderly, predictable process. It follows a technology-push model dependent on a meandering path of scientifi c breakthroughs with uneven timing and hard to foresee outcomes. Technological competency, decades of rigorous research, and profound understanding of unmet customer needs, while necessary, may prove insuffi cient for market success as the critical decision for commercialization remains outside the fi rm. Drug innovation as a business process requires savvy strategic, organizational, and managerial decisions. It is already enjoying intensive research coverage, giving rise to abundant but relatively dispersed knowledge of the mechanisms driving drug discovery and development. In this chapter, we present a comprehensive overview of the process of drug innovation from a business and academic perspective. We discuss the evolving organizational forms and models for collaboration, summarize signifi cant empirical regularities, and highlight differences in market positions related to fi rms' strategic orientation, innovation emphasis, attitudes to risk, and specialized resources. As a guide to future research, critical drivers and modes for drug innovation are systematized in a unifying framework of characteristics and process decisions, and multiple areas in need of further scrutiny, analysis, and optimization are suggested. Because of its rich potential and high signifi cance, research on drug innovation seems poised to gain increasing momentum in the years to come.

Marketing Intelligence & Planning

Stewart Adam

Said Salloum , D. Muhammad T U R K I Alshurideh

Journal of Personal Selling and Sales Management

Ravindra Chitturi

Ewa Kleczyk

James Tracy

A critical exploration of the history and present dynamics of drug advertising in the United States reveals how advertising practices exemplify the extent to which late capitalist market rationality impacts on popular under- standings of medicine, well being, and disease. An historical overview of drug advertising and regulation thereof contextualizes a closer analysis of the ways in which the pharmaceutical industry acts to maximize profits through marketing efforts and the creation of diseases as platforms for the expansion of drug product markets. In this way U.S. drug manufacturers operate on a variety of communicative levels to ensure that their promotional messages are among the most widely disseminated. As medical and pharmaceutical technology develops and plays an increasingly pronounced role in everyday life from casual to more profound levels via the mass media, a critical and historical understanding of how and for whom it acts may become a vital focus of future inquiry on social and communicative phenomena and processes.

Colin Bradley

Entrepreneurship Theory and Practice

ethne swartz

Opt-e-scrip, Inc., has developed a patented test for determining the efficacy of drugs in individual patients so that doctors can prescribe the drug that really works for each person. In addition, test results show that older, less expensive drugs are often as or more efficacious than the newer, expensive drugs pushed by manufacturers. It, thus, benefits physicians, patients, and drug benefit payers. However, the company has had difficulty entering the market, given its complexity and their lack of resources. The test remains a product in search of an application and a customer willing to pay for its usage.

RELATED PAPERS

Deyner Angel Alegria Balanta

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Leanne Casaubon

Universitas Telkom

Yuni Hestyana

Plastic and Reconstructive Surgery

Steven Greenbaum

James Thomas

Paulo Sérgio

Bath毕业证书 Bath毕业证成绩单

Journal of Agricultural and Food Chemistry

Gregory Kellett

Ferroelectrics

Robert L. Byer

Jakob Hallermann

Evidence-Based Complementary and Alternative Medicine

Mainen Moshi

Journal of acquired immune deficiency syndromes (1999)

Kawango Agot

Revista Eletrônica Acervo Enfermagem

Maria Gabriely Ferreira de Sousa

International Journal of Innovation and Knowledge Management in Middle East and North Africa

Abdul Hamid jamal Abdul Hamid jamal

Jurnal Kesehatan Gigi

M. Raihan Ramadhan

Joaquin Manjarrez-Marmolejo

Academia de Direito

Eduardo Puhl

Journal of Medical Entomology

Raul Alzogaray

Hubertus H Kohle

Actas del 8º Congreso Forestal Español

Luis A Gómez González

New Trends and Issues Proceedings on Humanities and Social Sciences

Virtop Sorin-Avram

  •   We're Hiring!
  •   Help Center
  • Find new research papers in:
  • Health Sciences
  • Earth Sciences
  • Cognitive Science
  • Mathematics
  • Computer Science
  • Academia ©2024

COMMENTS

  1. Pharmaceutical Business Plan Template

    Traditionally, a marketing plan includes the four P's: Product, Price, Place, and Promotion. For a pharmaceutical company, your marketing strategy should include the following: Product: In the product section, you should reiterate the type of pharmaceutical business that you documented in your company overview.

  2. Business Plan Template for Pharmaceutical Companies

    Pharmaceutical companies can use the Business Plan Template for Pharmaceutical Companies in ClickUp to effectively outline their strategic goals and financial projections, as well as navigate the complex and highly regulated pharmaceutical industry. First, hit "Add Template" to sign up for ClickUp and add the template to your Workspace.

  3. Pharmacy Business Plan Template: A Step-by-Step Guide (2024)

    As a pharmacy business, you can center your marketing around safe products, better service, and availability. According to various surveys, KAM, clinical sales force, and service rep model are three of the most successful strategies for pharmacies. 5. Web Plan.

  4. Pharmaceutical Company Business Plan [Sample Template]

    A Sample Pharmaceutical Company Business Plan Template 1. Industry Overview. The Generic pharmaceutical and medicine manufacturing companies primarily develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals.

  5. Pharmacy Business Plan PDF Example

    Debbie. March 19, 2024. Business Plan. Creating a comprehensive business plan is crucial for launching and running a successful pharmacy. This plan serves as your roadmap, detailing your vision, operational strategies, and financial plan. It helps establish your pharmacy's identity, navigate the competitive market, and secure funding for growth.

  6. Pharmacy Business Plan Example

    Cash at End of Period. $87,016. $45,597. $74,292. Download This Plan. Explore a real-world pharmacy business plan example and download a free template with this information to start writing your own business plan.

  7. Pharmacy Business Plan

    1. Identify and study the market needs for pharmaceuticals. Research on the regulatory requirements for setting up a pharmacy business. Prepare a business model and revenue plan. Create a detailed marketing and sales strategy. Draft a detailed organizational structure. Approval: Organizational Structure.

  8. Free Pharmacy Business Plan Template + Example

    1. Don't worry about finding an exact match. We have over 550 sample business plan templates. So, make sure the plan is a close match, but don't get hung up on the details. Your business is unique and will differ from any example or template you come across. So, use this example as a starting point and customize it to your needs.

  9. Pharmacy Business Plan Template (2024)

    PlanBuildr's Pharmacy business plan template will help you to quickly and easily complete your Pharmacy business plan. ... Healthy1 Pharmacy will provide all of the products and services that are available at large retail chains, only with a better price and a small-town atmosphere. ... Industry operators in the pharmaceutical market can ...

  10. How to write a business plan for a pharmaceutical manufacturer?

    A business plan has 2 main parts: a financial forecast outlining the funding requirements of your pharmaceutical manufacturer and the expected growth, profits and cash flows for the next 3 to 5 years; and a written part which gives the reader the information needed to decide if they believe the forecast is achievable.

  11. Pharmaceutical Business Plan Template & How-To Guide [Updated 2024

    How to Write a Business Plan for a Pharmaceutical Company. If you want for start a pharmaceutical company or expand your current one, you need a business plan. ... Essentially in one result and price sub-sections of thine plan, you are presenting the products and/or services you offer and own prices. Place: Put refers toward the web of is ...

  12. Top 5 Pharmacy Business Plan Templates (PDF and Editable ...

    Template 3: Pharmaceutical Sales Plan PowerPoint Template Bundles. This PPT Set is the presentation your sales team needs to create and execute their plans. Use this PPT Deck to boost your sales with slides focused on comparative analysis, 30-60-90-day plans, revenue forecasting, and more.

  13. Building Effective Business Development in Pharma

    Biopharma M&A deal value more than doubled between 2017 and 2019, from $138 billion to $336 billion, and valuations reached all-time highs. Most of those deals involved midsized biotech companies, for which the average premium paid was close to 70%, with an average EV/sales multiple of nearly 8x. All in all, close to 60% of new therapeutic ...

  14. Reshaping pharmaceuticals commercial strategy

    A survey conducted by McKinsey in Europe shows that the average number of in-person contacts between HCPs and pharma sales reps was 70 percent lower in September 2020 than before the pandemic. 5 In parallel, HCPs' adoption of digital channels and telemedicine has accelerated for interactions with patients and pharma reps alike.

  15. PDF Writing a Business Plan for a New Pharmacy Service

    Monograph 23. A Continuing Education Series supported by an educational grant from. Writing a Business Plan for a New Pharmacy Service. By putting their plans in writing before implementing new services, pharmacists are more likely to attain long-range goals and achieve success. Reviewed by Randy McDonough.

  16. Pharmaceutical Company Business Plan

    Encyclopedia of Business, 2nd ed. Pharmaceutical Company Business Plan: Business Plans - Volume 03. Toggle navigation. Encyclopedia . ... Any consumer product business is subject to the changing preferences of the marketplace. As presented in the marketing section of this proposal, the target markets are showing substantial growth, which limits ...

  17. How to write a business plan for a pharmaceutical wholesaler?

    Lastly, address any funding needs in the "ask" section of your executive summary. 2. The presentation of the company. The second section in your pharmaceutical wholesaler's business plan should focus on the structure and ownership, location, and management team of the company.

  18. Business Plan Template for Pharmaceutical Sales Representatives

    Selling pharmaceutical products in a competitive market requires a well-thought-out plan. That's where ClickUp's Business Plan Template for Pharmaceutical Sales Representatives comes in! This template is specifically designed for pharmaceutical companies and sales reps to outline their sales goals, target customers, and strategies for success.

  19. Crafting a Pharmaceutical Distribution Business Plan

    This guide delves into the key components that should be included in a pharmaceutical distribution business plan. 1. Executive Summary: Setting the Stage. The executive summary is a concise yet impactful overview that is the gateway to your pharmaceutical distribution business plan.

  20. (PDF) Pharmaceutical Business Plan

    The sales potential is staggering: the global pharmaceutical market is expected to reach $1.1 trillion by 2015. The pressure to succeed is tremendous. Yet, pharmaceutical innovation is hardly an orderly, predictable process. It follows a technology-push model dependent on a meandering path of scientifi c breakthroughs with uneven timing and ...

  21. PDF Sadc Pharmaceutical Business Plan 2007-2013

    pharmaceutical products including African Traditional Medicines that are relevant to local health problems. The pharmaceutical programme is one of the priorities under the RISDP. 1.3.3 It is against this background that a Business Plan has been developed in order to operationalize the Programme. The Plan has six main sections which include:

  22. Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement

    HAMILTON, ON and BOSTON, May 31, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as ...

  23. Boston Business News

    The Boston Business Journal features local business news about Boston. We also provide tools to help businesses grow, network and hire.